Professor John Thompson

Professor
Surgery, Central Clinical School

Telephone +61 2 9911 7366
Fax +61 2 9954 9435

Website Related website

Map

Biographical details

Professor John Francis Thompson (JT), AO, MD, FRACS, FACSwas appointed to the Chair of Melanoma and Surgical Oncology of the University of Sydney, based at the Royal Prince Alfred Hospital, in 1999. He is author of over 600 peer-reviewed articles in the scientific literature, as well as many review articles and book chapters, and holds positions on the editorial boards of several international journals.

JT is Executive Director of Melanoma Institute Australia,widely regarded as the world’s premier dedicated melanoma treatment and research centre. Around 30% of the newly diagnosed melanoma patients in NSW each year are seen and treated at the Institute. The Institute sees over 12,000 outpatients per year and treats over 1,300 new melanoma patients each year. Since its inception in the mid 1960s, the Institute has maintained a prospective research database, and the current international staging system for melanoma was developed by the American Joint Committee on Cancer drawing heavily on this database (over 17,000 MIA patients with long-term follow up, of a total of 30,000 patients incorporated in the (AJCC database). JT is a member of the AJCC melanoma staging task force which is engaged in a revision of the international AJCC staging system.

As a clinical academic of the University of Sydney, JT has various responsibilities in addition to his duties as Executive Director of the Melanoma Institute Australia. He is a former Academic and Research Director of the Melanoma Foundation of the University of Sydney, and is Head of the Melanoma and Surgical Oncology Department at the Royal Prince Alfred Hospital. He is actively involved in clinical activities, and also in teaching and curriculum development for medical undergraduates, hospital residents and surgical trainees through the Discipline of Surgery of the University of Sydney.

In 2014, JT was made an Officer of the Order of Australia “For distinguished service to medicine in the field of oncology research, particularly melanoma, to international and national professional organisations, and to medical education.”

Research interests

Pioneered the novel technique of isolated limb infusion with cytotoxic agents for melanoma, a simpler, less costly form of treatment than conventional isolated limb perfusion, but one that is equally effective. (Thompson JF et al. Isolated limb infusion with melphalan for recurrent limb melanoma: a simple alternative to isolated limb perfusion. Regional Cancer Treatment 1994;7:188-192). Trained others in Australia and internationally in the ILI technique. It is now used regularly throughout Australia, as well as in major North American melanoma treatment centres, the UK, continental Europe and South America.

Contributions to the development of lymphatic mapping and the sentinel node biopsy technique in the management of patients with melanoma. These studies have led to “routine” radical lymph node dissections, with their associated short-term and long-term morbidity being abandoned. (Thompson JF. Ann Surg Oncol, 2001; 8:44S-47S). The development of preoperative lymphoscintigraphy for SNB shed important new light on cutaneous lymphatic drainage pathways (Thompson JF, et al. The location of sentinel lymph nodes in cutaneous melanoma: new insights into lymphatic anatomy. J Am Coll Surg 1999; 189:195-206).

Contributions to the analysis and reporting of international data for the 6th and 7th editions of the American Joint Committee on Cancer (AJCC) staging system for cutaneous melanoma. Both analyses relied heavily on data obtained from Melanoma Institute Australia database. (Balch et al, Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 2001, 19:3635-3648; and Balch CM et al Final version of 2009 AJCC melanoma staging classification. J Clin Oncol 2009; 27:6199-6206.)

Involved in the development of an online electronic prediction tool for melanoma prognosis as a member of the AJCC Melanoma Staging Taskforce (www.melanomaprognosis.org, Soong et al ASO 2010).

Teaching and supervision

JT has successfully supervised 6 PhD students and been a thesis examiner for another 3 international PhD candidates. He has trained and mentored numerous researchers and surgical oncology fellows who have subsequently made a strong contribution to the field, including Marc Moncrieff and Howard Peach who are now leaders in the field of melanoma management, clinical trials and guidelines development in the UK, and Hidde Kroon, who is making important contributions in the Netherlands. He also trained and mentored Richard Martin who is now the Chairman of the National Melanoma Tumour Stream in New Zealand.

Associations

Since 1998, JT has been a member of the American Joint Committee on Cancer’s Melanoma Staging Committee, which has produced the last two melanoma staging systems (Balch JCO 2001, Balch JCO 2009). These are used by clinicians and researchers all over the world to stage patients. JT was Chairman of the Working Party which created the NHMRC-endorsed Clinical Practice Guidelines for the Management of Cutaneous Melanoma in Australia and New Zealand, which were published in 2008. He is now Chairman of a Working Group to update these guidelines. From 2002 to 2013, JT was the Chairman of the Australia and New Zealand Melanoma Trials Group, which coordinates and conducts quality research for melanoma control with researchers and health care professionals, support networks and consumers. From 2006 to 2008, he was the President of the International Sentinel Node Society, a global organisation to serve and coordinate the needs of the diverse community of scientists and physicians who study the sentinel node. He is a Taskforce Member of the UICC TNM Expert Panel (Skin) and a member of the Cochrane Skin Group on surgical excision margins for melanoma, which produced the 2009 review (Sladden et al 2009). Since 2010 he has been a member of the Editorial Board of Journal of Clinical Oncology; and Associate Editor of Annals of Surgical Oncology, Journal of Surgical Oncology (until 2013), ANZ Journal of Surgery and European Journal of Surgical Oncology (1999-2010). He has been appointed as Senior Editor of Melanoma Management (inaugural issue soon to be published).

Awards and honours

Since 2010 he has been invited to speak at 22 international meetings. Since 2010, he has been a visiting professor on a number of occasions, including to give the William Coon Lecture in Surgical Oncology at the University of Michigan in 2011; the Inaugural Visiting Scholar Lecture at Penn State Hershey Melanoma Center in 2011; and Visiting Professor at the MD Anderson Cancer Center in 2013. He was made an Officer in the Order of Australia (AO), Australia Day, 2014, “for distinguished service to medicine in the field of oncology research, particularly melanoma, to national and international professional organisations, and to medical education.” He received the Premier’s Award for Outstanding Cancer Research, Cancer Institute NSW Annual Awards, Sydney, August 2013. He was part of the group which received the 2009 Premier's Award for Excellence in Translational Research: Sydney Melanoma Unit.

Selected grants

2014

  • ANZMTG 03.12 Melanoma Margins Trial - A Phase Ill, Multi-centre Randomised Controlled Trial Investigating 1 cm v 2cm Wide Excision Margins for Primary Cutaneous Melanoma (MeiMarT); Henderson M, Coventry B, Spillane A, Neuhaus S, Smithers B, Moncrieff M, Thompson J; Cancer Council New South Wales/Research Project Grants.

2013

  • ANZMTG - Support for Cancer Clinical Trials; Thompson J; Cancer Australia/Support for Cancer Clinical Trials Program - National Cancer Cooperative Trials Groups.
  • 2013 Premiers Award for Outstanding Cancer Researcher of the Year; Thompson J; Cancer Institute New South Wales/Premier's Award.

2012

  • Melanoma Institute Australia (MIA) Clinical Trials Program; Thompson J; Cancer Institute New South Wales/Clinical Trials Infrastructure Grants.

2011

  • Development of a Quality of Life Module specific to Melanoma; Winstanley J, Bergenmar M, Bottomley A, Garioch J, Constantine A, Koller M, van de Poll-Franse L, Steinbauer J, Boyle F, Thompson J, King M; European Organisation for Research and Treatment of Cancer (EORTC)/Research Support.
  • Whole Brain Radiotherapy following local treatment of intracranial metastases of melanoma - a randomised phase III trial; Fogarty G, Burmeister B, Drummond K, Thompson J, Hong A; Cancer Australia/Priority Driven Collaborative Cancer Research Scheme.
  • Melanoma Institute Australia Translational Research Program; Mann G, Thompson J, Kefford R, Menzies S, Scolyer R, Christopherson R, Rizos H, Spillane A, Zhang X, Hersey P; Cancer Institute New South Wales/Translational Program Grant.
  • Molecular determinants of risk, progression and treatment response in melanoma; Hayward N, Hersey P, Kefford R, Thompson J, Hersey P, Mann G, Scolyer R; National Health and Medical Research Council (NHMRC)/Program Grants.

2010

  • Australia and NewZealand Melanoma Trials Group (ANZMTG); Thompson J; Cancer Australia/Support for Cancer Clinical Trials - Existing National Cooperative Oncology groups.
  • Unraveling of Inter-Institutional Prognostic Heterogeneity in Stage IV Melanoma; Thompson J, Gershenwald J; DVC Research/International Visiting Research Fellowship (IVRF).

2009

  • Clinical trials nurse and data manager; Thompson J; Cancer Institute New South Wales/Cancer Trial Nurse and Data Manager Grants.
  • Employment of clinical trials nurse or data manager; Thompson J; Cancer Institute New South Wales/Cancer Trial Nurse and Data Manager Grants.
  • Top-up funding: Melanoma Institute; Thompson J; Cancer Institute New South Wales/Cancer Trial Nurse and Data Manager Grants.
  • Improving Quality of Life measurement for melanoma patients: Validity and reliability study of QoL instruments in a NSW population; Winstanley J, King M, Thompson J; DVC Research/Cancer Research Fund.

2008

  • Grant Prog 06-RLP-1-02 .; Thompson J; Cancer Institute New South Wales/Research Support.
  • tba; Thompson J; John Wayne Cancer Institute (USA)/Research Support.

2006

  • Sydney Melanoma Unit Translational Research Program; Mann G, Thompson J, Kefford R, Scolyer R, Menzies S, Hersey P, Christopherson R; Cancer Institute New South Wales/Translational Research Program Grant.
  • Strengthen Cancer Care initiative - Infrastructure Support for Clinical Trials Program; Thompson J, Morton R; Cancer Australia/Support for Cancer Clinical Trials - Existing National Cooperative Oncology groups.
  • Cancer Institute NSW - Research Grants Program; Thompson J; Cancer Institute New South Wales/Research Grants.
  • Molecular determinants of melanoma risk, progression and response to treatment; Kefford R, Thompson J, Hersey P, Mann G, Scolyer R; National Health and Medical Research Council (NHMRC)/Program Grants.

2005

  • Lymphoedema following axillary and groin sentinal node biopsy; Saw R, Thompson J; Cancer Council New South Wales/Research Project Grants.

2003

  • Not known; Thompson J; University of Sydney/Cancer Research Fund.

Selected publications

Download citations: PDF RTF Endnote

Edited Books

  • Thompson, J., Fredericks, S., Taguchi, T., Sugarbaker, P., Picksley, S., Khayat, D., Hortobagyi, G., Allen-Mersh, T., Aigner, K. (2009). Basics of Oncology. Germany: Springer-Verlag.
  • Scolyer, R., Li, L., McCarthy, S., Shaw, H., Stretch, J., Sharma, R., Thompson, J. (2005). Micromorphometric features of positive sentinel nodes predict involvement of non-sentinel nodes in patients. United States: Mosby.
  • Thompson, J., Morton, D., Kroon, B. (2004). Textbook of Melanoma. London: Martin Dunitz.

Book Chapters

  • Schatton, T., Scolyer, R., Thompson, J., Mihm Jnr, M. (2014). Tumor-infiltrating lymphocytes and their significance in melanoma prognosis. In Magdalena Thurim, Francesco M. Marincola (Eds.), Molecular Diagnostics for Melanoma: Methods and Protocols, (pp. 287-324). New York: Humana Press. [More Information]
  • Thompson, J., Morton, D., Balch, C., Ross, M. (2010). Surgical excision of distant melanoma metastases. In Balch C; Houghton A; Sober A; Soong S; Atkins M; Thompson J (Eds.), Cutaneous Melanoma, (pp. 603-627). United States: Quality Medical Publishing.
  • Thompson, J., Shaw, H., Sober, A. (2009). A history of melanoma: From Hunter to Milton. In Balch C; Houghton A; Sober A; Soong S; Atkins M; Thompson J (Eds.), Cutaneous Melanoma, (pp. 1-14). United States: Quality Medical Publishing.
  • McMasters, K., Wong, S., Tyler, D., Balch, C., Thompson, J. (2009). Axillary and epitrochlear lymph node dissection for melanoma. In Balch C; Houghton A; Sober A; Soong S; Atkins M; Thompson J (Eds.), Cutaneous Melanoma, (pp. 447-455). United States: Quality Medical Publishing.
  • Gershenwald, J., Thompson, J., Mozzillo, N., Balch, C. (2009). Intraoperative mapping and sentinel node technology in patients with melanoma. In Balch C; Houghton A; Sober A; Soong S; Atkins M; Thompson J (Eds.), Cutaneous Melanoma, (pp. 411-420). United States: Quality Medical Publishing.
  • Thompson, J., Kroon, H., Ross, M., Kam, P., Tyler, D., Beasley, G. (2009). Isolated limb intrusion for melanoma. In Balch C; Houghton A; Sober A; Soong S; Atkins M; Thompson J (Eds.), Cutaneous Melanoma, (pp. 541-560). United States: Quality Medical Publishing.
  • Uren, R., Thompson, J., Coventry, B., Chatterton, B. (2009). Lymphoscintigraphy in patients with melanoma. In Balch C; Houghton A; Sober A; Soong S; Atkins M; Thompson J (Eds.), Cutaneous Melanoma, (pp. 387-413). United States: Quality Medical Publishing.
  • Gershenwald, J., Balch, C., Soong, S., Thompson, J. (2009). Prognostic Factors and Natural History of Melanoma. In Balch Houghton, Sober, Soong (Eds.), Cutaneous Melanoma, (pp. 35-64). Missouri: Quality Medical Publishing.
  • Morton, D., Cochran, A., Thompson, J., Sondak, V. (2009). The sentinel lymph node and regional melanoma micrometastases. In Balch C; Houghton A; Sober A; Soong S; Atkins M; Thompson J (Eds.), Cutaneous Melanoma, (pp. 373-386). United States: Quality Medical Publishing.
  • Thompson, J., Mohacsi, P. (2008). Cancer in dialysis and renal transplant patients. In Morris P; Knechtle S (Eds.), Kidney Transplantation: Principles and Practice, (pp. 564-577). United States: Saunders Elsevier.
  • Thompson, J., Gershenwald, J., Uren, R., Mariani, G. (2008). Sentinel lymph node biopsy in cutaneous melanoma. In G. Marian, A. Giuliano & H. W. Strauss (Eds.), Radioguided Surgery, (pp. 92-110). United States of America: Springer.
  • Lui, R., Brown, A., Wu, B., Lin, M., Thompson, J., Braet, F., Dyer, W., Lattimore, J., Macdonald, P., Adelstein, S., Dos Remedios, C. (2008). Use of Antibody Microarrays in the Analysis of Inflammation, Autoimmunity, Viral Infection, and Cancer Metastases. In J. E. Van Eyk and M. J. Dunn (Eds.), Clinical Proteomics: From Diagnosis to Therapy, (pp. 571-592). Weinheim: Wiley - V C H Verlag GmbH & Co. KGaA.
  • de Vries, E., Bray, F., Coebergh, J., Cerroni, L., RUITER, D., Elder, D., Thompson, J., Barnhill, R., van Muijen, G., Scolyer, R., et al (2006). Malignant melanoma: Introduction. In LeBoit P; Burg G; Weedon D; Sarasin A (Eds.), Pathology and Genetics of Skin Tumours, (pp. 52-65). Lyon: IARC Press.
  • Thompson, J., Bishop, J., Scolyer, R. (2006). Primary melanoma of the lung. In Derek Raghavan, Martin L Brecher and David H Johnson etal (Eds.), Textbook of Uncommon Cancer, (pp. 293-297). United States: John Wiley & Sons.
  • Thompson, J., Shaw, H. (2004). Cutaneous Melanoma In Childhood: Incidence And Prognosis. In John F Thompson, Donald L Morton, Bin BR Kroon (Eds.), Textbook of Melanoma, (pp. 379-386). London: Martin Dunitz.
  • Thompson, J., Morton, D. (2004). Surgical Treatment of Systemic Metastases: Rationale And Principles. In John F Thompson, Donald L Morton, Bin BR Kroon (Eds.), Textbook of Melanoma, (pp. 492-494). London: Martin Dunitz.
  • Reintgen, D., Thompson, J., Gershenwald, J. (2003). Intraoperative mapping and sentinel node technology. In Balch Houghton, Sober, Soong (Eds.), Cutaneous Melanoma, (pp. 353-377). Missouri: Quality Medical Publishing.
  • Thompson, J., Kam, P., Lindner, P., de Wilt, J. (2003). Isolated limb infusion. In Balch Houghton, Sober, Soong (Eds.), Cutaneous Melanoma, (pp. 495-506). Missouri: Quality Medical Publishing.
  • Thompson, J., Uren, R., Coventry, B., Chatterton, B. (2003). Lymphoscintigraphy. In Balch Houghton, Sober, Soong (Eds.), Cutaneous Melanoma, (pp. 329-352). Missouri: Quality Medical Publishing.
  • Gershenwald, J., Balch, C., Soong, S., Thompson, J. (2003). Prognostic factors and natural history. In Balch Houghton, Sober, Soong (Eds.), Cutaneous Melanoma, (pp. 25-54). Missouri: Quality Medical Publishing.
  • Thompson, J., Balch, C., Soong, S., Buzaid, A. (2002). Prognostic Factors and Staging of Melanoma. In DeVita VT, Hellman S, Rosenberg SA, Jones (Eds.), Progress in Oncology 2002, (pp. 215-250). Massachusetts, USA: Staempfli Publishers Ltd.
  • Thompson, J. (2002). The dye-plus-isotope technique. In Hiram S Cody III (Eds.), Sentinel Lymph Node Biopsy, (pp. 113-120). London, United Kingdom: Staempfli Publishers Ltd.

Journals

  • Rizos, H., Menzies, A., Pupo, G., Carlino, M., Fung, C., Hyman, J., Haydu, L., Mijatov, B., Becker, T., Boyd, S., Howle, J., Saw, R., Thompson, J., Kefford, R., Scolyer, R., Long, G. (2014). BRAF inhibitor resistance mechanisms in metastatic melanoma: spectrum and clinical impact. Clinical Cancer Research, 20(7), 1965-1977. [More Information]
  • Suttie, C., Hruby, G., Horvath, L., Thompson, J. (2014). Cardiac metastasis in Merkel cell carcinoma. Journal of Clinical Oncology, 32(13), e52-e53. [More Information]
  • Wilmott, J., Haydu, L., Menzies, A., Lum, T., Hyman, J., Thompson, J., Hersey, P., Kefford, R., Scolyer, R., Long, G. (2014). Dynamics of chemokine, cytokine, and growth factor serum levels in BRAF-mutant melanoma patients during BRAF inhibitor treatment. Journal of Immunology, 192(5), 2505-2513. [More Information]
  • Marzese, D., Scolyer, R., Huynh, J., Huang, S., Hirose, H., Chong, K., Kiyohara, E., Wang, J., Kawas, N., Donovan, N., Buckland, M., Thompson, J., et al (2014). Epigenome-wide DNA methylation landscape of melanoma progression to brain metastasis reveals aberrations on homeobox D cluster associated with prognosis. Human Molecular Genetics, 23(1), 226-238. [More Information]
  • Griewank, K., Scolyer, R., Thompson, J., Flaherty, K., Schadendorf, D., Murali, R. (2014). Genetic Alterations and Personalized Medicine in Melanoma: Progress and Future Prospects. National Cancer Institute. Journal, 106(2), 1-17. [More Information]
  • Zimmer, L., Haydu, L., Menzies, A., Scolyer, R., Kefford, R., Thompson, J., Schadendorf, D., Long, G. (2014). Incidence of New Primary Melanomas After Diagnosis of Stage III and IV Melanoma. Journal of Clinical Oncology, 32(8), 816-823. [More Information]
  • Menzies, A., Lum, T., Wilmott, J., Hyman, J., Kefford, R., Thompson, J., O'Toole, S., Long, G., Scolyer, R. (2014). Intrapatient Homogeneity of BRAFV600E Expression in Melanoma. The American Journal of Surgical Pathology, 38(3), 377-382. [More Information]
  • Kroon, H., Huismans, A., Kam, P., Thompson, J. (2014). Isolated limb infusion with melphalan and actinomycin D for melanoma: A systematic review. Journal of Surgical Oncology, 109(4), 348-351. [More Information]
  • Kroon, H., Huismans, A., Waugh, R., Kam, P., Thompson, J. (2014). Isolated limb infusion: Technical aspects. Journal of Surgical Oncology, 109(4), 352-356. [More Information]
  • Thompson, J. (2014). Local and regional therapies for melanoma: many arrows in the quiver. Journal of Surgical Oncology, 109(4). [More Information]
  • van der Ploeg, A., Haydu, L., Spillane, A., Quinn, M., Saw, R., Shannon, K., Stretch, J., Uren, R., Scolyer, R., Thompson, J. (2014). Outcome Following Sentinel Node Biopsy Plus Wide Local Excision Versus Wide Local Excision Only for Primary Cutaneous Melanoma: Analysis of 5840 Patients Treated at a Single Institution. Annals of Surgery, 260(1), 149-157. [More Information]
  • Niebling, M., Haydu, L., Karim, R., Thompson, J., Scolyer, R. (2014). Pathology Review Significantly Affects Diagnosis and Treatment of Melanoma Patients: An Analysis of 5011 Patients Treated at a Melanoma Treatment Center. Annals of Surgical Oncology, 21(7), 2245-2251. [More Information]
  • Spillane, A., Pasquali, S., Haydu, L., Thompson, J. (2014). Patterns of Recurrence and Survival After Lymphadenectomy in Melanoma Patients: Clarifying the Effects of Timing of Surgery and Lymph Node Tumor Burden. Annals of Surgical Oncology, 21(1), 292-299. [More Information]
  • Song, E., Scolyer, R., Damian, D., Thompson, J. (2014). Primary oesophageal melanoma - a case report. World Journal of Surgical Oncology, 12(1), 77-77. [More Information]
  • Shashank, A., Shehata, M., Morris, D., Thompson, J. (2014). Radiofrequency ablation in metastatic melanoma. Journal of Surgical Oncology, 109(4), 366-369. [More Information]
  • Howman-Giles, R., Uren, R., Thompson, J. (2014). Sentinel Lymph Node Biopsy in Pediatric and Adolescent Patients: A Proven Technique. Annals of Surgery, 259(6), e86-e86. [More Information]
  • Naehrig, D., Uren, R., Emmett, L., Ioannou, K., Hong, A., Wratten, C., Thompson, J., Hruby, G. (2014). Sentinel lymph node mapping for defining site and extent of elective radiotherapy management of regional nodes in Merkel cell carcinoma: a pilot case series. Journal of Medical Imaging and Radiation Oncology, 58, 353-359. [More Information]
  • Thompson, J., Hruby, G. (2014). The role of sentinel lymph node biopsy in patients with merkel cell carcinoma: uncertainty prevails. Annals of Surgical Oncology, 21(5), 1517-1519. [More Information]
  • Damian, D., Saw, R., Thompson, J. (2014). Topical Immunotherapy with Diphencyprone for in Transit and Cutaneously Metastatic Melanoma. Journal of Surgical Oncology, 109(4), 308-313. [More Information]
  • Balch, C., Soong, S., Gershenwald, J., Thompson, J., Coit, D., Atkins, M., Ding, S., Cochran, A., Eggermont, A., Flaherty, K., et al (2013). Age as a Prognostic Factor in Patients with Localized Melanoma and Regional Metastases. Annals of Surgical Oncology, 20(12), 3961-3968. [More Information]
  • Wevers, K., Murali, R., Bastiaannet, E., Scolyer, R., Suurmeijer, A., Thompson, J., Hoekstra, H. (2013). Assessment of a new scoring system for predicting non-sentinel node positivity in sentinel node-positive melanoma patients. European Journal of Surgical Oncology, 39(2), 179-184. [More Information]
  • Murali, R., Wilmott, J., Jakrot, V., Al-Ahmadie, H., Wiesner, T., McCarthy, S., Thompson, J., Scolyer, R. (2013). BAP1 expression in cutaneous melanoma: a pilot study. Pathology, 45(6), 606-609. [More Information]
  • Scolyer, R., Thompson, J. (2013). Biospecimen banking: The pathway to personalized medicine for patients with cancer. Journal of Surgical Oncology, 107(7), 681-682. [More Information]
  • Mann, G., Pupo, G., Campain, A., Carter, C., Schramm, S., Pianova, S., Gerega, S., Desilva, C., Lai, K., Wilmott, J., Hersey, P., Kefford, R., Thompson, J., Yang, J., Scolyer, R., et al (2013). BRAF Mutation, NRAS Mutation, and the Absence of an Immune-Related Expressed Gene Profile Predict Poor Outcome in Patients with Stage III Melanoma. The Journal of Investigative Dermatology, 133(2), 509-517. [More Information]
  • Wilmott, J., Menzies, A., Haydu, L., Capper, D., Preusser, M., Zhang, Y., Thompson, J., Kefford, R., von Diemling, A., Scolyer, R., Long, G. (2013). BRAF(V600E) protein expression and outcome from BRAF inhibitor treatment in BRAF(V600E) metastatic melanoma. British Journal of Cancer, 108(4), 924-931. [More Information]
  • Mar, V., Wong, S., Li, J., Scolyer, R., McLean, C., Papenfuss, A., Tothill, R., Kakavand, H., Mann, G., Thompson, J., et al (2013). BRAF/NRAS Wild-Type Melanomas Have a High Mutation Load Correlating with Histologic and Molecular Signatures of UV Damage. Clinical Cancer Research, 19(17), 4589-4598. [More Information]
  • Murali, R., Scolyer, R., Thompson, J. (2013). Completion lymph node dissection in melanoma patients with positive sentinel lymph nodes. European Journal of Surgical Oncology, 39(10), 1164-1165. [More Information]
  • Shiau, C., Thompson, J., Scolyer, R. (2013). Controversies and evolving concepts in the diagnosis, classification and management of lentigo maligna. Expert Review of Dermatology, 8(2), 195-214. [More Information]
  • Scolyer, R., Judge, M., Evans, A., Frishberg, D., Prieto, V., Thompson, J., Trotter, M., Walsh, M., Walsh, N., Ellis, D. (2013). Data set for pathology reporting of cutaneous invasive melanoma: Recommendations from the international collaboration on cancer reporting (ICCR). The American Journal of Surgical Pathology, 37(12), 1797-1814. [More Information]
  • Scolyer, R., Karim, R., Thompson, J., Stretch, J., McCarthy, S., Murali, R. (2013). Digital papillary adenocarcinoma: a tumour that should be considered in the differential diagnosis of neoplasms involving the digits. Pathology, 45(1), 55-61. [More Information]
  • Long, G., Wilmott, J., Haydu, L., Tembe, V., Sharma, R., Rizos, H., Thompson, J., Howle, J., Scolyer, R., Kefford, R. (2013). Effects of BRAF inhibitors on human melanoma tissue before treatment, early during treatment and on progression. Pigment Cell and Melanoma Research, 26(4), 499-508. [More Information]
  • Sondak, V., Wong, S., Gershenwald, J., Thompson, J. (2013). Evidence-Based Clinical Practice Guidelines on the Use of Sentinel Lymph Node Biopsy in Melanoma. American Society of Clinical Oncology Educational Book, 2013, 320-325. [More Information]
  • Rychetnik, L., McCaffery, K., Morton, R., Thompson, J., Menzies, S., Irwig, L. (2013). Follow-Up of Early Stage Melanoma: Specialist Clinician Perspectives on the Functions of Follow-Up and Implications for Extending Follow-Up Intervals. Journal of Surgical Oncology, 107(5), 463-468. [More Information]
  • Kakavand, H., Scolyer, R., Thompson, J., Mann, G. (2013). Identification of new prognostic biomarkers for Stage III metastatic melanoma patients. OncoImmunology, 2(9), e25564-1-e25564-3. [More Information]
  • Long, G., Wilmott, J., Capper, D., Preusser, M., Zhang, Y., Thompson, J., Kefford, R., von Deimling, A., Scolyer, R. (2013). Immunohistochemistry Is Highly Sensitive and Specific for the Detection of V600E BRAF Mutation in Melanoma. The American Journal of Surgical Pathology, 37(1), 61-65. [More Information]
  • Ryu, S., Robyn, S., Scolyer, R., Crawford, M., Thompson, J., Sandroussi, C. (2013). Liver resection for metastatic melanoma: Equivalent survival for cutaneous and ocular primaries. Journal of Surgical Oncology, 108(2), 129-135. [More Information]
  • Pasquali, S., van der Ploeg, A., Mocellin, S., Stretch, J., Thompson, J., Scolyer, R. (2013). Lymphatic biomarkers in primary melanomas as predictors of regional lymph node metastasis and patient outcomes. Pigment Cell and Melanoma Research, 26(3), 326-337. [More Information]
  • Harish, V., Bond, J., Scolyer, R., Haydu, L., Saw, R., Quinn, M., Benger, R., Uren, R., Stretch, J., Shannon, K., Thompson, J. (2013). Margins of excision and prognostic factors for cutaneous eyelid melanomas. Journal of Plastic, Reconstructive and Aesthetic Surgery, 66(8), 1066-1073. [More Information]
  • Thompson, J., Menzies, A. (2013). Melanoma. Cancer Forum, 37(1), 65-66.
  • Dutton-Regester, K., Kakavand, H., Aoude, L., Stark, M., Gartside, M., Johansson, P., O'Connor, L., Lanagan, C., Tembe, V., Pupo, G., Haydu, L., Mann, G., Thompson, J., Scolyer, R., et al (2013). Melanomas of unknown primary have a mutation profile consistent with cutaneous sun-exposed melanoma. Pigment Cell and Melanoma Research, 26(6), 852-860. [More Information]
  • Scolyer, R., Thompson, J. (2013). Mitotic rate in melanoma should be recorded as the number of mitoses per mm(2) (not per high power field): surgeons tell your pathologists!. The American Journal Of Surgery, 206(1), 142-143. [More Information]
  • Morton, R., Rychetnik, L., McCaffery, K., Thompson, J., Irwig, L. (2013). Patients' perspectives of long-term follow-up for localised cutaneous melanoma. European Journal of Surgical Oncology, 39, 297-303. [More Information]
  • Niebling, M., Haydu, L., Karim, R., Thompson, J., Scolyer, R. (2013). Reproducibility of AJCC Staging Parameters in Primary Cutaneous Melanoma: An Analysis of 4,924 Cases. Annals of Surgical Oncology, 20(12), 3969-3975. [More Information]
  • Winstanley, J., Saw, R., Boyle, F., Thompson, J. (2013). The FACT-Melanoma Quality-of-Life Instrument: comparison of a five-point and four-point response scale using the Rasch measurement model. Melanoma Research, 23(1), 61-69. [More Information]
  • Pasquali, S., Haydu, L., Scolyer, R., Winstanley, J., Spillane, A., Quinn, M., Saw, R., Shannon, K., Stretch, J., Thompson, J. (2013). The Importance of Adequate Primary Tumor Excision Margins and Sentinel Node Biopsy in Achieving Optimal Locoregional Control for Patients With Thick Primary Melanomas. Annals of Surgery, 258(1), 152-157. [More Information]
  • Hruby, G., Scolyer, R., Thompson, J. (2013). The important role of radiation treatment in the management of Merkel cell carcinoma. British Journal of Dermatology, 169(5), 975-982. [More Information]
  • Peach, H., van der Ploeg, A., Haydu, L., Stretch, J., Shannon, K., Uren, R., Thompson, J. (2013). The Unpredictability of Lymphatic Drainage from the Ear in Melanoma Patients, and Its Implications for Management. Annals of Surgical Oncology, 20(5), 1707-1713. [More Information]
  • Winstanley, J., White, E., Boyle, F., Thompson, J. (2013). What are the pertinent quality-of-life issues for melanoma cancer patients? Aiming for the development of a new module to accompany the EORTC core questionnaire. Melanoma Research, 23(2), 167-174. [More Information]
  • Huynh, K., Takei, Y., Scolyer, R., Murali, R., Chong, K., Takeshima, L., Sim, M., Morton, D., Turner, R., Thompson, J., et al (2012). Aberrant hypermethylation in primary tumours and sentinel lymph node metastases in paediatric patients with cutaneous melanoma. British Journal of Dermatology, 166(6), 1319-1326. [More Information]
  • Tran, S., Haferkamp, S., Scurr, L., Gowrishankar, K., Becker, T., Desilva, C., Thompson, J., Scolyer, R., Kefford, R., Rizos, H. (2012). Absence of Distinguishing Senescence Traits in Human Melanocytic Nevi. The Journal of Investigative Dermatology, 132(9), 2226-2234. [More Information]
  • Burmeister, B., Henderson, M., Thompson, J. (2012). Adjuvant nodal irradiation in melanoma- Authors' reply. Lancet Oncology, 13(8), e327-e327.
  • Burmeister, B., Henderson, M., Ainslie, J., Fisher, R., Dilulio, J., Smithers, B., Hong, A., Shannon, K., Scolyer, R., Carruthers, S., Thompson, J., et al (2012). Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial. The Lancet Oncology, 13(6), 589-597. [More Information]
  • Wilmott, J., Haydu, L., Bagot, M., Zhang, Y., Jakrot, V., McCarthy, S., Lugassy, C., Thompson, J., Scolyer, R., Jakrot, V., et al (2012). Angiotropism is an independent predictor of microscopic satellites in primary cutaneous melanoma. Histopathology, 61(5), 889-898. [More Information]
  • Hoshimoto, S., Faries, M., Morton, D., Shingai, T., Kuo, C., Wang, H., Elashoff, R., Mozzillo, N., Kelley, M., Thompson, J., et al (2012). Assessment of Prognostic Circulating Tumor Cells in a Phase III Trial of Adjuvant Immunotherapy After Complete Resection of Stage IV Melanoma. Annals of Surgery, 255(2), 357-362. [More Information]
  • Murali, R., Scolyer, R., Thompson, J. (2012). Can we better identify thin cutaneous melanomas that are likely to metastasize and cause death? Annals of Surgical Oncology, 19(11), 3310-3312. [More Information]
  • Kim, J., McCarthy, S., Thompson, J., Pupo, G., Vonthethoff, L., Nash, P., Mann, G., Scolyer, R. (2012). Cellular blue naevus involving the urinary bladder. Pathology, 44(7), 664-668. [More Information]
  • Murali, R., Haydu, L., Long, G., Quinn, M., Saw, R., Shannon, K., Spillane, A., Stretch, J., Kefford, R., Thompson, J., Scolyer, R. (2012). Clinical and Pathologic Factors Associated with Distant Metastasis and Survival in Patients with Thin Primary Cutaneous Melanoma. Annals of Surgical Oncology, 19(6), 1782-1789. [More Information]
  • Bastiaannet, E., Uyl-de Groot, C., Brouwers, A., van der Jagt, E., Hoekstra, O., Oyen, W., Verzijlbergen, F., van Ooijen, B., Thompson, J., Hoekstra, H. (2012). Cost-effectiveness of adding FDG-PET or CT to the diagnostic work-up of patients with stage III melanoma. Annals of Surgery, 255(4), 771-776. [More Information]
  • Sundaresan, P., Hruby, G., Hamilton, A., Hong, A., Boyer, M., Chatfield, M., Thompson, J. (2012). Definitive Radiotherapy or Chemoradiotherapy in the Treatment of Merkel Cell Carcinoma. Clinical Oncology, 24(9), e131-e136. [More Information]
  • Menzies, A., Haydu, L., Visintin, L., Carlino, M., Howle, J., Thompson, J., Kefford, R., Scolyer, R., Long, G. (2012). Distinguishing Clinicopathologic Features of Patients with V600E and V600K BRAF-Mutant Metastatic Melanoma. Clinical Cancer Research, 18(12), 3242-3249. [More Information]
  • Spillane, A., Haydu, L., Lee, N., Uren, R., Stretch, J., Shannon, K., Quinn, M., Saw, R., McCarthy, W., Thompson, J. (2012). Evaluation of Incomplete Sentinel Node Biopsy Procedures and Sentinel Node Positivity Rates as Surgical Quality-Assurance Parameters in Melanoma Patients. Annals of Surgical Oncology, 19(12), 3919-3925. [More Information]
  • Lim, C., Whalley, D., Haydu, L., Murali, R., Tippett, J., Thompson, J., Hruby, G., Scolyer, R. (2012). Increasing Tumor Thickness is Associated with Recurrence and Poorer Survival in Patients with Merkel Cell Carcinoma. Annals of Surgical Oncology, 19(11), 3325-3334. [More Information]
  • Wilmott, J., Tembe, V., Howle, J., Sharma, R., Thompson, J., Rizos, H., Lo, R., Kefford, R., Scolyer, R., Long, G. (2012). Intratumoral Molecular Heterogeneity in a BRAF-Mutant, BRAF Inhibitor-Resistant Melanoma: A Case Illustrating the Challenges for Personalized Medicine. Molecular Cancer Therapeutics, 11(12), 2704-2708. [More Information]
  • Huismans, A., Kroon, H., Haydu, L., Kam, P., Thompson, J. (2012). Is Melphalan Dose Adjustment According to Ideal Body Weight Useful in Isolated Limb Infusion for Melanoma? Annals of Surgical Oncology, 19(9), 3050-3056. [More Information]
  • Lian, C., Xu, Y., Ceol, C., Wu, F., Larson, A., Dresser, K., Xu, W., Tan, L., Hu, Y., Zhan, Q., Scolyer, R., Thompson, J., Kakavand, H., et al (2012). Loss of 5-Hydroxymethylcytosine Is an Epigenetic Hallmark of Melanoma. Cell, 150(6), 1135-1146. [More Information]
  • Shayan, R., Karnezis, T., Murali, R., Wilmott, J., Ashton, M., Taylor, G., Thompson, J., Hersey, P., Achen, M., Scolyer, R., et al (2012). Lymphatic vessel density in primary melanomas predicts sentinel lymph node status and risk of metastasis. Histopathology, 61(4), 702-710. [More Information]
  • Thompson, J., Scolyer, R., Kefford, R. (2012). Melanoma: A management guide for GPs. Australian Family Physician, 41(7), 470-473. [More Information]
  • Howard, J., Thompson, J., Mozzillo, N., Nieweg, O., Hoekstra, H., Roses, D., Sondak, V., Reintgen, D., Kashani-Sabet, M., Karakousis, C., et al (2012). Metastasectomy for Distant Metastatic Melanoma: Analysis of Data from the First Multicenter Selective Lymphadenectomy Trial (MSLT-I). Annals of Surgical Oncology, 19(8), 2547-2555. [More Information]
  • Murali, R., Brown, P., Kefford, R., Scolyer, R., Thompson, J., Atkins, M., Long, G. (2012). Number of Primary Melanomas Is an Independent Predictor of Survival in Patients With Metastatic Melanoma. Cancer, 118(18), 4519-4529. [More Information]
  • Lim, C., Thompson, J., McKenzie, P., McCarthy, S., Scolyer, R. (2012). Peritoneal melanosis associated with metastatic melanoma involving the omentum. Pathology, 44(3), 255-257. [More Information]
  • in 't Hout, F., Haydu, L., Murali, R., Bonenkamp, J., Thompson, J., Scolyer, R. (2012). Prognostic Importance of the Extent of Ulceration in Patients With Clinically Localized Cutaneous Melanoma. Annals of Surgery, 255(6), 1165-1170. [More Information]
  • Thompson, J., Hong, A., Fogarty, G. (2012). Publication and Interpretation of Clinical Trial Results: The Need for Caution. Annals of Surgical Oncology, 19(6), 1745-1747. [More Information]
  • Wilmott, J., Long, G., Howle, J., Haydu, L., Sharma, R., Thompson, J., Kefford, R., Hersey, P., Scolyer, R. (2012). Selective BRAF inhibitors induce marked T - cell infiltration into human metastatic melanoma. Clinical Cancer Research, 18(5), 1386-1394. [More Information]
  • Murali, R., Haydu, L., Quinn, M., Saw, R., Shannon, K., Spillane, A., Stretch, J., Thompson, J., Scolyer, R. (2012). Sentinel Lymph Node Biopsy in Patients With Thin Primary Cutaneous Melanoma. Annals of Surgery, 255(1), 128-133. [More Information]
  • Murali, R., Desilva, C., McCarthy, S., Thompson, J., Scolyer, R. (2012). Sentinel Lymph Nodes Containing Very Small (<0.1 mm) Deposits of Metastatic Melanoma Cannot Be Safely Regarded as Tumor-Negative. Annals of Surgical Oncology, 19(4), 1089-1099. [More Information]
  • Spillane, A., Thompson, J. (2012). Sentinel node biopsy for breast cancer: then and now. ANZ Journal of Surgery, 82(7/8), 481-483. [More Information]
  • Rychetnik, L., Morton, R., McCaffery, K., Thompson, J., Menzies, S., Irwig, L. (2012). Shared care in the follow-up of early-stage melanoma: a qualitative study of Australian melanoma clinicians' perspectives and models of care. BMC Health Services Research, 12, 1-9. [More Information]
  • Girouard, S., Laga, A., Mihm, M., Scolyer, R., Thompson, J., Zhan, Q., Widlund, H., Lee, C., Murphy, G. (2012). SOX2 contributes to melanoma cell invasion. Laboratory Investigation, 92(3), 362-370. [More Information]
  • Pasquali, S., Spillane, A., de Wilt, J., McCaffery, K., Rossi, C., Quinn, M., Saw, R., Shannon, K., Stretch, J., Thompson, J. (2012). Surgeons' Opinions on Lymphadenectomy in Melanoma Patients with Positive Sentinel Nodes: A Worldwide Web-Based Survey. Annals of Surgical Oncology, 19(13), 4322-4329. [More Information]
  • Chua, T., Scolyer, R., Kennedy, C., Yan, T., McCaughan, B., Thompson, J. (2012). Surgical Management of Melanoma Lung Metastasis: An Analysis of Survival Outcomes in 292 Consecutive Patients. Annals of Surgical Oncology, 19(6), 1774-1781. [More Information]
  • Gershenwald, J., Coit, D., Sondak, V., Thompson, J. (2012). The challenge of defining guidelines for sentinel lymph node biopsy in patients with thin primary cutaneous melanomas. Annals of Surgical Oncology, 19(11), 3301-3303. [More Information]
  • Martin, R., Shannon, K., Quinn, M., Saw, R., Spillane, A., Stretch, J., Colman, M., Gao, K., Thompson, J. (2012). The Management of Cervical Lymph Nodes in Patients with Cutaneous Melanoma. Annals of Surgical Oncology, 19(12), 3926-3932. [More Information]
  • Azimi, F., Scolyer, R., Rumcheva, P., Moncrieff, M., Murali, R., McCarthy, S., Saw, R., Thompson, J. (2012). Tumor-Infiltrating Lymphocyte Grade Is an Independent Predictor of Sentinel Lymph Node Status and Survival in Patients With Cutaneous Melanoma. Journal of Clinical Oncology, 30(21), 2678-2683. [More Information]
  • Svobodova, S., Browning, J., MacGregor, D., Pollara, G., Scolyer, R., Murali, R., Thompson, J., Deb, S., Azad, A., Davis, I., et al (2011). Cancer-testis antigen expression in primary cutaneous melanoma has independent prognostic value comparable to that of Breslow thickness, ulceration and mitotic rate. European Journal of Cancer, 47(3), 460-469. [More Information]
  • Prakoso, E., Fulham, M., Thompson, J., Selby, W. (2011). Capsule endoscopy versus positron emission tomography for detection of small-bowel metastatic melanoma: a pilot study. Gastrointestinal Endoscopy, 73(4), 750-756. [More Information]
  • Murali, R., Zannino, D., Synnott, M., McCarthy, S., Thompson, J., Scolyer, R. (2011). Clinical and Pathological Features of Metastases of Primary Cutaneous Desmoplastic Melanoma. Histopathology, 58(6), 886-895. [More Information]
  • Huismans, A., Kroon, H., Kam, P., Thompson, J. (2011). Does Increased Experience with Isolated Limb Infusion for Advanced Limb Melanoma Influence Outcome? A Comparison of Two Treatment Periods at a Single Institution. Annals of Surgical Oncology, 18(7), 1877-1883. [More Information]
  • Scolyer, R., Long, G., Thompson, J. (2011). Evolving concepts in melanoma classification and their relevance to multidisciplinary melanoma patient care. Molecular Oncology, 5(2), 124-136. [More Information]
  • Murali, R., Desilva, C., Thompson, J., Scolyer, R. (2011). Factors Predicting Recurrence and Survival in Sentinel Lymph Node-Positive Melanoma Patients. Annals of Surgery, 253(6), 1155-1164. [More Information]
  • Uren, R., Howman-Giles, R., Chung, D., Thompson, J. (2011). Guidelines for lymphoscintigraphy and F18 FDG PET scans in Melanoma. Journal of Surgical Oncology, 104(4), 405-419. [More Information]
  • Sanki, A., Kroon, H., Kam, P., Thompson, J. (2011). In brief. Current Problems in Surgery, 48(6), 366-369. [More Information]
  • Sanki, A., Kroon, H., Kam, P., Thompson, J. (2011). Isolated Limb Perfusion and Isolated Limb Infusion for Malignant Lesions of the Extremities. Current Problems in Surgery, 48(6), 371-430. [More Information]
  • Testori, A., Faries, M., Thompson, J., Pennacchioli, E., Deroose, J., Van Geel, A., Verhoef, C., Verrecchia, F., Soteldo, J. (2011). Local and intralesional therapy of in-transit melanoma metastase. Journal of Surgical Oncology, 104(4), 391-396. [More Information]
  • Spillane, A., Cheung, B., Winstanley, J., Thompson, J. (2011). Lymph Node Ratio Provides Prognostic Information in Addition to American Joint Committee on Cancer N Stage in Patients With Melanoma, Even If Quality of Surgery Is Standardized. Annals of Surgery, 253(1), 109-115. [More Information]
  • Schrama, D., Peitsch, W., Zapatka, M., Kneitz, H., Houben, R., Eib, S., Haferkamp, S., Moore, P., Shuda, M., Thompson, J., Scolyer, R., et al (2011). Merkel Cell Polyomavirus Status Is Not Associated with Clinical Course of Merkel Cell Carcinoma. The Journal of Investigative Dermatology, 131(8), 1631-1638. [More Information]
  • Turner, R., Bell, K., Morton, R., Hayen, A., Francken, A., Howard, K., Armstrong, B., Thompson, J., Irwig, L. (2011). Optimizing the Frequency of Follow-Up Visits for Patients Treated for Localized Primary Cutaneous Melanoma. Journal of Clinical Oncology, 29(35), 4641-4646. [More Information]
  • Thompson, J., Ollila, D. (2011). Optimum excision margins for melanoma. The Lancet, 378(9803), 1608-1610. [More Information]
  • Long, G., Menzies, A., Nagrial, A., Haydu, L., Hamilton, A., Mann, G., Hughes, T., Thompson, J., Scolyer, R., Kefford, R. (2011). Prognostic and Clinicopathologic Associations of Oncogenic BRAF in Metastatic Melanoma. Journal of Clinical Oncology, 29(10), 1239-1246. [More Information]
  • Thompson, J., Soong, S., Balch, C., Gershenwald, J., Ding, S., Coit, D., Flaherty, K., Gimotty, P., Johnson, T., Johnson, M., et al (2011). Prognostic Significance of Mitotic Rate in Localized Primary Cutaneous Melanoma: An Analysis of Patients in the Multi-Institutional American Joint Committee on Cancer Melanoma Staging Database. Journal of Clinical Oncology, 29(16), 2199-2205. [More Information]
  • Spillane, A., Haydu, L., McMillan, W., Stretch, J., Thompson, J. (2011). Quality Assurance Parameters and Predictors of Outcome for Ilioinguinal and Inguinal Dissection in a Contemporary Melanoma Patient Population. Annals of Surgical Oncology, 18(9), 2521-2528. [More Information]
  • Chmiel, K., Suan, D., Liddle, C., Nankivell (Nankievell), B., Ibrahim, R., Bautista, C., Thompson, J., Fulcher, D., Kefford, R. (2011). Resolution of Severe Ipilimumab-Induced Hepatitis After Antithymocyte Globulin Therapy. Journal of Clinical Oncology, 29(9), 237-240. [More Information]
  • Ross, M., Thompson, J., Gershenwald, J. (2011). Sentinel Lymph Node Biopsy for Melanoma: Critical Assessment at its Twentieth Anniversary. Surgical Oncology Clinics of North America, 20(1), 57-78. [More Information]
  • Nielsen, K., Chakera, A., Hesse, B., Scolyer, R., Stretch, J., Thompson, J., Nielsen, M., Uren, R., Oturai, P. (2011). The diagnostic value of adding dynamic scintigraphy to standard delayed planar imaging for sentinel node identification in melanoma patients. European Journal of Nuclear Medicine and Molecular Imaging, 38(11), 1999-2004. [More Information]
  • Damian, D., Thompson, J. (2011). Topical diphencyprone immunotherapy for a large primary melanoma on an elderly leg. American Journal of Clinical Dermatology, 12(6), 403-404. [More Information]
  • Verwer, N., Scolyer, R., Uren, R., Winstanley, J., Brown, P., de Wilt, J., Thompson, J. (2011). Treatment and Prognostic Significance of Positive Interval Sentinel Nodes in Patients with Primary Cutaneous Melanoma. Annals of Surgical Oncology, 18(12), 3292-3299. [More Information]
  • Testori, A., Verhoef, C., Kroon, H., Pennacchioli, E., Faries, M., Eggermont, A., Thompson, J. (2011). Treatment of melanoma metastases in a limb by isolated limb perfusion and isolated limb infusion. Journal of Surgical Oncology, 104(4), 397-404. [More Information]
  • Sunderland, N., Thomson, S., Heffernan, S., Lim, S., Thompson, J., Ogle, R., McKenzie, P., Kirwan, P., Makris, A., Hennessy, A. (2011). Tumor necrosis factor α induces a model of preeclampsia in pregnant baboons (Papio hamadryas). Cytokine, 56(2), 192-199. [More Information]
  • Thompson, J., Haydu, L., Sanki, A., Uren, R. (2011). Ultrasound assessment of lymph nodes in the management of early-stage melanoma. Journal of Surgical Oncology, 104(4), 354-360. [More Information]
  • Balch, C., Gershenwald, J., Soong, S., Thompson, J. (2011). Update on the melanoma staging system: the importance of sentinel node staging and primary tumor mitotic rate. Journal of Surgical Oncology, 104(4), 379-385. [More Information]
  • Fogarty, G., Morton, R., Vardy, J., Nowak, A., Mandel, C., Forder, P., Hong, A., Hruby, G., Burmeister, B., Shivalingam, B., Dhillon, H., Thompson, J. (2011). Whole brain radiotherapy after local treatment of brain metastases in melanoma patients - a randomised phase III trial. BMC Cancer, 11(142), 1-8. [More Information]
  • Murali, R., Thompson, J., Scolyer, R. (2010). Can Histologic Parameters of Melanoma Metastases in Sentinel Lymph Nodes Reliably Select Patients Who Can Be Safely Spared Completion Lymph Node Dissection? Annals of Surgery, 251(6), 1188-9; author reply 1189-90. [More Information]
  • Attia, J., Thakkinstian, A., McElduff, P., Milne, E., Dawson, S., Scott, R., de Klerk, N., Armstrong, B., Thompson, J. (2010). Detecting genotyping error using measures of degree of Hardy-Weinberg disequilibrium. Statistical Applications in Genetics and Molecular Biology, 9(1), Article 5-1-Article 5-15. [More Information]
  • Guitera, P., Bourgeat, P., Stretch, J., Scolyer, R., Ourselin, S., Lean, C., Thompson, J., Bourne, R. (2010). Diagnostic value of 8.5 T magnetic resonance spectroscopy of benign and malignant skin lesion biopsies. Melanoma Research: a journal for basic, translational and clinical research in melanoma, 20(4), 311-317. [More Information]
  • Murali, R., Thompson, J., Uren, R., Scolyer, R. (2010). Fine-needle biopsy of metastatic melanoma: clinical use and new applications. Lancet Oncology, 11(4), 391-400. [More Information]
  • Moncrieff, M., Spira, K., Clark, J., Thompson, J., Clifford, A., O'Brien, C., Shannon, K. (2010). Free flap reconstruction for melanoma of the head and neck: indications and outcomes. Journal of Plastic, Reconstructive and Aesthetic Surgery, 63, 205-212. [More Information]
  • Reynolds, H., Walker, C., Dunbar, P., O'Sullivan, M., Uren, R., Thompson, J., Smith, N. (2010). Functional anatomy of the lymphatics draining the skin: a detailed statistical analysis. Journal of Anatomy, 216(3), 344-355. [More Information]
  • Waterworth, D., Ricketts, S., Song, K., Chen, L., Zhao, J., Ripatti, S., Aulchenko, Y., Zhang, W., Yuan, X., Lim, N., et al (2010). Genetic variants influencing circulating lipid levels and risk of coronary artery disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 30(11), 2264-2276. [More Information]
  • Scolyer, R., Murali, R., McCarthy, S., Thompson, J. (2010). Histologically Ambiguous ("Borderline") Primary Cutaneous Melanocytic Tumors - Approaches to Patient Management Including the Roles of Molecular Testing and Sentinel Lymph Node Biopsy. Archives of Pathology and Laboratory Medicine, 134(12), 1770-1777. [More Information]
  • Morton, R., Howard, K., Thompson, J. (2010). In Reply: Cost Effectiveness of Staging Procedures in Patients with Stage I/II Melanoma. Annals of Surgical Oncology, 17(2), 663-664. [More Information]
  • Kam, P., Thompson, J. (2010). Isolated limb infusion with melphalan and actinomycin D in melanoma patients: factors predictive of acute regional toxicity. Expert opinion on drug metabolism & toxicology, 6(9), 1039-45. [More Information]
  • Zhuang, L., Scolyer, R., Murali, R., McCarthy, S., Zhang, X., Thompson, J., Hersey, P. (2010). Lactate dehydrogenase 5 expression in melanoma increases with disease progression and is associated with expression of Bcl-XL and Mcl-1, but not Bcl-2 proteins. Modern Pathology, 23(1), 45-53. [More Information]
  • Murali, R., Thompson, J., Scolyer, R. (2010). Location of Melanoma Metastases in Sentinel Lymph Nodes: What are the Implications for Histologic Processing of Sentinel Lymph Nodes in Routine Practice? The American Journal of Surgical Pathology, 34(1), 127-129. [More Information]
  • Verwer, N., Murali, R., Winstanley, J., Cooper, W., Stretch, J., Thompson, J., Scolyer, R. (2010). Lymphoma occurring in patients with cutaneous melanoma. Journal of Clinical Pathology, 63(9), 777-781. [More Information]
  • Field, A., McKenzie, P., McLeod, D., Stretch, J., Thompson, J., Scolyer, R. (2010). Melanotic schwannoma mimicking metastatic pigmented melanoma: a pitfall in cytological diagnosis. Pathology, 42(3), 287-289. [More Information]
  • Balch, C., Gershenwald, J., Soong, S., Thompson, J., Ding, S., Byrd, D., Cascinelli, N., Cochran, A., Coit, D., Eggermont, A., et al (2010). Multivariate Analysis of Prognostic Factors Among 2,313 Patients With Stage III Melanoma: Comparison of Nodal Micrometastases Versus Macrometastases. Journal of Clinical Oncology, 28(14), 2452-2459. [More Information]
  • Murali, R., Desilva, C., Thompson, J., Scolyer, R. (2010). Non-Sentinel Node Risk Score (N-SNORE): A Scoring System for Accurately Stratifying Risk of Non-Sentinel Node Positivity in Patients With Cutaneous Melanoma With Positive Sentinel Lymph Nodes. Journal of Clinical Oncology, 28(29), 4441-4449. [More Information]
  • Soong, S., Ding, S., Coit, D., Balch, C., Gershenwald, J., Thompson, J., Gimotty, P. (2010). Predicting survival outcome of localized melanoma: an electronic prediction tool based on the AJCC Melanoma Database. Annals of Surgical Oncology, 17(8), 2006-2014. [More Information]
  • Balasuriya, H., Bell, P., Waugh, R., Thompson, J., Gillin, A., Hennessy, A., Makris, A. (2010). Primate maternal placental angiography. Placenta, 31(1), 32-36. [More Information]
  • Murali, R., Shaw, H., McCarthy, S., Quinn, M., Stretch, J., Thompson, J., Scolyer, R. (2010). Prognostic Factors in Cutaneous Desmoplastic Melanoma: A Study of 252 Patients. Cancer, 116(17), 4130-4138. [More Information]
  • Haydu, L., Holt, P., Karim, R., Madronio, C., Thompson, J., Armstrong, B., Scolyer, R. (2010). Quality of histopathological reporting on melanoma and influence of use of a synoptic template. Histopathology, 56(6), 768-774. [More Information]
  • Cadili, A., Dabbs, K., Scolyer, R., Brown, P., Thompson, J. (2010). Re-evaluation of a scoring system to predict nonsentinel-node metastasis and prognosis in melanoma patients. Journal of the American College of Surgeons, 211(4), 522-525. [More Information]
  • Christou, E., Damian, D., Thompson, J. (2010). Regressing metastatic melanoma and vitiligo-like depigmentation in an Indigenous Australian. Medical Journal of Australia, 192(3), 171. [More Information]
  • Wiener, M., Acland, K., Shaw, H., Soong, S., Li, H., Chen, D., Scolyer, R., Winstanley, J., Thompson, J. (2010). Sentinel Node Positive Melanoma Patients: Prediction and Prognostic Significance of Nonsentinel Node Metastases and Development of a Survival Tree Model. Annals of Surgical Oncology, 17(8), 1995-2005. [More Information]
  • Cooper, C., Murali, R., Doubrovsky, A., Watson, G., McKenzie, P., Thompson, J., Scolyer, R. (2010). Synchronous and metachronous malignancies in patients with melanoma: a clinicopathologic study highlighting the role of fine-needle biopsy cytology and potential diagnostic pitfalls. Melanoma Research: a journal for basic, translational and clinical research in melanoma, 20(3), 203-211. [More Information]
  • Martiniuk, F., Damian, D., Thompson, J., Scolyer, R., Tchou-Wong, K., Levis, W. (2010). TH17 is involved in the remarkable regression of metastatic malignant melanoma to topical diphencyprone. Journal of Drugs in Dermatology: new methods and technology, 9(11), 1368-1372. [More Information]
  • Faries, M., Thompson, J., Cochrane, A., Elashoff, R., Glass, E., Mozzillo, N., Nieweg, O., Roses, D., Hoekstra, H., Karakousis, C., et al (2010). The Impact on Morbidity and Length of Stay of Early Versus Delayed Complete Lymphadenectomy in Melanoma: Results of the Multicenter Selective Lymphadenectomy Trial (I). Annals of Surgical Oncology, 17, 3324-3329.
  • Murali, R., Moncrieff, M., Hong, J., Cooper, C., Shingde, M., Samuel, D., Thompson, J., Scolyer, R. (2010). The Prognostic Value of Tumor Mitotic Rate and Other Clinicopathologic Factors in Patients with Locoregional Recurrences of Melanoma. Annals of Surgical Oncology, 17(11), 2992-2999. [More Information]
  • Cadili, A., Scolyer, R., Brown, P., Dabbs, K., Thompson, J. (2010). Total sentinel lymph node tumor size predicts nonsentinel node metastasis and survival in patients with melanoma. Annals of Surgical Oncology, 17(11), 3015-3020. [More Information]
  • Busam, K., Murali, R., Pulitzer, M., McCarthy, S., Thompson, J., Shaw, H., Brady, M., Coit, D., Dusza, S., Wilmott, J., Scolyer, R., et al (2009). Atypical Spitzoid Melanocytic Tumors With Positive Sentinel Lymph Nodes in Children and Teenagers, and Comparison With Histologically Unambiguous and Lethal Melanomas. American Journal of Surgical Pathology, 33(9), 1386-1395. [More Information]
  • Thompson, J., Scolyer, R., Kefford, R. (2009). Cutaneous melanoma in the era of molecular profiling. The Lancet, 374(9687), 362-365. [More Information]
  • Murali, R., Loughman, N., McKenzie, P., Watson, G., Thompson, J., Scolyer, R. (2009). Cytological features of melanoma in exfoliative fluid specimens. Journal of Clinical Pathology, 62(7), 638-643. [More Information]
  • Chakera, A., Hesse, B., Burak, Z., Ballinger, J., Britten, A., Caraco, C., Cochran, A., Cook, M., Drzewiecki, K., Scolyer, R., Thompson, J., Uren, R., et al (2009). EANM-EORTC general recommendations for sentinel node diagnostics in melanoma. European Journal of Nuclear Medicine and Molecular Imaging, 36(10), 1713-1742. [More Information]
  • Kroon, H., Lin, D., Kam, P., Thompson, J. (2009). Efficacy of repeat isolated limb infusion with melphalan and actinomycin D for recurrent melanoma. Cancer, 115(9), 1932-1940. [More Information]
  • Hare, D., Burger, F., Austin, C., Fryer, F., Grimm, R., Reedy, B., Scolyer, R., Thompson, J., Doble, P. (2009). Elemental bio-imaging of melanoma in lymph node biopsies. The Analyst, 134(3), 450-453. [More Information]
  • Orlow, I., Tommasi, D., Bloom, B., Ostrovnaya, I., Cotignola, J., Mujumdar, U., Busam, K., Jungbluth, A., Scolyer, R., Thompson, J., Armstrong, B., et al (2009). Evaluation of the Clonal Origin of Multiple Primary Melanomas Using Molecular Profiling. The Journal of Investigative Dermatology, 129(8), 1972-1982. [More Information]
  • Zhuang, L., Scolyer, R., Lee, C., McCarthy, S., Cooper, W., Zhang, X., Thompson, J., Hersey, P. (2009). Expression of glucose-regulated stress protein GRP78 is related to progression of melanoma. Histopathology, 54(4), 462-470. [More Information]
  • Moncrieff, M., Thompson, J., Stretch, J. (2009). Extended experience and modifications in the design and concepts of the keystone design island flap. Journal of Plastic Reconstructive & Aesthetic Surgery : JPRAS, 63, 1359-63. [More Information]
  • Kroon, H., Moncrieff, M., Kam, P., Thompson, J. (2009). Factors predictive of acute regional toxicity after isolated limb infusion with melphalan and actinomycin D in melanoma patients. Annals of Surgical Oncology, 16(5), 1184-1192. [More Information]
  • Lam, T., Uren, R., Scolyer, R., Shannon, K., Thompson, J. (2009). False-negative sentinel node biopsy because of obstruction of lymphatics by metastatic melanoma: the value of ultrasound in conjunction with preoperative lymphoscintigraphy. Melanoma Research, 19(2), 94-99. [More Information]
  • Balch, C., Gershenwald, J., Soong, S., Thompson, J., Atkins, M., Byrd, D., Buzaid, A., Cochran, A., Coit, D., Ding, S., et al (2009). Final Version of 2009 AJCC Melanoma Staging and Classification. Journal of Clinical Oncology, 27(36), 6199-6206. [More Information]
  • Narita, N., Tanemura, A., Murali, R., Scolyer, R., Huang, S., Arigami, T., Yanagita, S., Chong, K., Thompson, J., Morton, D., et al (2009). Functional RET G691S polymorphism in cutaneous malignant melanoma. Oncogene, 28(34), 3058-3068. [More Information]
  • Thompson, J., Morton, R. (2009). In Reply: Cost-Effectiveness of Sentinel Node Biopsy for Melanoma. Annals of Surgical Oncology, 16(10), 2962-2963. [More Information]
  • Murali, R., Cochran, A., Cook, M., Hillman, J., Karim, R., Moncrieff, M., Starz, H., Thompson, J., Scolyer, R. (2009). Interobserver reproducibility of histologic parameters of melanoma deposits in sentinel lymph nodes: implications for management of patients with melanoma. Cancer, 115(21), 5026-5037. [More Information]
  • Murali, R., Hughes, M., FitzGerald, P., Thompson, J., Scolyer, R. (2009). Interobserver Variation in the Histopathologic Reporting of Key Prognostic Parameters, Particularly Clark Level, Affects Pathologic Staging of Primary Cutaneous Melanoma. Annals of Surgery, 249(4), 641-647. [More Information]
  • Kroon, H., Lin, D., Kam, P., Thompson, J. (2009). Isolated limb infusion as palliative treatment for advanced limb disease in patients with AJCC stage IV melanoma. Annals of Surgical Oncology, 16(5), 1193-1201. [More Information]
  • Kroon, H., Thompson, J. (2009). Isolated limb infusion: A review. Journal of Surgical Oncology, 100(2), 169-77. [More Information]
  • Kroon, H., Thompson, J., Hoekstra, H. (2009). Isolatie-infusie effectief bij melanoom en sarcoom: Goed alternate voor regionale isolatieperfusie met cytostatica [Isolated infusion effective in melanoma and sarcoma: Good alternative for regional isolated cytostatic perfusion]. Nederlands Tijdschrift voor Geneeskunde, 153(11), 508-514. [More Information]
  • Spillane, A., Winstanley, J., Thompson, J. (2009). Lymph node ratio in melanoma: A marker of variation in surgical quality? Cancer, 115(11), 2384-2387. [More Information]
  • Kroon, H., Lin, D., Kam, P., Thompson, J. (2009). Major amputation for irresectable extremity melanoma after failure of isolated limb infusion. Annals of Surgical Oncology, 16(6), 1543-1547. [More Information]
  • Guminski, A., Thompson, J. (2009). Predicting response to IL-2 therapy for metastatic melanoma. Expert Review of Anticancer Therapy: an essential contribution to decision making in cancer care, 9(11), 1571-1575. [More Information]
  • Shingde, M., Buckland,, M., Busam, K., McCarthy, S., Wilmott, J., Thompson, J., Scolyer, R. (2009). Primary cutaneous Ewing sarcoma/primitive neuroectodermal tumour: a clinicopathological analysis of seven cases highlighting diagnostic pitfalls and the role of FISH testing in diagnosis. Journal of Clinical Pathology, 62(10), 915-919. [More Information]
  • Spillane, A., Cheung, B., Stretch, J., Scolyer, R., Shannon, K., Quinn, M., Saw, R., McCarthy, W., Thompson, J. (2009). Proposed quality standards for regional lymph node dissections in patients with melanoma. Annals of Surgery, 249(3), 473-480. [More Information]
  • Moncrieff, M., Thompson, J., Stretch, J. (2009). Reconstruction after wide excision of primary cutaneous melanomas: part I-the head and neck. The Lancet Oncology, 10(7), 700-708. [More Information]
  • Moncrieff, M., Thompson, J., Stretch, J. (2009). Reconstruction after wide excision of primary cutaneous melanomas: part II--the extremities. The Lancet Oncology, 10(8), 810-815. [More Information]
  • Karim, R., Li, W., Sanki, A., Colman, M., Yang, J., Thompson, J., Scolyer, R. (2009). Reduced p16 and increased cyclin D1 and pRb expression are correlated with progression in cutaneous melanocytic tumors. International Journal of Surgical Pathology, 17(5), 361-367. [More Information]
  • Kroon, H., Lin, D., Kam, P., Thompson, J. (2009). Safety and efficacy of isolated limb infusion with cytotoxic drugs in elderly patients with advanced locoregional melanoma. Annals of Surgery, 249(6), 1008-1013. [More Information]
  • Howman-Giles, R., Shaw, H., Scolyer, R., Murali, R., Wilmott, J., McCarthy, S., Uren, R., Thompson, J. (2009). Sentinel Lymph Node Biopsy in Pediatric and Adolescent Cutaneous Melanoma Patients. Annals of Surgical Oncology, Online(DOI: 10.1245/s10434-009-0657-4), 1-6. [More Information]
  • Balch, C., Morton, D., Gershenwald, J., McMasters, K., Nieweg, O., Powell, B., Ross, M., Sondak, V., Thompson, J. (2009). Sentinel node biopsy and standard of care for melanoma. Journal Of The American Academy Of Dermatology, 60(5), 872-875. [More Information]
  • Mocellin, S., Thompson, J., Pasquali, S., Montesco, M., Pilati, P., Nitti, D., Saw, R., Scolyer, R., Stretch, J., Rossi, C. (2009). Sentinel Node Status Prediction by Four Statistical Models Results From a Large Bi-Institutional Series (n=1132). Annals of Surgery, 250(6), 964-969. [More Information]
  • Martin, R., Murali, R., Scolyer, R., FitzGerald, P., Colman, M., Thompson, J. (2009). So-called "malignant blue nevus": a clinicopathologic study of 23 patients. Cancer, 115(13), 2949-2955. [More Information]
  • Sanki, A., Scolyer, R., Thompson, J. (2009). Surgery for melanoma metastases of the gastrointestinal tract: Indications and results. European Journal of Surgical Oncology, 35, 313-319. [More Information]
  • Sladden, M., Balch, C., Barzilai, D., Berg, D., Freiman, A., Handiside, T., Hollis, S., Lens, M., Thompson, J. (2009). Surgical excision margins for primary cutaneous melanoma. Cochrane Database of Systematic Reviews, 10.1002/14651858.CD004835.pub2(4), 1-33. [More Information]
  • Sanki, A., Uren, R., Moncrieff, M., Tran, K., Scolyer, R., Lin, H., Thompson, J. (2009). Targeted High-Resolution Ultrasound Is Not an Effective Substitute for Sentinel Lymph Node Biopsy in Patients With Primary Cutaneous Melanoma. Journal of Clinical Oncology, 27(22), 5614-5619. [More Information]
  • Morton, R., Craig, J., Thompson, J. (2009). The Role of Surveillance Chest X-Rays in the Follow-Up of High-Risk Melanoma Patients. Annals of Surgical Oncology, 16(3), 571-577. [More Information]
  • Reynolds, H., Smith, N., Uren, R., Thompson, J., Rod Dunbar, P. (2009). Three-dimensional visualization of skin lymphatic drainage patterns of the head and neck. Head and Neck, 31(10), 1316-1325. [More Information]
  • Damian, D., Shannon, K., Thompson, J. (2009). Topical diphencyprone immunotherapy for cutaneous metastatic melanoma. Australasian Journal of Dermatology, 50(4), 266-271. [More Information]
  • Amersi, F., Terando, A., Goto, Y., Scolyer, R., Thompson, J., Tran, A., Faries, M., Morton, D., Hoon, D. (2008). Activation of CCR9/CCL25 in cutaneous melanoma mediates preferential metastasis to the small intestine. Clinical Cancer Research, 14(3), 638-645. [More Information]
  • Moncrieff, M., Martin, R., O'Brien, C., Shannon, K., Clark, J., Gao, K., McCarthy, W., Thompson, J. (2008). Adjuvant Postoperative Radiotherapy to the Cervical Lymph Nodes in Cutaneous Melanoma: Is There Any Benefit for High-Risk Patients? Annals of Surgical Oncology, 15(11), 3022-3027. [More Information]
  • Van Es, S., Colman, M., Thompson, J., McCarthy, S., Scolyer, R. (2008). Angiotropism is an Independent Predictor of Local Recurrence and In-transit Metastasis in Primary Cutaneous Melanoma. American Journal of Surgical Pathology, 32(9), 1396-403. [More Information]
  • Thompson, J., Hersey, P., Wachter, E. (2008). Chemoablation of metastatic melanoma using intralesional Rose Bengal. Melanoma Research: a journal for basic, translational and clinical research in melanoma, 18, 405-411. [More Information]
  • Beavis, A., Dawson, M., Doble, P., Scolyer, R., Bourne, R., Li, L., Murali, R., Stretch, J., Lean, C., Uren, R., Thompson, J. (2008). Confirmation of Sentinel Lymph Node Identity by Analysis of Fine-Needle Biopsy Samples Using Inductively Coupled Plasma-Mass Spectrometry. Annals of Surgical Oncology, 15(3), 934-940. [More Information]
  • Moncrieff, M., Scolyer, R., Thompson, J., Beavis, A., Uren, R., Stretch, J. (2008). Correct identification of a sentinel node postselective lymphadenectomy using antimony levels. Melanoma Research: a journal for basic, translational and clinical research in melanoma, 18(5), 365-366. [More Information]
  • Thompson, J., Kam, P. (2008). Current status of isolated limb infusion with mild hyperthermia for melanoma. International Journal of Hyperthermia, 24(3), 219-225. [More Information]
  • Murali, R., Loughman, N., McKenzie, P., Watson, G., Thompson, J., Scolyer, R. (2008). Cytologic Features of Metastatic and Recurrent Melanoma in Patients With Primary Cutaneous Desmoplastic Melanoma. American Journal of Clinical Pathology, 130(5), 715-723. [More Information]
  • Spillane, A., Saw, R., Tucker, M., Byth Wilson, K., Thompson, J. (2008). Defining lower limb lymphedema after inguinal or ilio-inguinal dissection in patients with melanoma using classification and regression tree analysis. Annals of Surgery, 248(2), 286-293. [More Information]
  • Chen, J., Hruby, G., Scolyer, R., Murali, R., Hong, A., FitzGerald, P., Pham, T., Quinn, M., Thompson, J. (2008). Desmoplastic neurotropic melanoma: a clinicopathologic analysis of 128 cases. Cancer, 113(10), 2770-2778. [More Information]
  • Francken, A., Thompson, J., Bastiaannet, E., Hoekstra, H. (2008). Detection of the first recurrence in patients with melanoma: three quarters by the patient, one quarter during outpatient follow-up. Nederlands Tijdschrift voor Geneeskunde, 152(10), 557-562. [More Information]
  • Doubrovsky, A., Scolyer, R., Murali, R., McKenzie, P., Watson, G., Lee, C., McLeod, D., McCarthy, W., Uren, R., Stretch, J., Saw, R., Thompson, J. (2008). Diagnostic Accuracy of Fine Needle Biopsy for Metastatic Melanoma and Its Implications for Patient Management. Annals of Surgical Oncology, 15(1), 323-332. [More Information]
  • Moncrieff, M., Shannon, K., Hong, A., Thompson, J. (2008). Dramatic reduction of chronic lymphoedema of the lower limb with sorafenib therapy. Melanoma Research, 18(2), 161-162. [More Information]
  • Karim, R., Scolyer, R., Li, W., Yee, V., McKinnon, J., Li, L., Uren, R., Lam, S., Beavis, A., Dawson, M., Thompson, J., et al (2008). False Negative Sentinel Lymph Node Biopsies in Melanoma May Result From Deficiencies in Nuclear Medicine, Surgery, or Pathology. Annals of Surgery, 247(6), 1003-1010. [More Information]
  • Murali, R., Thompson, J., Scolyer, R. (2008). Fine-needle biopsy as a diagnostic technique for metastatic melanoma. Expert Opinion on Medical Diagnostics, 2, 1-10.
  • Francken, A., Accortt, N., Shaw, H., Colman, M., Wiener, M., Soong, S., Hoekstra, H., Thompson, J. (2008). Follow-up schedules after treatment for malignant melanoma. British Journal of Surgery, 95(11), 1401-1407. [More Information]
  • Chung, D., Saw, R., Thompson, J. (2008). Guidelines for imaging in cutaneous melanoma. Nuclear Medicine Communications, 29(10), 877-879. [More Information]
  • Chung, D., Saw, R., Thompson, J. (2008). Imaging in cutaneous melanoma. Nuclear Medicine Communications, 29(10), 847-876. [More Information]
  • Moncrieff, M., Kroon, H., Kam, P., Stalley, P., Scolyer, R., Thompson, J. (2008). Isolated Limb Infusion for Advanced Soft Tissue Sarcoma of the Extremity. Annals of Surgical Oncology, 15(10), 2749-2756. [More Information]
  • Moncrieff, M., Bowen, F., Thompson, J., Saw, R., Shannon, K., Spillane, A., Quinn, M., Stretch, J. (2008). Keystone Flap Reconstruction of Primary Melanoma Excision Defects of the Leg-The End of the Skin Graft. Annals of Surgical Oncology, 15(10), 2867-2873. [More Information]
  • Collinson, F., Lam, T., Bruijn, W., de Wilt, J., Lamont, M., Thompson, J., Kefford, R. (2008). Long-term survival and occasional regression of distant melanoma metastases after adrenal metastasectomy. Annals of Surgical Oncology, 15(6), 1741-1749. [More Information]
  • Cochran, A., Thompson, J. (2008). Lymphatic mapping and sentinel node biopsy: the data unclouded by speculation. Archives of Dermatology, 144(5), 687-8; author reply 688-9. [More Information]
  • Warner, R., Quinn, M., Hruby, G., Scolyer, R., Uren, R., Thompson, J. (2008). Management of Merkel Cell Carcinoma: The Roles of Lymphoscintigraphy, Sentinel Lymph Node Biopsy and Adjuvant Radiotherapy. Annals of Surgical Oncology, 15(9), 2509-2518. [More Information]
  • Kroon, H., Moncrieff, M., Kam, P., Thompson, J. (2008). Outcomes Following Isolated Limb Infusion for Melanoma. A 14-Year Experience. Annals of Surgical Oncology, 15(11), 3003-3013. [More Information]
  • Gallagher, S., Thompson, J., Indsto, J., Scurr, L., Lett, M., Gao, B., Dunleavey, R., Mann, G., Kefford, R., Rizos, H. (2008). p16INK4a expression and absence of activated B-RAF are independent predictors of chemosensitivity in melanoma tumors. NeoPlasia: an international journal of oncology research, 10(11), 1231-1239. [More Information]
  • Scolyer, R., Murali, R., McCarthy, S., Thompson, J. (2008). Pathologic examination of sentinel lymph nodes from melanoma patients. Seminars in Diagnostic Pathology, 25(2), 100-111. [More Information]
  • Kam, P., Thompson, J. (2008). Pharmacokinetics of regional therapy: isolated limb infusion and other low flow techniques for extremity melanoma. Surgical Oncology Clinics of North America, 17(4), 795-804. [More Information]
  • Francken, A., Accortt, N., Shaw, H., Wiener, M., Soong, S., Hoekstra, H., Thompson, J. (2008). Prognosis and determinants of outcome following locoregional or distant recurrence in patients with cutaneous melanoma. Annals of Surgical Oncology, 15(5), 1476-1484. [More Information]
  • Shaw, H., Scolyer, R., Thompson, J. (2008). Prognostic significance of histopathological parameters in sentinel nodes of melanoma patients. Histopathology, 53(3), 345. [More Information]
  • Murali, R., Thompson, J., Scolyer, R. (2008). Sentinel lymph node biopsy for melanoma: aspects of pathologic assessment. Future Oncology, 4(4), 535-551. [More Information]
  • Wiener, M., Damian, D., Thompson, J. (2008). Systemic phototoxicity following intralesional rose bengal for subcutaneous melanoma metastases. Dermatology, 216(4), 361-362. [More Information]
  • Karim, R., van den Berg, K., Colman, M., McCarthy, S., Thompson, J., Scolyer, R. (2008). The advantage of using a synoptic pathology report format for cutaneous melanoma. Histopathology, 52(2), 130-138. [More Information]
  • Morton, R., Howard, K., Thompson, J. (2008). The Cost-Effectiveness of Sentinel Node Biopsy in Patients with Intermediate Thickness Primary Cutaneous Melanoma. Annals of Surgical Oncology, Published Online DOI: 10.1245/s10434-008-0164-z, 1-12. [More Information]
  • Scolyer, R., Murali, R., Satzger, I., Thompson, J. (2008). The detection and significance of melanoma micrometastases in sentinel nodes. Surgical oncology, 17(3), 165-174. [More Information]
  • Thompson, J., Shaw, H., Scolyer, R. (2008). The Prognostic Significance of Isolated Immunohistochemically Positive Cells in Sentinel Lymph Nodes of Melanoma Patients. The American Journal of Surgical Pathology, 32(7), 1106-7; author reply 1107-8. [More Information]
  • Morton, D., Cochran, A., Thompson, J. (2008). The rationale for sentinel-node biopsy in primary melanoma. Nature clinical practice. Oncology, 5(9), 510-511. [More Information]
  • Thompson, J. (2008). The value of sentinel node biopsy in patients with primary cutaneous melanoma. Dermatologic Surgery, 34(4), 550-555. [More Information]
  • Thompson, J., Scolyer, R., Kefford, R., Uren, R. (2007). (Letter to the Editor) Melanoma Management in 2007. Australian Family Physician, 36(7), 487-488. [More Information]
  • Kelly, J., McArthur, G., Wolfe, R., Thompson, J., Liu, W. (2007). A confusing message will not improve the detection of melanoma. Archives of Dermatology, 143, 806-807.
  • Thompson, J. (2007). Abdominal resectional surgery in metastatic melanoma. ANZ Journal of Surgery, 77(10), 813. [More Information]
  • Morton, D., Cochran, A., Thompson, J. (2007). Authors' response to a letter to the editor re: Sentinel node biopsy for early-stage melanoma. Annals of Surgery, 245(5), 828-829. [More Information]
  • Thompson, J., Hodi, F., Zhang, Y. (2007). Case records of the Massachusetts General Hospital. Case 2-2007. A 49-year-old woman with a pigmented lesion on the arm. The New England Journal of Medicine, 356(3), 285-292. [More Information]
  • Murali, R., Gershenwald, J., Cochran, A., Thompson, J. (2007). Clinical relevance of melanoma micrometastases in sentinel nodes: too early to tell. Annals of Oncology, 18(4), 806-8. [More Information]
  • Tan, K., Thompson, J., Arnold, C., McCarthy, S., Scolyer, R. (2007). Current perspectives on the pathologic diagnosis and reporting of melanocytic tumors. Giornale Italiano di Dermatologia e Venereologia, 142, 83-97.
  • Thompson, J., Menzies, S., Shaw, H., Kefford, R. (2007). Cutaneous melanoma/Authors' reply. The Lancet, 365(9476), 2004-2005.
  • Francken, A., Shaw, H., Accortt, N., Soong, S., Hoekstra, H., Thompson, J. (2007). Detection of First Relapse in Cutaneous Melanoma Patients: Implications for the Formulation of Evidence-Based Follow-up Guidelines. Annals of Surgical Oncology, 14(6), 1924-1933. [More Information]
  • Francken, A., Shaw, H., Thompson, J. (2007). Detection of second primary cutaneous melanomas. European Journal of Surgical Oncology, 34(5), 587-592. [More Information]
  • Murali, R., Doubrovsky, A., Watson, G., McKenzie, P., Lee, C., McLeod, D., Uren, R., Stretch, J., Saw, R., Thompson, J., Scolyer, R. (2007). Diagnosis of metastatic melanoma by fine-needle biopsy: analysis of 2,204 cases. American Journal of Clinical Pathology, 127(3), 385. [More Information]
  • Kelly, J., McArthur, G., Wolfe, R., Thompson, J., Liu, W. (2007). Fast-growing and slow-growing melanomas. Archives of Dermatology, 143, 803-804.
  • Raja, C., Graham, P., Rizvi, S., Song, E., Goldsmith, H., Thompson, J., Bosserhoff, A., Morgenstern, A., Apostolidis, C., Kearsley, J., Allen, B., et al (2007). Interim Analysis of Toxicity and Response in Phase 1 Trial of Systemic Targeted Alpha Therapy for Metastatic Melanoma. Cancer Biology and Therapy, 6(6), 846-852. [More Information]
  • Elliott, B., Scolyer, R., Suciu, S., Lebecque, S., Rimoldi, D., Gugerli, O., Musat, E., Sharma, R., Lienard, D., Keilholz, U., Thompson, J., et al (2007). Long-term protective effect of mature DC-LAMP+ dendritic cell accumulation in sentinel lymph nodes containing micrometastatic melanoma. Clinical Cancer Research, 13(13), 3825-3830. [More Information]
  • Sanki, A., Kam, P., Thompson, J. (2007). Long-term results of hyperthermic, isolated limb perfusion for melanoma: a reflection of tumor biology. Annals of Surgery, 245(4), 591-596. [More Information]
  • Reynolds, H., Dunbar, P., Uren, R., Thompson, J., Smith, N. (2007). Mapping melanoma lymphoscintigraphy data onto a 3D anatomically based model. Annals of Biomedical Engineering, 35(8), 1444-1457. [More Information]
  • Zhuang, L., Lee, C., Scolyer, R., McCarthy, S., Hersey, P., Thompson, J., Zhang, X. (2007). Mcl-1, Bcl-XL and Stat3 expression are associated with progression of melanoma whereas Bcl-2, AP-2 and MITF levels decrease during progression of melanoma. Modern Pathology, 20(4), 416-426. [More Information]
  • Murali, R., McCarthy, S., Thompson, J. (2007). Melanocytic nevus with focal atypical epithelioid components (clonal nevus) is a combined nevus. Journal Of The American Academy Of Dermatology, 56(5), 889-890. [More Information]
  • Jabbour, J., Cumming, R., Scolyer, R., Hruby, G., Thompson, J., Lee, S. (2007). Merkel Cell Carcinoma: Assessing the Effect of Wide Local Excision, Lymph Node Dissection, and Radiotherapy on Recurrence and Survival in Early-Stage Disease-Results From a Review of 82 Consecutive Cases Diagnosed Between 1992 and 2004. Annals of Surgical Oncology, 14(6), 1943-1952. [More Information]
  • Howman-Giles, R., Chung, D., Thompson, J. (2007). Metastatic occlusion of a lymphatic collecting vessel in a patient with cutaneous melanoma and clinically normal lymph nodes. Clinical Nuclear Medicine, 32(4), 312-313. [More Information]
  • Scolyer, R., Thompson, J. (2007). Primary melanoma of the lung. The American surgeon, 73(9), 937-938. [More Information]
  • Shaw, H., Scolyer, R., Thompson, J. (2007). Re: NM patients and SN. The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland, 5(5), 320. [More Information]
  • Sanki, A., Li, W., Colman, M., Karim, R., Thompson, J., Scolyer, R. (2007). Reduced expression of p16 and p27 is correlated with tumour progression in cutaneous melanoma. Pathology, 39(6), 551-557. [More Information]
  • Murali, R., Sharma, R., Thompson, J., Stretch, J., Lee, C., McCarthy, S., Scolyer, R. (2007). Sentinel Lymph Node Biopsy in Histologically Ambiguous Melanocytic Tumors With Spitzoid Features (So-Called Atypical Spitzoid Tumors). Annals of Surgical Oncology, 15(1), 302-309. [More Information]
  • Thompson, J., Shaw, H. (2007). Sentinel node mapping for melanoma: results of trials and current applications. Surgical Oncology Clinics of North America, 16, 35-54. [More Information]
  • Morton, D., Cochran, A., Thompson, J. (2007). Sentinel-node biopsy in melanoma. New England Journal of Medicine, 356, 419-420.
  • Tan, K., Moncrieff, M., Thompson, J., McCarthy, S., Shaw, H., Quinn, M., Li, L., Crotty, K., Stretch, J., Scolyer, R. (2007). Subungual Melanoma: A Study of 124 Cases Highlighting Features of Early Lesions, Potential Pitfalls in Diagnosis, and Guidelines for Histologic Reporting. American Journal of Surgical Pathology, 31(12), 1902-1912. [More Information]
  • Sassen, S., Shaw, H., Colman, M., Scolyer, R., Thompson, J. (2007). The Complex Relationships Between Sentinel Node Positivity, Patient Age, and Primary Tumor Desmoplasia: Analysis of 2303 Melanoma Patients Treated at a Single Center. Annals of Surgical Oncology, 15(2), 630-637. [More Information]
  • Scolyer, R., Thompson, J., Shaw, H., McCarthy, S. (2007). The importance of mitotic rate as a prognostic factor for localized primary cutaneous melanoma. Journal Of Cutaneous Pathology, 33(5), 395-396. [More Information]
  • Uren, R., Sanki, A., Thompson, J. (2007). The utility of ultrasound in patients with melanoma. Expert Review of Anticancer Therapy, 7(11), 1633-1642. [More Information]
  • Reynolds, H., Dunbar, P., Uren, R., Blackett, S., Thompson, J., Smith, N. (2007). Three-dimensional visualisation of lymphatic drainage patterns in patients with cutaneous melanoma. Lancet Oncology, 8(9), 806-812. [More Information]
  • Makris, A., Thornton, C., Thompson, J., Thomson, S., Martin, R., Ogle, R., Waugh, R., McKenzie, P., Kirwan, P., Hennessy, A. (2007). Uteroplacental ischemia results in proteinuric hypertension and elevated sFLT-1. Kidney International, 71(10), 977-984. [More Information]
  • Thompson, J., Shaw, H. (2006). Benefits of sentinel node biopsy for melanoma: a review based on interim results of the first Multicenter Selective Lymphadenectomy Trial. ANZ Journal of Surgery, 76(3), 100-103. [More Information]
  • Francken, A., Fulham, M., Millward, M., Thompson, J. (2006). Detection of metastatic disease in patients with uveal melanoma using positron emission tomography. European Journal of Surgical Oncology, 32(7), 780-784. [More Information]
  • Thompson, J., McCarthy, S., Strutton, G., Elder, D. (2006). Incomplete biopsy of melanocytic lesions can impair the accuracy of pathological diagnosis. The Australasian Journal of Dermatology, 47(1), 71-3; author reply 74-5. [More Information]
  • Thompson, J., Shaw, H. (2006). Is sentinel lymph node biopsy appropriate in patients with thin melanomas: Too early to tell? Annals of Surgical Oncology, 13(3), 279-281.
  • Uren, R., Thompson, J., Howman-Giles, R., Chung, D. (2006). Lymphatic drainage-in patients with primary cutaneous melanoma - the role of lymphoscintigraphy in sentinel lymph node biopsy. Current Medical Imaging Reviews, 2(2), 261-270.
  • Wong, S., Morton, D., Thompson, J., Gershenwald, J., Leong, S., Reintgen, D., Gutman, H., Sabel, M., Carlson, G., McMasters, K., et al (2006). Melanoma patients with positive sentinel nodes who did not undergo completion lymphadenectomy: a multi-institutional study. Annals of Surgical Oncology, 13(6), 809-816. [More Information]
  • Makris, A., Thornton, C., Thompson, S., Thompson, J., Martin, R., McKenzie, P., Ogle, R., Waugh, R., Hennessy, A. (2006). Primate Uteroplacental Ischaemia results in proteinuric hypertension and elevated soluble Flt-1 (Sflt-1). Hypertension in Pregnancy, 25(Supplement 1), 13 O005-13.
  • Zhuang, L., Lee, C., Scolyer, R., McCarthy, S., Zhang, X., Thompson, J., Screaton, G., Hersey, P. (2006). Progression in melanoma is associated with decreased expression of death receptors for tumor necrosis factor-related apoptosis-inducing ligand. Human Pathology, 37(10), 1286-1294. [More Information]
  • Kohonen-Corish, M., Cooper, W., Saab, J., Thompson, J., Trent, R., Millward, M. (2006). Promoter hypermethylation of the O(6)-methylguanine DNA methyltransferase gene and microsatellite instability in metastatic melanoma. The Journal of Investigative Dermatology, 126(1), 167-171. [More Information]
  • Liu, W., Dowling, J., Murray, W., McArthur, G., Thompson, J., Wolfe, R., Kelly, J. (2006). Rate of growth in melanomas: characteristics and associations of rapidly growing melanomas. Archives of Dermatology, 142(12), 1551-1558. [More Information]
  • Thompson, J., Shaw, H. (2006). Re: Sydney Melanoma Unit patients in breach of multicentre selective lymphadenectomy trial protocol? ANZ Journal of Surgery, 76(11), 1039-1040. [More Information]
  • Byrne, C., Thompson, J. (2006). Role of electrochemotherapy in the treatment of metastatic melanoma and other metastatic and primary skin tumors. Expert Review of Anticancer Therapy, 6(5), 671-8. [More Information]
  • Morton, D., Thompson, J., Cochran, A., Mozzillo, N., Elashoff, R., Essner, R., Nieweg, O., Roses, D., Hoekstra, H., Karakousis, C., et al (2006). Sentinel-node biopsy or nodal observation in melanoma. New England Journal of Medicine, 355(13), 1307-1317.
  • Thompson, J., Shaw, H. (2006). Surgical management of melanoma: have we made any progress in 100 years? Cancer Forum, 30(2), 103-107.
  • Thompson, J., Scolyer, R., Uren, R. (2006). Surgical management of primary cutaneous melanoma: excision margins and the role of sentinel lymph node examination. Surgical Oncology Clinics of North America, 15(2), 301-18. [More Information]
  • Barton, M., Gabriel, G., Frommer, M., Holt, P., Thompson, J. (2006). Surgical procedures for melanoma in public and private New South Wales hospitals, 2001-2002. ANZ Journal of Surgery, 76(5), 318-324.
  • Shaw, H., Quinn, M., Scolyer, R., Thompson, J. (2006). Survival in patients with desmoplastic melanoma. Journal of Clinical Oncology, 24(8), e12-e12. [More Information]
  • Uren, R., Howman-Giles, R., Chung, D., Thompson, J. (2006). The clinical importance of lymphoscintigraphy for sentinel lymph node biopsy in melanoma and breast cancer. World Journal of Nuclear Medicine, 5(Supplement 1), S379-S382.
  • Uren, R., Howman-Giles, R., Chung, D., Morton, R., Thompson, J. (2006). The Reproducibility in Routine Clinical Practice of Sentinel Lymph Node Identification by Pre-operative Lymphoscintigraphy in Patients with Cutaneous Melanoma. Annals of Surgical Oncology, 14(2), 899-905. [More Information]
  • Li, W., Sanki, A., Karim, R., Thompson, J., Soon, L., Zhuang, L., McCarthy, S., Scolyer, R. (2006). The role of cell cycle regulatory proteins in the pathogenesis of melanoma. Pathology, 38(4), 287-301. [More Information]
  • Thompson, J., Howman-Giles, R., Chung, D. (2006). The role of lymphoscintigraphy in the detection of lymph node drainage in melanoma. Surgical Oncology Clinics of North America, 15(2), 285-300. [More Information]
  • Thompson, J., Uren, R., Shaw, H. (2006). Time for comprehensive reporting of MSLT-I -author reply. Lancet Oncology, 7(1), 11-12.
  • Damian, D., Barnetson, R., Thompson, J. (2006). Treatment of refractory chromomycosis by isolated limb infusion with melphalan and actinomycin D. Journal of Cutaneous Medicine and Surgery, 10(1), 48-51.
  • van Poll, D., Thompson, J., Colman, M., McKinnon, J., Saw, R., Stretch, J., Scolyer, R., Uren, R. (2005). A sentinel node biopsy does not increase the incidence of in-transit metastasis in patients with primary cutaneous melanoma. Annals of Surgical Oncology, 12(8), 597-608. [More Information]
  • Zhuang, L., Lee, C., Scolyer, R., McCarthy, S., Palmer, A., Zhang, X., Thompson, J., Bron, L., Hersey, P. (2005). Activation of the extracellular signal regulated kinase (ERK) pathway in human melanoma. Journal of Clinical Pathology, 58(11), 1163-1169. [More Information]
  • Thompson, J., Stretch, J., McCarthy, S. (2005). Collaboration between clinicians and pathologists: a necessity for the optimal management of melanoma patients. Cancer Forum, 29, 76-81.
  • Thompson, J., Saw, R., Stretch, J. (2005). Current strategies for the surgical management of melanoma. Cancer Forum, 29(2), 81-86.
  • Thompson, J., Shaw, H., Scolyer, R., Kefford, R. (2005). Cutaneous melanoma - Reply. The Lancet, 365(9476), 2004-2005.
  • Thompson, J., Scolyer, R., Kefford, R. (2005). Cutaneous melanoma. The Lancet, 365(9460), 687-701. [More Information]
  • Scolyer, R., Thompson, J. (2005). Desmoplastic melanoma: a heterogeneous entity in which subclassification as pure" or "mixed" may have important prognostic significance.". Annals of Surgical Oncology, 12(3), 197-9. [More Information]
  • Francken, A., Hong, A., Fulham, M., Millward, M., McCarthy, W., Thompson, J. (2005). Detection of unsuspected spinal cord compression in melanoma patients by 18F-fluorodeoxyglucose-positron emission tomography. European Journal of Surgical Oncology, 31(2), 197-204. [More Information]
  • Bron, L., Scolyer, R., Thompson, J., Hersey, P. (2005). Histological expression of tumour necrosis factor-related apotosis-induced ligand (TRAIL) in human primary melanoma. Pathology, 36(6), 561-565. [More Information]
  • McKinnon, J., Starritt, E., Scolyer, R., McCarthy, W., Thompson, J. (2005). Histopathologic excision margin affects local recurrence rate: analysis of 2681 patients with melanomas < or =2 mm thick. Annals of Surgery, 241(2), 326-333. [More Information]
  • Bourne, R., Stanwell, P., Stretch, J., Scolyer, R., Thompson, J., Mountford, C., Lean, C. (2005). In vivo and ex vivo proton MR spectroscopy of primary and secondary melanoma. European Journal of Radiology, 53(3), 506-513. [More Information]
  • Orange, S., Rasko, J., Thompson, J., Vaughan, J., Olive, E., Pedler, M., Horvath, J., Hennessy, A. (2005). Interleukin-10 regulates arterial pressure in early primate pregnancy. Cytokine, 29(4), 176-185. [More Information]
  • Thompson, J., Uren, R., Stevens, G. (2005). Internal mammary node metastasis from primary cutaneous melanoma on the anterior chest. ANZ Journal of Surgery, 75(8), 723-5. [More Information]
  • Allen, B., Raja, C., Rizvi, S., Li, Y., Tsui, W., Graham, P., Thompson, J., Reisfeld, R., Kearsley, J. (2005). Intralesional targeted alpha therapy for metastatic melanoma. Cancer Biology and Therapy, 4(12), 1318-1324. [More Information]
  • Scolyer, R., Thompson, J., McCarthy, S., Gershenwald, J., Ross, M., Cochran, A. (2005). Intraoperative frozen-section evaluation can reduce accuracy of pathologic assessment of sentinel nodes in melanoma patients. Journal of the American College of Surgeons, 201(5), 821-3; author reply 823-4. [More Information]
  • de Wilt, J., Farmer, S., Scolyer, R., McCaughan, B., Thompson, J. (2005). Isolated melanoma in the lung where there is no known primary site: metastatic disease or primary lung tumour? Melanoma Research: a journal for basic, translational and clinical research in melanoma, 15(6), 531-537. [More Information]
  • Thompson, J., Uren, R. (2005). Lymphatic mapping in management of patients with primary cutaneous melanoma. Lancet Oncology, 6(11), 877-885. [More Information]
  • Stretch, J., Thompson, J., Scolyer, R., Mountford, C., Lean, C. (2005). Magnetic resonance spectroscopy in the management of melanoma. Cancer Forum, 29(2), 73-76.
  • Stretch, J., Somorjai, R., Bourne, R., Hsiao, E., Scolyer, R., Dolenko, B., Thompson, J., Mountford, C., Lean, C. (2005). Melanoma metastases in regional lymph nodes are accurately detected by proton magnetic resonance spectroscopy of fine-needle aspirate biopsy samples. Annals of Surgical Oncology, 12(11), 943-949. [More Information]
  • Mansberg, R., Crawford, B., Uren, R., Thompson, J. (2005). Minimally invasive radio-guided surgery for recurrent thyroid cancer using iodine-123. Clinical Nuclear Medicine, 30(1), 43-44.
  • Yee, V., Thompson, J., McKinnon, J., Scolyer, R., Li, L., McCarthy, W., O'Brien, C., Quinn, M., Saw, R., Shannon, K., Stretch, J., Uren, R. (2005). Outcome in 846 cutaneous melanoma patients from a single center after a negative sentinel node biopsy. Annals of Surgical Oncology, 12(6), 429-439. [More Information]
  • Pawlik, T., Ross, M., Shaw, H., Thompson, J., Gershenwald, J. (2005). Re: Selective lymphadenectomy in sentinel node-positive patients may increase the risk of local/in-transit recurrence in malignant melanoma, Thomas and Clark. European Journal of Surgical Oncology, 31(3), 323-324. [More Information]
  • Uren, R., Howman-Giles, R., Thompson, J., Chung, D. (2005). Role of lymphoscintigraphy for selective sentinel lymphadenectomy. Cancer Treatment and Research, 127, 15-38. [More Information]
  • Thompson, J., Uren, R., Stretch, J., Scolyer, R. (2005). Selective sentinel lymphadenectomy: progress to date and prospects for the future. Cancer Treatment and Research, 127(Supplement), 269-287. [More Information]
  • Morton, D., Cochran, A., Thompson, J., Elashoff, R., Essner, R., Glass, E., Mozzillo, N., Nieweg, O., Roses, D., Hoekstra, H., et al (2005). Sentinel Node Biopsy for Early-Stage Melanoma Accuracy and Morbidity in MSLT-I, an International Multicenter Trial. Annals of Surgery, 242(3), 302-313. [More Information]
  • Pawlik, T., Ross, M., Thompson, J., Eggermont, A., Gershenwald, J. (2005). The risk of in-transit melanoma metastasis depends on tumor biology and not the surgical approach to regional lymph nodes. Journal of Clinical Oncology, 23(21), 4588-4590. [More Information]
  • Byrne, C., Thompson, J., Johnston, H., Hersey, P., Quinn, M., Hughes, M., McCarthy, W. (2005). Treatment of metastatic melanoma using electroporation therapy with bleomycin (electrochemotherapy). Melanoma Research: a journal for basic, translational and clinical research in melanoma, 15(1), 45-51. [More Information]
  • Starritt, E., Uren, R., Scolyer, R., Quinn, M., Thompson, J. (2005). Ultrasound examination of sentinel nodes in the initial assessment of patients with primary cutaneous melanoma. Annals of Surgical Oncology, 12(1), 18-23. [More Information]
  • Thompson, J., Shaw, H. (2005). Who should treat patients with primary melanoma? British Journal of Dermatology, 153(2), 459-460. [More Information]
  • Balch, C., Soong, S., Atkins, M., Buzaid, A., Cascinelli, N., Coit, D., Fleming, I., Gershenwald, J., Houghton, A., et, A., Thompson, J. (2004). An Evidence-Based Staging System For Cutaneous Melanoma. CA-a Cancer Journal for Clinicians, 54(3), 131-149.
  • Scolyer, R., Thompson, J., Li, L., Beavis, A., Dawson, M., Doble, P., Soper, R., Uren, R., Stretch, J., Sharma, R., et al (2004). Antimony Concentrations In Nodal Tissue Can Confirm Sentinel Node Identity. Modern Pathology, 17(10), 1191-1197.
  • Scolyer, R., Zhuang, L., Palmer, A., Thompson, J., McCarthy, S. (2004). Combined Naevus: A Benign Lesion Frequently Misdiagnosed Both Clinically And Pathologically As Melanoma. Pathology, 36(5), 419-427.
  • Thompson, J., Scolyer, R. (2004). Cooperation Between Surgical Oncologists And Pathologists: A Key Element Of Multidisciplinary Care For Patients With Cancer. Pathology, 36(5), 496-503.
  • de Wilt, J., Thompson, J., Uren, R., Ka, V., Scolyer, R., McCarthy, W., O'Brien, C., Quinn, M., Shannon, K. (2004). Correlation Between Preoperative Lymphoscintigraphy And Metastatic Nodal Disease Sites In 362 Patients With Cutaneous Melanomas Of The Head And Neck. Annals of Surgery, 239(4), 544-552.
  • Sarris, M., Scolyer, R., Konopka, M., Thompson, J., Harper, C., Lee, S. (2004). Cytoplasmic Expression Of Nm23 Predicts The Potential For Cerebral Metastasis In Patients With Primary Cutaneous Melanoma. Melanoma Research: a journal for basic, translational and clinical research in melanoma, 14(1), 23-27.
  • Fife, K., Colman, M., Stevens, G., Firth, I., Moon, D., Shannon, K., Harman, R., Petersen-Schaefer, K., Zacest, A., Besser, M., Milton, G., McCarthy, W., Thompson, J. (2004). Determinants Of Outcome In Melanoma Patients With Cerebral Metastases. Journal of Clinical Oncology, 22(7), 1293-1300.
  • Lindner, P., Thompson, J., de Wilt, J., Colman, M., Kam, P. (2004). Double Isolated Limb Infusion With Cytotoxic Agents For Recurrent And Metastatic Limb Melanoma. European Journal of Surgical Oncology, 30(4), 433-439. [More Information]
  • Scolyer, R., Thompson, J., Li, L., Beavis, A., Dawson, M., Doble, P., Ka, V., McKinnon, J., Soper, R., Uren, R., Shaw, H., Stretch, J., McCarthy, S. (2004). Failure To Remove True Sentinel Nodes Can Cause Failure Of The Sentinel Node Biopsy Technique: Evidence From Antimony Concentrations In False-Negative Sentinel Nodes From Melanoma Patients. Annals of Surgical Oncology, 11(Supplement 3), 174S-178S.
  • Bron, L., Scolyer, R., Thompson, J., Hersey, P. (2004). Histological Expression Of Tumour Necrosis Factor-Related Apoptosis-Inducing Ligand (Trail) In Human Primary Melanoma. Pathology, 36(6), 561-565.
  • Scolyer, R., Li, L., McCarthy, S., Shaw, H., Stretch, J., Sharma, R., Thompson, J. (2004). Immunohistochemical Stains Fail To Increase The Detection Rate Of Micrometastatic Melanoma In Completion Regional Lymph Node Dissection Specimens. Melanoma Research: a journal for basic, translational and clinical research in melanoma, 14(4), 263-268.
  • Bonenkamp, J., Thompson, J., de Wilt, J., Doubrovsky, A., de Faria Lima, R., Kam, P. (2004). Isolated Limb Infusion With Fotemustine After Dacarbazine Chemosensitisation For Inoperable Loco-Regional Melanoma Recurrence. European Journal of Surgical Oncology, 30(9), 1107-1112. [More Information]
  • Starritt, E., Joseph, D., McKinnon, J., Lo, S., de Wilt, J., Thompson, J. (2004). Lymphedema After Complete Axillary Node Dissection For Melanoma: Assessment Using A New, Objective Definition. Annals of Surgery, 240(5), 866-874.
  • Scolyer, R., Li, L., McCarthy, S., Shaw, H., Stretch, J., Sharma, R., Thompson, J. (2004). Micromorphometric Features Of Positive Sentinel Lymph Nodes Predict Involvement Of Nonsentinel Nodes In Patients With Melanoma. American Journal of Clinical Pathology, 122(4), 532-539.
  • Howman-Giles, R., Thompson, J., Chung, D., Uren, R. (2004). Nuclear Medicine Aspects Of Melanoma And Breast Lymphatic Mapping. Seminars in Oncology, 31(3), 338-348.
  • Scolyer, R., Thompson, J., Stretch, J., Sharma, R., McCarthy, S. (2004). Pathology Of Melanocytic Lesions: New, Controversial, And Clinically Important Issues. Journal of Surgical Oncology, 86(4), 200-211. [More Information]
  • Thompson, J., Stretch, J., Uren, R., Ka, V., Scolyer, R. (2004). Sentinel Node Biopsy For Melanoma: Where Have We Been And Where Are We Going? Annals of Surgical Oncology, 11(Supplement 3), 147S-151S.
  • Doubrovsky, A., De Wilt, J., Scolyer, R., McCarthy, W., Thompson, J. (2004). Sentinel Node Biopsy Provides More Accurate Staging Than Elective Lymph Node Dissection In Patients With Cutaneous Melanoma. Annals of Surgical Oncology, 11(9), 829-836.
  • Thompson, J., Shaw, H. (2004). Should Tumor Mitotic Rate and Patient Age, As Well As Tumor Thickness, be Used to Select Melanoma Patients for Sentinel Node Biopsy? Annals of Surgical Oncology, 11(3), 233-235.
  • Thompson, J., Scolyer, R., Dahlstrom, J., Jain, S. (2004). Spitz Naevus: Diagnostic Problems And Their Management Implications. Pathology, 36(5), 452-457.
  • Allen, B., Raja, C., Rizvi, S., Li, Y., Tsui, W., Zhang, D., Song, E., Qu, C., Kearsley, J., Graham, P., Thompson, J. (2004). Targeted Alpha Therapy For Cancer. Physics in Medicine and Biology, 49(16), 3703-3712.
  • Thompson, J., Uren, R. (2004). Teaching Points On Lymphatic Mapping For Melanoma From The Sydney Melanoma Unit. Seminars in Oncology, 31(3), 349-356.
  • Thompson, J., Shaw, H., Hersey, P., Scolyer, R. (2004). The History And Future Of Melanoma Staging. Journal of Surgical Oncology, 86(4), 224-235. [More Information]
  • Francken, A., Shaw, H., Thompson, J., Soong, S., Accortt, N., Azzola, M., Scolyer, R., Milton, G., McCarthy, W., Colman, M., et al (2004). The Prognostic Importance Of Tumor Mitotic Rate Confirmed In 1317 Patients With Primary Cutaneous Melanoma And Long Follow-Up. Annals of Surgical Oncology, 11(4), 426-433.
  • Shaw, H., Thompson, J. (2004). Validity of reported melanoma incidence rates in New Zealand. ANZ Journal of Surgery, 74(11), 1016-1017.
  • Dawson, M., Doble, P., Beavis, A., Li, L., Soper, R., Scolyer, R., Uren, R., Thompson, J. (2003). Antimony by ICP-MS as a marker for sentinel lymphnodes in melanoma patients. The Analyst, 128(3), 217-219.
  • Li, L., Crotty, K., Palmer, A., Kril, J., Scolyer, R., Thompson, J., Li, L., McCarthy, S. (2003). Argyrophilic staining of nucleolar organizer region count and morphometry in benign and melignant melanocytic lesions. American Journal Of Dermatopathology, 25(3), 190-197.
  • McJannett, M., Butow, P., Tattersall, M., Thompson, J. (2003). Asking questions can help: development of a question prompt list for cancer patients seeing a surgeon. European Journal of Cancer Prevention, 12(5), 397-405.
  • Slater, M., Scolyer, R., Gidley-Baird, A., Thompson, J., Barden, J. (2003). Increased expression of apoptotic markers in melanoma. Melanoma Research: a journal for basic, translational and clinical research in melanoma, 13(2), 137-145.
  • Scolyer, R., Shaw, H., Thompson, J., Li, L., Colman, M., Lo, S., McCarthy, S., Palmer, A., Nicoll, K., Dutta, B., Stretch, J., et al (2003). Interobserver reproducibility of histopathologic prognostic variables in primary cutaneous melanomas. American Journal of Surgical Pathology, 27(12), 1571-1576.
  • Balch, C., Buzaid, A., Soong, S., Atkins, M., Cascinelli, N., Coit, D., Fleming, I., Gershenwald, J., Houghton, A., Kirkwood, J., Thompson, J., et al (2003). New TNM melanoma staging system: linking biology and natural history to clinical outcomes. Seminars in Surgical Oncology, 21(1), 43-52. [More Information]
  • Li, L., Scolyer, R., Ka, V., McKinnon, J., Shaw, H., McCarthy, S., Thompson, J. (2003). Pathologic Review of Negative Sentinel Lymph Nodes in Melanoma Patients With Regional Recurrence: A Clinicopathologic Study of 1152 Patients Undergoing Sentinel Lymph Node Biopsy. American Journal of Surgical Pathology, 27(9), 1197-1202.
  • Uren, R., Howman-Giles, R., Thompson, J. (2003). Patterns of lymphatic drainage from the skin in patients with melanoma*. The Journal of Nuclear Medicine, 44, 570-582.
  • McKinnon, J., Yu, X., McCarthy, W., Thompson, J. (2003). Prognosis for patients with thin cutaneous melanoma. Cancer, 98(6), 1223-1231. [More Information]
  • Schofield, P., Butow, P., Thompson, J., Tattersall, M., Beeney, L., Dunn, S. (2003). Psychological responses of patients receiving a diagnosis of cancer. Annals of Oncology, 14, 48-56.
  • Lean, C., Bourne, R., Thompson, J., Scolyer, R., Stretch, J., Li, L., Russell, P., Mountford, C. (2003). Rapid detection of metastatic melanoma in lymph nodes using proton magnetic resonance spectroscopy of fine needle aspiration biospy specimens. Melanoma Research: a journal for basic, translational and clinical research in melanoma, 13(3), 259-261.
  • Uren, R., Howman-Giles, R., Thompson, J. (2003). Reconfirmation of clinical unpredictability of lymphatic drainage in cutaneous melanoma and new developments in sentinel lymph node diagnostics. The Journal of Nuclear Medicine, 11, 1871-1872.
  • de Wilt, J., McCarthy, W., Thompson, J. (2003). Surgical treatment of splenic metastases in patients with melanoma. Journal of the American College of Surgeons, 197(1), 38-43.
  • Thompson, J., Shaw, H., Stretch, J., McCarthy, W., Milton, G. (2003). The Sydney Melanoma Unit - a multidisciplinary melanoma treatment center. Surgical Clinics of North America, 83(2), 431-451.
  • Azzola, M., Shaw, H., Thompson, J., Soong, S., Scolyer, R., Watson, G., Colman, M., Zhang, Y. (2003). Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma: An analysis of 3661 patients from a single center. Cancer, 97(6), 1488-1498. [More Information]
  • Li, L., Crotty, K., Scolyer, R., Thompson, J., Kril, J., Palmer, A., McCarthy, S. (2003). Use of multiple cytometric markers improves discrimination between benign and malignant melanocytic lesions: a study of DNA microdensitometry, karyometry, argyophilic staining of nucleolar organizer regions and MIBI1-Ki67 immunoreactivity. Melanoma Research: a journal for basic, translational and clinical research in melanoma, 13(6), 581-586.
  • Coates, A., Thompson, J., McMullen, A., Simes, R., McCarthy, W., Hersey, P., Sillar, R., Mcleod, R., Gill, P., Coventry, B., Dhillon, H. (2002). Adjuvant Immunotherapy of Patients with High-Risk Melanoma Using Vaccinia Viral Lysates of Melanoma: Results of a Randomized Trial. Journal of Clinical Oncology, 20(20), 4181-4189.
  • Shaw, H., Thompson, J. (2002). Frequency of nonsentinel lymph node metastasis in melanoma. Annals of Surgical Oncology, 9(9), 934-934.
  • Tattersall, M., Butow, P., Brown, J., Thompson, J. (2002). Improving doctors' letters. Medical Journal of Australia, 177(4), 516-520.
  • Lindner, P., Doubrovsky, A., Kam, P., Thompson, J. (2002). Prognostic Factors After Isolated Limb Infusion With Cytotoxic Agents for Melanoma. Annals of Surgical Oncology, , 127-136.
  • Zacest, A., Besser, M., Stevens, G., Thompson, J., McCarthy, W., Culjak, G. (2002). Surgical management of cerebral metastases from melanoma: outcome in 147 patients treated at a single institution over two decades. Journal of Neurosurgery, 96(3), 552-558.
  • Thompson, J., Shaw, H. (2002). The Prognosis of Patients With Thick Primary Melanomas: Is Regional Lymph Node Status Relevant, and Does Removing Positive Regional Nodes Influence Outcome? Annals of Surgical Oncology, 9(8), 719-722.
  • Thompson, J., Uren, R. (2001). Anomalous lymphatic drainage patterns in patients with cutaneous melanoma. Tumori: a journal of experimental and clinical oncology, 87.
  • Thompson, J., Balch, C., Buzaid, A., Soong, S., Atkins,, M., Cascinelli, N., Coit,, D., Fleming, I., Gershenwald, J., Houghton,, A., et al (2001). Final version of the american joint committee on cancer staging system for cutaneous melanoma. Journal of Clinical Oncology, 19, 3635-3648.
  • Beeney, L., Thompson, J., Butow, P., Tattersall, M., Dunn, S., Schofield, P. (2001). Hearing the bad news of a cancer diagnosis: the Australian melanoma patient's perspective. Annals of Oncology, 12, 365-371.
  • Thompson, J., Fife, K. (2001). Lymph-node metastases in patients with melanoma: what is the optimum management? Lancet Oncology, 2, 614-621.
  • Thompson, J., Uren, R. (2001). Lymphatic mapping and sentinel node biopsy for melanoma. Expert Review of Anticancer Therapy, 1, 446-452.
  • Thompson, J., Siebert, G., Anissimov, Y., Smithers, B., Doubrovsky, A., Anderson, C., Roberts, M. (2001). Microdialysis and response during regional chemotherapy by isolated limb infusion of melphalan for limb malignancies. British Journal of Cancer, 85 (2), 157-165.
  • Thompson, J., Roberts, M., Wu, Z., Siebert, G., Anissimov, Y., Smithers, B. (2001). Pharmacokinetics and pharmacodynamics of melphalan in isolated limb infusion for recurrent localized limb malignancy. Melanoma Research: a journal for basic, translational and clinical research in melanoma, 11(4), 423-431.
  • Thompson, J., Balch, C., Soong, S., Gershenwald, J., Reintgen, D., Cascinelli, N., Urist, M., McMasters, K., Ross, M., Kirkwod, J., et al (2001). Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System. Journal of Clinical Oncology, 19, 3622-3634.
  • Thompson, J., Roberts, M., Wu, Z., Siebert, G., Smithers, B. (2001). Saturable dose-response relationships for melphalan in melanoma treatment by isolated limb infusion in the nude rat. Melanoma Research: a journal for basic, translational and clinical research in melanoma, 11, 611-618.
  • Thompson, J. (2001). The sydney melanoma unit experience of sentinel lymphadenectomy for melanoma. Annals of Surgical Oncology, 8.
  • Barnetson, R., Rose, B., Thompson, J., Damian,, D., Bonenkamp, J. (2001). Treatment of refractory hand warts by isolated limb infusion with melphalan and actinomycin D. Australasian Journal of Dermatology, 42, 106-109.
  • Uren, R., Howman-Giles, R., Thompson, J., McCarthy, W., Quinn, M., Roberts, J., Shaw, H. (2000). Interval nodes: The forgotten sentinel nodes in patients with melanoma. JAMA (formerly Archives Of Surgery), 135(10), 1168-1172.

Conferences

  • Cochran, A., Morton, D., Thompson, J. (2006). Pathology-driven immediate lymphadenectomy for primary melanoma: Impact on staging, prognostication and outcome. United States and Canadian Academy of Pathology Annual Meeting 2006, United States: Nature Publishing Group.

Patents

  • Thompson, J., Armstrong, B., Barbour, A., Barnetson, R., Beanland, H., Beer, T., Brookshank, M., Burmeister, B., Butow, P., Clark, K., Conway, R., Damian, D., Frommer, M., Kefford, R., Lee, S., Mason, R., Mann, G., McCarthy, W., Menzies, S., Olver, I., Quinn, M., Saw, R., Shaw, H., Stretch, J., Barraclough, B., Holt, P., Reeve, T., et al (2008).

2014

  • Rizos, H., Menzies, A., Pupo, G., Carlino, M., Fung, C., Hyman, J., Haydu, L., Mijatov, B., Becker, T., Boyd, S., Howle, J., Saw, R., Thompson, J., Kefford, R., Scolyer, R., Long, G. (2014). BRAF inhibitor resistance mechanisms in metastatic melanoma: spectrum and clinical impact. Clinical Cancer Research, 20(7), 1965-1977. [More Information]
  • Suttie, C., Hruby, G., Horvath, L., Thompson, J. (2014). Cardiac metastasis in Merkel cell carcinoma. Journal of Clinical Oncology, 32(13), e52-e53. [More Information]
  • Wilmott, J., Haydu, L., Menzies, A., Lum, T., Hyman, J., Thompson, J., Hersey, P., Kefford, R., Scolyer, R., Long, G. (2014). Dynamics of chemokine, cytokine, and growth factor serum levels in BRAF-mutant melanoma patients during BRAF inhibitor treatment. Journal of Immunology, 192(5), 2505-2513. [More Information]
  • Marzese, D., Scolyer, R., Huynh, J., Huang, S., Hirose, H., Chong, K., Kiyohara, E., Wang, J., Kawas, N., Donovan, N., Buckland, M., Thompson, J., et al (2014). Epigenome-wide DNA methylation landscape of melanoma progression to brain metastasis reveals aberrations on homeobox D cluster associated with prognosis. Human Molecular Genetics, 23(1), 226-238. [More Information]
  • Griewank, K., Scolyer, R., Thompson, J., Flaherty, K., Schadendorf, D., Murali, R. (2014). Genetic Alterations and Personalized Medicine in Melanoma: Progress and Future Prospects. National Cancer Institute. Journal, 106(2), 1-17. [More Information]
  • Zimmer, L., Haydu, L., Menzies, A., Scolyer, R., Kefford, R., Thompson, J., Schadendorf, D., Long, G. (2014). Incidence of New Primary Melanomas After Diagnosis of Stage III and IV Melanoma. Journal of Clinical Oncology, 32(8), 816-823. [More Information]
  • Menzies, A., Lum, T., Wilmott, J., Hyman, J., Kefford, R., Thompson, J., O'Toole, S., Long, G., Scolyer, R. (2014). Intrapatient Homogeneity of BRAFV600E Expression in Melanoma. The American Journal of Surgical Pathology, 38(3), 377-382. [More Information]
  • Kroon, H., Huismans, A., Kam, P., Thompson, J. (2014). Isolated limb infusion with melphalan and actinomycin D for melanoma: A systematic review. Journal of Surgical Oncology, 109(4), 348-351. [More Information]
  • Kroon, H., Huismans, A., Waugh, R., Kam, P., Thompson, J. (2014). Isolated limb infusion: Technical aspects. Journal of Surgical Oncology, 109(4), 352-356. [More Information]
  • Thompson, J. (2014). Local and regional therapies for melanoma: many arrows in the quiver. Journal of Surgical Oncology, 109(4). [More Information]
  • van der Ploeg, A., Haydu, L., Spillane, A., Quinn, M., Saw, R., Shannon, K., Stretch, J., Uren, R., Scolyer, R., Thompson, J. (2014). Outcome Following Sentinel Node Biopsy Plus Wide Local Excision Versus Wide Local Excision Only for Primary Cutaneous Melanoma: Analysis of 5840 Patients Treated at a Single Institution. Annals of Surgery, 260(1), 149-157. [More Information]
  • Niebling, M., Haydu, L., Karim, R., Thompson, J., Scolyer, R. (2014). Pathology Review Significantly Affects Diagnosis and Treatment of Melanoma Patients: An Analysis of 5011 Patients Treated at a Melanoma Treatment Center. Annals of Surgical Oncology, 21(7), 2245-2251. [More Information]
  • Spillane, A., Pasquali, S., Haydu, L., Thompson, J. (2014). Patterns of Recurrence and Survival After Lymphadenectomy in Melanoma Patients: Clarifying the Effects of Timing of Surgery and Lymph Node Tumor Burden. Annals of Surgical Oncology, 21(1), 292-299. [More Information]
  • Song, E., Scolyer, R., Damian, D., Thompson, J. (2014). Primary oesophageal melanoma - a case report. World Journal of Surgical Oncology, 12(1), 77-77. [More Information]
  • Shashank, A., Shehata, M., Morris, D., Thompson, J. (2014). Radiofrequency ablation in metastatic melanoma. Journal of Surgical Oncology, 109(4), 366-369. [More Information]
  • Howman-Giles, R., Uren, R., Thompson, J. (2014). Sentinel Lymph Node Biopsy in Pediatric and Adolescent Patients: A Proven Technique. Annals of Surgery, 259(6), e86-e86. [More Information]
  • Naehrig, D., Uren, R., Emmett, L., Ioannou, K., Hong, A., Wratten, C., Thompson, J., Hruby, G. (2014). Sentinel lymph node mapping for defining site and extent of elective radiotherapy management of regional nodes in Merkel cell carcinoma: a pilot case series. Journal of Medical Imaging and Radiation Oncology, 58, 353-359. [More Information]
  • Thompson, J., Hruby, G. (2014). The role of sentinel lymph node biopsy in patients with merkel cell carcinoma: uncertainty prevails. Annals of Surgical Oncology, 21(5), 1517-1519. [More Information]
  • Damian, D., Saw, R., Thompson, J. (2014). Topical Immunotherapy with Diphencyprone for in Transit and Cutaneously Metastatic Melanoma. Journal of Surgical Oncology, 109(4), 308-313. [More Information]
  • Schatton, T., Scolyer, R., Thompson, J., Mihm Jnr, M. (2014). Tumor-infiltrating lymphocytes and their significance in melanoma prognosis. In Magdalena Thurim, Francesco M. Marincola (Eds.), Molecular Diagnostics for Melanoma: Methods and Protocols, (pp. 287-324). New York: Humana Press. [More Information]

2013

  • Balch, C., Soong, S., Gershenwald, J., Thompson, J., Coit, D., Atkins, M., Ding, S., Cochran, A., Eggermont, A., Flaherty, K., et al (2013). Age as a Prognostic Factor in Patients with Localized Melanoma and Regional Metastases. Annals of Surgical Oncology, 20(12), 3961-3968. [More Information]
  • Wevers, K., Murali, R., Bastiaannet, E., Scolyer, R., Suurmeijer, A., Thompson, J., Hoekstra, H. (2013). Assessment of a new scoring system for predicting non-sentinel node positivity in sentinel node-positive melanoma patients. European Journal of Surgical Oncology, 39(2), 179-184. [More Information]
  • Murali, R., Wilmott, J., Jakrot, V., Al-Ahmadie, H., Wiesner, T., McCarthy, S., Thompson, J., Scolyer, R. (2013). BAP1 expression in cutaneous melanoma: a pilot study. Pathology, 45(6), 606-609. [More Information]
  • Scolyer, R., Thompson, J. (2013). Biospecimen banking: The pathway to personalized medicine for patients with cancer. Journal of Surgical Oncology, 107(7), 681-682. [More Information]
  • Mann, G., Pupo, G., Campain, A., Carter, C., Schramm, S., Pianova, S., Gerega, S., Desilva, C., Lai, K., Wilmott, J., Hersey, P., Kefford, R., Thompson, J., Yang, J., Scolyer, R., et al (2013). BRAF Mutation, NRAS Mutation, and the Absence of an Immune-Related Expressed Gene Profile Predict Poor Outcome in Patients with Stage III Melanoma. The Journal of Investigative Dermatology, 133(2), 509-517. [More Information]
  • Wilmott, J., Menzies, A., Haydu, L., Capper, D., Preusser, M., Zhang, Y., Thompson, J., Kefford, R., von Diemling, A., Scolyer, R., Long, G. (2013). BRAF(V600E) protein expression and outcome from BRAF inhibitor treatment in BRAF(V600E) metastatic melanoma. British Journal of Cancer, 108(4), 924-931. [More Information]
  • Mar, V., Wong, S., Li, J., Scolyer, R., McLean, C., Papenfuss, A., Tothill, R., Kakavand, H., Mann, G., Thompson, J., et al (2013). BRAF/NRAS Wild-Type Melanomas Have a High Mutation Load Correlating with Histologic and Molecular Signatures of UV Damage. Clinical Cancer Research, 19(17), 4589-4598. [More Information]
  • Murali, R., Scolyer, R., Thompson, J. (2013). Completion lymph node dissection in melanoma patients with positive sentinel lymph nodes. European Journal of Surgical Oncology, 39(10), 1164-1165. [More Information]
  • Shiau, C., Thompson, J., Scolyer, R. (2013). Controversies and evolving concepts in the diagnosis, classification and management of lentigo maligna. Expert Review of Dermatology, 8(2), 195-214. [More Information]
  • Scolyer, R., Judge, M., Evans, A., Frishberg, D., Prieto, V., Thompson, J., Trotter, M., Walsh, M., Walsh, N., Ellis, D. (2013). Data set for pathology reporting of cutaneous invasive melanoma: Recommendations from the international collaboration on cancer reporting (ICCR). The American Journal of Surgical Pathology, 37(12), 1797-1814. [More Information]
  • Scolyer, R., Karim, R., Thompson, J., Stretch, J., McCarthy, S., Murali, R. (2013). Digital papillary adenocarcinoma: a tumour that should be considered in the differential diagnosis of neoplasms involving the digits. Pathology, 45(1), 55-61. [More Information]
  • Long, G., Wilmott, J., Haydu, L., Tembe, V., Sharma, R., Rizos, H., Thompson, J., Howle, J., Scolyer, R., Kefford, R. (2013). Effects of BRAF inhibitors on human melanoma tissue before treatment, early during treatment and on progression. Pigment Cell and Melanoma Research, 26(4), 499-508. [More Information]
  • Sondak, V., Wong, S., Gershenwald, J., Thompson, J. (2013). Evidence-Based Clinical Practice Guidelines on the Use of Sentinel Lymph Node Biopsy in Melanoma. American Society of Clinical Oncology Educational Book, 2013, 320-325. [More Information]
  • Rychetnik, L., McCaffery, K., Morton, R., Thompson, J., Menzies, S., Irwig, L. (2013). Follow-Up of Early Stage Melanoma: Specialist Clinician Perspectives on the Functions of Follow-Up and Implications for Extending Follow-Up Intervals. Journal of Surgical Oncology, 107(5), 463-468. [More Information]
  • Kakavand, H., Scolyer, R., Thompson, J., Mann, G. (2013). Identification of new prognostic biomarkers for Stage III metastatic melanoma patients. OncoImmunology, 2(9), e25564-1-e25564-3. [More Information]
  • Long, G., Wilmott, J., Capper, D., Preusser, M., Zhang, Y., Thompson, J., Kefford, R., von Deimling, A., Scolyer, R. (2013). Immunohistochemistry Is Highly Sensitive and Specific for the Detection of V600E BRAF Mutation in Melanoma. The American Journal of Surgical Pathology, 37(1), 61-65. [More Information]
  • Ryu, S., Robyn, S., Scolyer, R., Crawford, M., Thompson, J., Sandroussi, C. (2013). Liver resection for metastatic melanoma: Equivalent survival for cutaneous and ocular primaries. Journal of Surgical Oncology, 108(2), 129-135. [More Information]
  • Pasquali, S., van der Ploeg, A., Mocellin, S., Stretch, J., Thompson, J., Scolyer, R. (2013). Lymphatic biomarkers in primary melanomas as predictors of regional lymph node metastasis and patient outcomes. Pigment Cell and Melanoma Research, 26(3), 326-337. [More Information]
  • Harish, V., Bond, J., Scolyer, R., Haydu, L., Saw, R., Quinn, M., Benger, R., Uren, R., Stretch, J., Shannon, K., Thompson, J. (2013). Margins of excision and prognostic factors for cutaneous eyelid melanomas. Journal of Plastic, Reconstructive and Aesthetic Surgery, 66(8), 1066-1073. [More Information]
  • Thompson, J., Menzies, A. (2013). Melanoma. Cancer Forum, 37(1), 65-66.
  • Dutton-Regester, K., Kakavand, H., Aoude, L., Stark, M., Gartside, M., Johansson, P., O'Connor, L., Lanagan, C., Tembe, V., Pupo, G., Haydu, L., Mann, G., Thompson, J., Scolyer, R., et al (2013). Melanomas of unknown primary have a mutation profile consistent with cutaneous sun-exposed melanoma. Pigment Cell and Melanoma Research, 26(6), 852-860. [More Information]
  • Scolyer, R., Thompson, J. (2013). Mitotic rate in melanoma should be recorded as the number of mitoses per mm(2) (not per high power field): surgeons tell your pathologists!. The American Journal Of Surgery, 206(1), 142-143. [More Information]
  • Morton, R., Rychetnik, L., McCaffery, K., Thompson, J., Irwig, L. (2013). Patients' perspectives of long-term follow-up for localised cutaneous melanoma. European Journal of Surgical Oncology, 39, 297-303. [More Information]
  • Niebling, M., Haydu, L., Karim, R., Thompson, J., Scolyer, R. (2013). Reproducibility of AJCC Staging Parameters in Primary Cutaneous Melanoma: An Analysis of 4,924 Cases. Annals of Surgical Oncology, 20(12), 3969-3975. [More Information]
  • Winstanley, J., Saw, R., Boyle, F., Thompson, J. (2013). The FACT-Melanoma Quality-of-Life Instrument: comparison of a five-point and four-point response scale using the Rasch measurement model. Melanoma Research, 23(1), 61-69. [More Information]
  • Pasquali, S., Haydu, L., Scolyer, R., Winstanley, J., Spillane, A., Quinn, M., Saw, R., Shannon, K., Stretch, J., Thompson, J. (2013). The Importance of Adequate Primary Tumor Excision Margins and Sentinel Node Biopsy in Achieving Optimal Locoregional Control for Patients With Thick Primary Melanomas. Annals of Surgery, 258(1), 152-157. [More Information]
  • Hruby, G., Scolyer, R., Thompson, J. (2013). The important role of radiation treatment in the management of Merkel cell carcinoma. British Journal of Dermatology, 169(5), 975-982. [More Information]
  • Peach, H., van der Ploeg, A., Haydu, L., Stretch, J., Shannon, K., Uren, R., Thompson, J. (2013). The Unpredictability of Lymphatic Drainage from the Ear in Melanoma Patients, and Its Implications for Management. Annals of Surgical Oncology, 20(5), 1707-1713. [More Information]
  • Winstanley, J., White, E., Boyle, F., Thompson, J. (2013). What are the pertinent quality-of-life issues for melanoma cancer patients? Aiming for the development of a new module to accompany the EORTC core questionnaire. Melanoma Research, 23(2), 167-174. [More Information]

2012

  • Huynh, K., Takei, Y., Scolyer, R., Murali, R., Chong, K., Takeshima, L., Sim, M., Morton, D., Turner, R., Thompson, J., et al (2012). Aberrant hypermethylation in primary tumours and sentinel lymph node metastases in paediatric patients with cutaneous melanoma. British Journal of Dermatology, 166(6), 1319-1326. [More Information]
  • Tran, S., Haferkamp, S., Scurr, L., Gowrishankar, K., Becker, T., Desilva, C., Thompson, J., Scolyer, R., Kefford, R., Rizos, H. (2012). Absence of Distinguishing Senescence Traits in Human Melanocytic Nevi. The Journal of Investigative Dermatology, 132(9), 2226-2234. [More Information]
  • Burmeister, B., Henderson, M., Thompson, J. (2012). Adjuvant nodal irradiation in melanoma- Authors' reply. Lancet Oncology, 13(8), e327-e327.
  • Burmeister, B., Henderson, M., Ainslie, J., Fisher, R., Dilulio, J., Smithers, B., Hong, A., Shannon, K., Scolyer, R., Carruthers, S., Thompson, J., et al (2012). Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial. The Lancet Oncology, 13(6), 589-597. [More Information]
  • Wilmott, J., Haydu, L., Bagot, M., Zhang, Y., Jakrot, V., McCarthy, S., Lugassy, C., Thompson, J., Scolyer, R., Jakrot, V., et al (2012). Angiotropism is an independent predictor of microscopic satellites in primary cutaneous melanoma. Histopathology, 61(5), 889-898. [More Information]
  • Hoshimoto, S., Faries, M., Morton, D., Shingai, T., Kuo, C., Wang, H., Elashoff, R., Mozzillo, N., Kelley, M., Thompson, J., et al (2012). Assessment of Prognostic Circulating Tumor Cells in a Phase III Trial of Adjuvant Immunotherapy After Complete Resection of Stage IV Melanoma. Annals of Surgery, 255(2), 357-362. [More Information]
  • Murali, R., Scolyer, R., Thompson, J. (2012). Can we better identify thin cutaneous melanomas that are likely to metastasize and cause death? Annals of Surgical Oncology, 19(11), 3310-3312. [More Information]
  • Kim, J., McCarthy, S., Thompson, J., Pupo, G., Vonthethoff, L., Nash, P., Mann, G., Scolyer, R. (2012). Cellular blue naevus involving the urinary bladder. Pathology, 44(7), 664-668. [More Information]
  • Murali, R., Haydu, L., Long, G., Quinn, M., Saw, R., Shannon, K., Spillane, A., Stretch, J., Kefford, R., Thompson, J., Scolyer, R. (2012). Clinical and Pathologic Factors Associated with Distant Metastasis and Survival in Patients with Thin Primary Cutaneous Melanoma. Annals of Surgical Oncology, 19(6), 1782-1789. [More Information]
  • Bastiaannet, E., Uyl-de Groot, C., Brouwers, A., van der Jagt, E., Hoekstra, O., Oyen, W., Verzijlbergen, F., van Ooijen, B., Thompson, J., Hoekstra, H. (2012). Cost-effectiveness of adding FDG-PET or CT to the diagnostic work-up of patients with stage III melanoma. Annals of Surgery, 255(4), 771-776. [More Information]
  • Sundaresan, P., Hruby, G., Hamilton, A., Hong, A., Boyer, M., Chatfield, M., Thompson, J. (2012). Definitive Radiotherapy or Chemoradiotherapy in the Treatment of Merkel Cell Carcinoma. Clinical Oncology, 24(9), e131-e136. [More Information]
  • Menzies, A., Haydu, L., Visintin, L., Carlino, M., Howle, J., Thompson, J., Kefford, R., Scolyer, R., Long, G. (2012). Distinguishing Clinicopathologic Features of Patients with V600E and V600K BRAF-Mutant Metastatic Melanoma. Clinical Cancer Research, 18(12), 3242-3249. [More Information]
  • Spillane, A., Haydu, L., Lee, N., Uren, R., Stretch, J., Shannon, K., Quinn, M., Saw, R., McCarthy, W., Thompson, J. (2012). Evaluation of Incomplete Sentinel Node Biopsy Procedures and Sentinel Node Positivity Rates as Surgical Quality-Assurance Parameters in Melanoma Patients. Annals of Surgical Oncology, 19(12), 3919-3925. [More Information]
  • Lim, C., Whalley, D., Haydu, L., Murali, R., Tippett, J., Thompson, J., Hruby, G., Scolyer, R. (2012). Increasing Tumor Thickness is Associated with Recurrence and Poorer Survival in Patients with Merkel Cell Carcinoma. Annals of Surgical Oncology, 19(11), 3325-3334. [More Information]
  • Wilmott, J., Tembe, V., Howle, J., Sharma, R., Thompson, J., Rizos, H., Lo, R., Kefford, R., Scolyer, R., Long, G. (2012). Intratumoral Molecular Heterogeneity in a BRAF-Mutant, BRAF Inhibitor-Resistant Melanoma: A Case Illustrating the Challenges for Personalized Medicine. Molecular Cancer Therapeutics, 11(12), 2704-2708. [More Information]
  • Huismans, A., Kroon, H., Haydu, L., Kam, P., Thompson, J. (2012). Is Melphalan Dose Adjustment According to Ideal Body Weight Useful in Isolated Limb Infusion for Melanoma? Annals of Surgical Oncology, 19(9), 3050-3056. [More Information]
  • Lian, C., Xu, Y., Ceol, C., Wu, F., Larson, A., Dresser, K., Xu, W., Tan, L., Hu, Y., Zhan, Q., Scolyer, R., Thompson, J., Kakavand, H., et al (2012). Loss of 5-Hydroxymethylcytosine Is an Epigenetic Hallmark of Melanoma. Cell, 150(6), 1135-1146. [More Information]
  • Shayan, R., Karnezis, T., Murali, R., Wilmott, J., Ashton, M., Taylor, G., Thompson, J., Hersey, P., Achen, M., Scolyer, R., et al (2012). Lymphatic vessel density in primary melanomas predicts sentinel lymph node status and risk of metastasis. Histopathology, 61(4), 702-710. [More Information]
  • Thompson, J., Scolyer, R., Kefford, R. (2012). Melanoma: A management guide for GPs. Australian Family Physician, 41(7), 470-473. [More Information]
  • Howard, J., Thompson, J., Mozzillo, N., Nieweg, O., Hoekstra, H., Roses, D., Sondak, V., Reintgen, D., Kashani-Sabet, M., Karakousis, C., et al (2012). Metastasectomy for Distant Metastatic Melanoma: Analysis of Data from the First Multicenter Selective Lymphadenectomy Trial (MSLT-I). Annals of Surgical Oncology, 19(8), 2547-2555. [More Information]
  • Murali, R., Brown, P., Kefford, R., Scolyer, R., Thompson, J., Atkins, M., Long, G. (2012). Number of Primary Melanomas Is an Independent Predictor of Survival in Patients With Metastatic Melanoma. Cancer, 118(18), 4519-4529. [More Information]
  • Lim, C., Thompson, J., McKenzie, P., McCarthy, S., Scolyer, R. (2012). Peritoneal melanosis associated with metastatic melanoma involving the omentum. Pathology, 44(3), 255-257. [More Information]
  • in 't Hout, F., Haydu, L., Murali, R., Bonenkamp, J., Thompson, J., Scolyer, R. (2012). Prognostic Importance of the Extent of Ulceration in Patients With Clinically Localized Cutaneous Melanoma. Annals of Surgery, 255(6), 1165-1170. [More Information]
  • Thompson, J., Hong, A., Fogarty, G. (2012). Publication and Interpretation of Clinical Trial Results: The Need for Caution. Annals of Surgical Oncology, 19(6), 1745-1747. [More Information]
  • Wilmott, J., Long, G., Howle, J., Haydu, L., Sharma, R., Thompson, J., Kefford, R., Hersey, P., Scolyer, R. (2012). Selective BRAF inhibitors induce marked T - cell infiltration into human metastatic melanoma. Clinical Cancer Research, 18(5), 1386-1394. [More Information]
  • Murali, R., Haydu, L., Quinn, M., Saw, R., Shannon, K., Spillane, A., Stretch, J., Thompson, J., Scolyer, R. (2012). Sentinel Lymph Node Biopsy in Patients With Thin Primary Cutaneous Melanoma. Annals of Surgery, 255(1), 128-133. [More Information]
  • Murali, R., Desilva, C., McCarthy, S., Thompson, J., Scolyer, R. (2012). Sentinel Lymph Nodes Containing Very Small (<0.1 mm) Deposits of Metastatic Melanoma Cannot Be Safely Regarded as Tumor-Negative. Annals of Surgical Oncology, 19(4), 1089-1099. [More Information]
  • Spillane, A., Thompson, J. (2012). Sentinel node biopsy for breast cancer: then and now. ANZ Journal of Surgery, 82(7/8), 481-483. [More Information]
  • Rychetnik, L., Morton, R., McCaffery, K., Thompson, J., Menzies, S., Irwig, L. (2012). Shared care in the follow-up of early-stage melanoma: a qualitative study of Australian melanoma clinicians' perspectives and models of care. BMC Health Services Research, 12, 1-9. [More Information]
  • Girouard, S., Laga, A., Mihm, M., Scolyer, R., Thompson, J., Zhan, Q., Widlund, H., Lee, C., Murphy, G. (2012). SOX2 contributes to melanoma cell invasion. Laboratory Investigation, 92(3), 362-370. [More Information]
  • Pasquali, S., Spillane, A., de Wilt, J., McCaffery, K., Rossi, C., Quinn, M., Saw, R., Shannon, K., Stretch, J., Thompson, J. (2012). Surgeons' Opinions on Lymphadenectomy in Melanoma Patients with Positive Sentinel Nodes: A Worldwide Web-Based Survey. Annals of Surgical Oncology, 19(13), 4322-4329. [More Information]
  • Chua, T., Scolyer, R., Kennedy, C., Yan, T., McCaughan, B., Thompson, J. (2012). Surgical Management of Melanoma Lung Metastasis: An Analysis of Survival Outcomes in 292 Consecutive Patients. Annals of Surgical Oncology, 19(6), 1774-1781. [More Information]
  • Gershenwald, J., Coit, D., Sondak, V., Thompson, J. (2012). The challenge of defining guidelines for sentinel lymph node biopsy in patients with thin primary cutaneous melanomas. Annals of Surgical Oncology, 19(11), 3301-3303. [More Information]
  • Martin, R., Shannon, K., Quinn, M., Saw, R., Spillane, A., Stretch, J., Colman, M., Gao, K., Thompson, J. (2012). The Management of Cervical Lymph Nodes in Patients with Cutaneous Melanoma. Annals of Surgical Oncology, 19(12), 3926-3932. [More Information]
  • Azimi, F., Scolyer, R., Rumcheva, P., Moncrieff, M., Murali, R., McCarthy, S., Saw, R., Thompson, J. (2012). Tumor-Infiltrating Lymphocyte Grade Is an Independent Predictor of Sentinel Lymph Node Status and Survival in Patients With Cutaneous Melanoma. Journal of Clinical Oncology, 30(21), 2678-2683. [More Information]

2011

  • Svobodova, S., Browning, J., MacGregor, D., Pollara, G., Scolyer, R., Murali, R., Thompson, J., Deb, S., Azad, A., Davis, I., et al (2011). Cancer-testis antigen expression in primary cutaneous melanoma has independent prognostic value comparable to that of Breslow thickness, ulceration and mitotic rate. European Journal of Cancer, 47(3), 460-469. [More Information]
  • Prakoso, E., Fulham, M., Thompson, J., Selby, W. (2011). Capsule endoscopy versus positron emission tomography for detection of small-bowel metastatic melanoma: a pilot study. Gastrointestinal Endoscopy, 73(4), 750-756. [More Information]
  • Murali, R., Zannino, D., Synnott, M., McCarthy, S., Thompson, J., Scolyer, R. (2011). Clinical and Pathological Features of Metastases of Primary Cutaneous Desmoplastic Melanoma. Histopathology, 58(6), 886-895. [More Information]
  • Huismans, A., Kroon, H., Kam, P., Thompson, J. (2011). Does Increased Experience with Isolated Limb Infusion for Advanced Limb Melanoma Influence Outcome? A Comparison of Two Treatment Periods at a Single Institution. Annals of Surgical Oncology, 18(7), 1877-1883. [More Information]
  • Scolyer, R., Long, G., Thompson, J. (2011). Evolving concepts in melanoma classification and their relevance to multidisciplinary melanoma patient care. Molecular Oncology, 5(2), 124-136. [More Information]
  • Murali, R., Desilva, C., Thompson, J., Scolyer, R. (2011). Factors Predicting Recurrence and Survival in Sentinel Lymph Node-Positive Melanoma Patients. Annals of Surgery, 253(6), 1155-1164. [More Information]
  • Uren, R., Howman-Giles, R., Chung, D., Thompson, J. (2011). Guidelines for lymphoscintigraphy and F18 FDG PET scans in Melanoma. Journal of Surgical Oncology, 104(4), 405-419. [More Information]
  • Sanki, A., Kroon, H., Kam, P., Thompson, J. (2011). In brief. Current Problems in Surgery, 48(6), 366-369. [More Information]
  • Sanki, A., Kroon, H., Kam, P., Thompson, J. (2011). Isolated Limb Perfusion and Isolated Limb Infusion for Malignant Lesions of the Extremities. Current Problems in Surgery, 48(6), 371-430. [More Information]
  • Testori, A., Faries, M., Thompson, J., Pennacchioli, E., Deroose, J., Van Geel, A., Verhoef, C., Verrecchia, F., Soteldo, J. (2011). Local and intralesional therapy of in-transit melanoma metastase. Journal of Surgical Oncology, 104(4), 391-396. [More Information]
  • Spillane, A., Cheung, B., Winstanley, J., Thompson, J. (2011). Lymph Node Ratio Provides Prognostic Information in Addition to American Joint Committee on Cancer N Stage in Patients With Melanoma, Even If Quality of Surgery Is Standardized. Annals of Surgery, 253(1), 109-115. [More Information]
  • Schrama, D., Peitsch, W., Zapatka, M., Kneitz, H., Houben, R., Eib, S., Haferkamp, S., Moore, P., Shuda, M., Thompson, J., Scolyer, R., et al (2011). Merkel Cell Polyomavirus Status Is Not Associated with Clinical Course of Merkel Cell Carcinoma. The Journal of Investigative Dermatology, 131(8), 1631-1638. [More Information]
  • Turner, R., Bell, K., Morton, R., Hayen, A., Francken, A., Howard, K., Armstrong, B., Thompson, J., Irwig, L. (2011). Optimizing the Frequency of Follow-Up Visits for Patients Treated for Localized Primary Cutaneous Melanoma. Journal of Clinical Oncology, 29(35), 4641-4646. [More Information]
  • Thompson, J., Ollila, D. (2011). Optimum excision margins for melanoma. The Lancet, 378(9803), 1608-1610. [More Information]
  • Long, G., Menzies, A., Nagrial, A., Haydu, L., Hamilton, A., Mann, G., Hughes, T., Thompson, J., Scolyer, R., Kefford, R. (2011). Prognostic and Clinicopathologic Associations of Oncogenic BRAF in Metastatic Melanoma. Journal of Clinical Oncology, 29(10), 1239-1246. [More Information]
  • Thompson, J., Soong, S., Balch, C., Gershenwald, J., Ding, S., Coit, D., Flaherty, K., Gimotty, P., Johnson, T., Johnson, M., et al (2011). Prognostic Significance of Mitotic Rate in Localized Primary Cutaneous Melanoma: An Analysis of Patients in the Multi-Institutional American Joint Committee on Cancer Melanoma Staging Database. Journal of Clinical Oncology, 29(16), 2199-2205. [More Information]
  • Spillane, A., Haydu, L., McMillan, W., Stretch, J., Thompson, J. (2011). Quality Assurance Parameters and Predictors of Outcome for Ilioinguinal and Inguinal Dissection in a Contemporary Melanoma Patient Population. Annals of Surgical Oncology, 18(9), 2521-2528. [More Information]
  • Chmiel, K., Suan, D., Liddle, C., Nankivell (Nankievell), B., Ibrahim, R., Bautista, C., Thompson, J., Fulcher, D., Kefford, R. (2011). Resolution of Severe Ipilimumab-Induced Hepatitis After Antithymocyte Globulin Therapy. Journal of Clinical Oncology, 29(9), 237-240. [More Information]
  • Ross, M., Thompson, J., Gershenwald, J. (2011). Sentinel Lymph Node Biopsy for Melanoma: Critical Assessment at its Twentieth Anniversary. Surgical Oncology Clinics of North America, 20(1), 57-78. [More Information]
  • Nielsen, K., Chakera, A., Hesse, B., Scolyer, R., Stretch, J., Thompson, J., Nielsen, M., Uren, R., Oturai, P. (2011). The diagnostic value of adding dynamic scintigraphy to standard delayed planar imaging for sentinel node identification in melanoma patients. European Journal of Nuclear Medicine and Molecular Imaging, 38(11), 1999-2004. [More Information]
  • Damian, D., Thompson, J. (2011). Topical diphencyprone immunotherapy for a large primary melanoma on an elderly leg. American Journal of Clinical Dermatology, 12(6), 403-404. [More Information]
  • Verwer, N., Scolyer, R., Uren, R., Winstanley, J., Brown, P., de Wilt, J., Thompson, J. (2011). Treatment and Prognostic Significance of Positive Interval Sentinel Nodes in Patients with Primary Cutaneous Melanoma. Annals of Surgical Oncology, 18(12), 3292-3299. [More Information]
  • Testori, A., Verhoef, C., Kroon, H., Pennacchioli, E., Faries, M., Eggermont, A., Thompson, J. (2011). Treatment of melanoma metastases in a limb by isolated limb perfusion and isolated limb infusion. Journal of Surgical Oncology, 104(4), 397-404. [More Information]
  • Sunderland, N., Thomson, S., Heffernan, S., Lim, S., Thompson, J., Ogle, R., McKenzie, P., Kirwan, P., Makris, A., Hennessy, A. (2011). Tumor necrosis factor α induces a model of preeclampsia in pregnant baboons (Papio hamadryas). Cytokine, 56(2), 192-199. [More Information]
  • Thompson, J., Haydu, L., Sanki, A., Uren, R. (2011). Ultrasound assessment of lymph nodes in the management of early-stage melanoma. Journal of Surgical Oncology, 104(4), 354-360. [More Information]
  • Balch, C., Gershenwald, J., Soong, S., Thompson, J. (2011). Update on the melanoma staging system: the importance of sentinel node staging and primary tumor mitotic rate. Journal of Surgical Oncology, 104(4), 379-385. [More Information]
  • Fogarty, G., Morton, R., Vardy, J., Nowak, A., Mandel, C., Forder, P., Hong, A., Hruby, G., Burmeister, B., Shivalingam, B., Dhillon, H., Thompson, J. (2011). Whole brain radiotherapy after local treatment of brain metastases in melanoma patients - a randomised phase III trial. BMC Cancer, 11(142), 1-8. [More Information]

2010

  • Murali, R., Thompson, J., Scolyer, R. (2010). Can Histologic Parameters of Melanoma Metastases in Sentinel Lymph Nodes Reliably Select Patients Who Can Be Safely Spared Completion Lymph Node Dissection? Annals of Surgery, 251(6), 1188-9; author reply 1189-90. [More Information]
  • Attia, J., Thakkinstian, A., McElduff, P., Milne, E., Dawson, S., Scott, R., de Klerk, N., Armstrong, B., Thompson, J. (2010). Detecting genotyping error using measures of degree of Hardy-Weinberg disequilibrium. Statistical Applications in Genetics and Molecular Biology, 9(1), Article 5-1-Article 5-15. [More Information]
  • Guitera, P., Bourgeat, P., Stretch, J., Scolyer, R., Ourselin, S., Lean, C., Thompson, J., Bourne, R. (2010). Diagnostic value of 8.5 T magnetic resonance spectroscopy of benign and malignant skin lesion biopsies. Melanoma Research: a journal for basic, translational and clinical research in melanoma, 20(4), 311-317. [More Information]
  • Murali, R., Thompson, J., Uren, R., Scolyer, R. (2010). Fine-needle biopsy of metastatic melanoma: clinical use and new applications. Lancet Oncology, 11(4), 391-400. [More Information]
  • Moncrieff, M., Spira, K., Clark, J., Thompson, J., Clifford, A., O'Brien, C., Shannon, K. (2010). Free flap reconstruction for melanoma of the head and neck: indications and outcomes. Journal of Plastic, Reconstructive and Aesthetic Surgery, 63, 205-212. [More Information]
  • Reynolds, H., Walker, C., Dunbar, P., O'Sullivan, M., Uren, R., Thompson, J., Smith, N. (2010). Functional anatomy of the lymphatics draining the skin: a detailed statistical analysis. Journal of Anatomy, 216(3), 344-355. [More Information]
  • Waterworth, D., Ricketts, S., Song, K., Chen, L., Zhao, J., Ripatti, S., Aulchenko, Y., Zhang, W., Yuan, X., Lim, N., et al (2010). Genetic variants influencing circulating lipid levels and risk of coronary artery disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 30(11), 2264-2276. [More Information]
  • Scolyer, R., Murali, R., McCarthy, S., Thompson, J. (2010). Histologically Ambiguous ("Borderline") Primary Cutaneous Melanocytic Tumors - Approaches to Patient Management Including the Roles of Molecular Testing and Sentinel Lymph Node Biopsy. Archives of Pathology and Laboratory Medicine, 134(12), 1770-1777. [More Information]
  • Morton, R., Howard, K., Thompson, J. (2010). In Reply: Cost Effectiveness of Staging Procedures in Patients with Stage I/II Melanoma. Annals of Surgical Oncology, 17(2), 663-664. [More Information]
  • Kam, P., Thompson, J. (2010). Isolated limb infusion with melphalan and actinomycin D in melanoma patients: factors predictive of acute regional toxicity. Expert opinion on drug metabolism & toxicology, 6(9), 1039-45. [More Information]
  • Zhuang, L., Scolyer, R., Murali, R., McCarthy, S., Zhang, X., Thompson, J., Hersey, P. (2010). Lactate dehydrogenase 5 expression in melanoma increases with disease progression and is associated with expression of Bcl-XL and Mcl-1, but not Bcl-2 proteins. Modern Pathology, 23(1), 45-53. [More Information]
  • Murali, R., Thompson, J., Scolyer, R. (2010). Location of Melanoma Metastases in Sentinel Lymph Nodes: What are the Implications for Histologic Processing of Sentinel Lymph Nodes in Routine Practice? The American Journal of Surgical Pathology, 34(1), 127-129. [More Information]
  • Verwer, N., Murali, R., Winstanley, J., Cooper, W., Stretch, J., Thompson, J., Scolyer, R. (2010). Lymphoma occurring in patients with cutaneous melanoma. Journal of Clinical Pathology, 63(9), 777-781. [More Information]
  • Field, A., McKenzie, P., McLeod, D., Stretch, J., Thompson, J., Scolyer, R. (2010). Melanotic schwannoma mimicking metastatic pigmented melanoma: a pitfall in cytological diagnosis. Pathology, 42(3), 287-289. [More Information]
  • Balch, C., Gershenwald, J., Soong, S., Thompson, J., Ding, S., Byrd, D., Cascinelli, N., Cochran, A., Coit, D., Eggermont, A., et al (2010). Multivariate Analysis of Prognostic Factors Among 2,313 Patients With Stage III Melanoma: Comparison of Nodal Micrometastases Versus Macrometastases. Journal of Clinical Oncology, 28(14), 2452-2459. [More Information]
  • Murali, R., Desilva, C., Thompson, J., Scolyer, R. (2010). Non-Sentinel Node Risk Score (N-SNORE): A Scoring System for Accurately Stratifying Risk of Non-Sentinel Node Positivity in Patients With Cutaneous Melanoma With Positive Sentinel Lymph Nodes. Journal of Clinical Oncology, 28(29), 4441-4449. [More Information]
  • Soong, S., Ding, S., Coit, D., Balch, C., Gershenwald, J., Thompson, J., Gimotty, P. (2010). Predicting survival outcome of localized melanoma: an electronic prediction tool based on the AJCC Melanoma Database. Annals of Surgical Oncology, 17(8), 2006-2014. [More Information]
  • Balasuriya, H., Bell, P., Waugh, R., Thompson, J., Gillin, A., Hennessy, A., Makris, A. (2010). Primate maternal placental angiography. Placenta, 31(1), 32-36. [More Information]
  • Murali, R., Shaw, H., McCarthy, S., Quinn, M., Stretch, J., Thompson, J., Scolyer, R. (2010). Prognostic Factors in Cutaneous Desmoplastic Melanoma: A Study of 252 Patients. Cancer, 116(17), 4130-4138. [More Information]
  • Haydu, L., Holt, P., Karim, R., Madronio, C., Thompson, J., Armstrong, B., Scolyer, R. (2010). Quality of histopathological reporting on melanoma and influence of use of a synoptic template. Histopathology, 56(6), 768-774. [More Information]
  • Cadili, A., Dabbs, K., Scolyer, R., Brown, P., Thompson, J. (2010). Re-evaluation of a scoring system to predict nonsentinel-node metastasis and prognosis in melanoma patients. Journal of the American College of Surgeons, 211(4), 522-525. [More Information]
  • Christou, E., Damian, D., Thompson, J. (2010). Regressing metastatic melanoma and vitiligo-like depigmentation in an Indigenous Australian. Medical Journal of Australia, 192(3), 171. [More Information]
  • Wiener, M., Acland, K., Shaw, H., Soong, S., Li, H., Chen, D., Scolyer, R., Winstanley, J., Thompson, J. (2010). Sentinel Node Positive Melanoma Patients: Prediction and Prognostic Significance of Nonsentinel Node Metastases and Development of a Survival Tree Model. Annals of Surgical Oncology, 17(8), 1995-2005. [More Information]
  • Thompson, J., Morton, D., Balch, C., Ross, M. (2010). Surgical excision of distant melanoma metastases. In Balch C; Houghton A; Sober A; Soong S; Atkins M; Thompson J (Eds.), Cutaneous Melanoma, (pp. 603-627). United States: Quality Medical Publishing.
  • Cooper, C., Murali, R., Doubrovsky, A., Watson, G., McKenzie, P., Thompson, J., Scolyer, R. (2010). Synchronous and metachronous malignancies in patients with melanoma: a clinicopathologic study highlighting the role of fine-needle biopsy cytology and potential diagnostic pitfalls. Melanoma Research: a journal for basic, translational and clinical research in melanoma, 20(3), 203-211. [More Information]
  • Martiniuk, F., Damian, D., Thompson, J., Scolyer, R., Tchou-Wong, K., Levis, W. (2010). TH17 is involved in the remarkable regression of metastatic malignant melanoma to topical diphencyprone. Journal of Drugs in Dermatology: new methods and technology, 9(11), 1368-1372. [More Information]
  • Faries, M., Thompson, J., Cochrane, A., Elashoff, R., Glass, E., Mozzillo, N., Nieweg, O., Roses, D., Hoekstra, H., Karakousis, C., et al (2010). The Impact on Morbidity and Length of Stay of Early Versus Delayed Complete Lymphadenectomy in Melanoma: Results of the Multicenter Selective Lymphadenectomy Trial (I). Annals of Surgical Oncology, 17, 3324-3329.
  • Murali, R., Moncrieff, M., Hong, J., Cooper, C., Shingde, M., Samuel, D., Thompson, J., Scolyer, R. (2010). The Prognostic Value of Tumor Mitotic Rate and Other Clinicopathologic Factors in Patients with Locoregional Recurrences of Melanoma. Annals of Surgical Oncology, 17(11), 2992-2999. [More Information]
  • Cadili, A., Scolyer, R., Brown, P., Dabbs, K., Thompson, J. (2010). Total sentinel lymph node tumor size predicts nonsentinel node metastasis and survival in patients with melanoma. Annals of Surgical Oncology, 17(11), 3015-3020. [More Information]

2009

  • Thompson, J., Shaw, H., Sober, A. (2009). A history of melanoma: From Hunter to Milton. In Balch C; Houghton A; Sober A; Soong S; Atkins M; Thompson J (Eds.), Cutaneous Melanoma, (pp. 1-14). United States: Quality Medical Publishing.
  • Busam, K., Murali, R., Pulitzer, M., McCarthy, S., Thompson, J., Shaw, H., Brady, M., Coit, D., Dusza, S., Wilmott, J., Scolyer, R., et al (2009). Atypical Spitzoid Melanocytic Tumors With Positive Sentinel Lymph Nodes in Children and Teenagers, and Comparison With Histologically Unambiguous and Lethal Melanomas. American Journal of Surgical Pathology, 33(9), 1386-1395. [More Information]
  • McMasters, K., Wong, S., Tyler, D., Balch, C., Thompson, J. (2009). Axillary and epitrochlear lymph node dissection for melanoma. In Balch C; Houghton A; Sober A; Soong S; Atkins M; Thompson J (Eds.), Cutaneous Melanoma, (pp. 447-455). United States: Quality Medical Publishing.
  • Thompson, J., Fredericks, S., Taguchi, T., Sugarbaker, P., Picksley, S., Khayat, D., Hortobagyi, G., Allen-Mersh, T., Aigner, K. (2009). Basics of Oncology. Germany: Springer-Verlag.
  • Thompson, J., Scolyer, R., Kefford, R. (2009). Cutaneous melanoma in the era of molecular profiling. The Lancet, 374(9687), 362-365. [More Information]
  • Murali, R., Loughman, N., McKenzie, P., Watson, G., Thompson, J., Scolyer, R. (2009). Cytological features of melanoma in exfoliative fluid specimens. Journal of Clinical Pathology, 62(7), 638-643. [More Information]
  • Chakera, A., Hesse, B., Burak, Z., Ballinger, J., Britten, A., Caraco, C., Cochran, A., Cook, M., Drzewiecki, K., Scolyer, R., Thompson, J., Uren, R., et al (2009). EANM-EORTC general recommendations for sentinel node diagnostics in melanoma. European Journal of Nuclear Medicine and Molecular Imaging, 36(10), 1713-1742. [More Information]
  • Kroon, H., Lin, D., Kam, P., Thompson, J. (2009). Efficacy of repeat isolated limb infusion with melphalan and actinomycin D for recurrent melanoma. Cancer, 115(9), 1932-1940. [More Information]
  • Hare, D., Burger, F., Austin, C., Fryer, F., Grimm, R., Reedy, B., Scolyer, R., Thompson, J., Doble, P. (2009). Elemental bio-imaging of melanoma in lymph node biopsies. The Analyst, 134(3), 450-453. [More Information]
  • Orlow, I., Tommasi, D., Bloom, B., Ostrovnaya, I., Cotignola, J., Mujumdar, U., Busam, K., Jungbluth, A., Scolyer, R., Thompson, J., Armstrong, B., et al (2009). Evaluation of the Clonal Origin of Multiple Primary Melanomas Using Molecular Profiling. The Journal of Investigative Dermatology, 129(8), 1972-1982. [More Information]
  • Zhuang, L., Scolyer, R., Lee, C., McCarthy, S., Cooper, W., Zhang, X., Thompson, J., Hersey, P. (2009). Expression of glucose-regulated stress protein GRP78 is related to progression of melanoma. Histopathology, 54(4), 462-470. [More Information]
  • Moncrieff, M., Thompson, J., Stretch, J. (2009). Extended experience and modifications in the design and concepts of the keystone design island flap. Journal of Plastic Reconstructive & Aesthetic Surgery : JPRAS, 63, 1359-63. [More Information]
  • Kroon, H., Moncrieff, M., Kam, P., Thompson, J. (2009). Factors predictive of acute regional toxicity after isolated limb infusion with melphalan and actinomycin D in melanoma patients. Annals of Surgical Oncology, 16(5), 1184-1192. [More Information]
  • Lam, T., Uren, R., Scolyer, R., Shannon, K., Thompson, J. (2009). False-negative sentinel node biopsy because of obstruction of lymphatics by metastatic melanoma: the value of ultrasound in conjunction with preoperative lymphoscintigraphy. Melanoma Research, 19(2), 94-99. [More Information]
  • Balch, C., Gershenwald, J., Soong, S., Thompson, J., Atkins, M., Byrd, D., Buzaid, A., Cochran, A., Coit, D., Ding, S., et al (2009). Final Version of 2009 AJCC Melanoma Staging and Classification. Journal of Clinical Oncology, 27(36), 6199-6206. [More Information]
  • Narita, N., Tanemura, A., Murali, R., Scolyer, R., Huang, S., Arigami, T., Yanagita, S., Chong, K., Thompson, J., Morton, D., et al (2009). Functional RET G691S polymorphism in cutaneous malignant melanoma. Oncogene, 28(34), 3058-3068. [More Information]
  • Thompson, J., Morton, R. (2009). In Reply: Cost-Effectiveness of Sentinel Node Biopsy for Melanoma. Annals of Surgical Oncology, 16(10), 2962-2963. [More Information]
  • Murali, R., Cochran, A., Cook, M., Hillman, J., Karim, R., Moncrieff, M., Starz, H., Thompson, J., Scolyer, R. (2009). Interobserver reproducibility of histologic parameters of melanoma deposits in sentinel lymph nodes: implications for management of patients with melanoma. Cancer, 115(21), 5026-5037. [More Information]
  • Murali, R., Hughes, M., FitzGerald, P., Thompson, J., Scolyer, R. (2009). Interobserver Variation in the Histopathologic Reporting of Key Prognostic Parameters, Particularly Clark Level, Affects Pathologic Staging of Primary Cutaneous Melanoma. Annals of Surgery, 249(4), 641-647. [More Information]
  • Gershenwald, J., Thompson, J., Mozzillo, N., Balch, C. (2009). Intraoperative mapping and sentinel node technology in patients with melanoma. In Balch C; Houghton A; Sober A; Soong S; Atkins M; Thompson J (Eds.), Cutaneous Melanoma, (pp. 411-420). United States: Quality Medical Publishing.
  • Kroon, H., Lin, D., Kam, P., Thompson, J. (2009). Isolated limb infusion as palliative treatment for advanced limb disease in patients with AJCC stage IV melanoma. Annals of Surgical Oncology, 16(5), 1193-1201. [More Information]
  • Kroon, H., Thompson, J. (2009). Isolated limb infusion: A review. Journal of Surgical Oncology, 100(2), 169-77. [More Information]
  • Thompson, J., Kroon, H., Ross, M., Kam, P., Tyler, D., Beasley, G. (2009). Isolated limb intrusion for melanoma. In Balch C; Houghton A; Sober A; Soong S; Atkins M; Thompson J (Eds.), Cutaneous Melanoma, (pp. 541-560). United States: Quality Medical Publishing.
  • Kroon, H., Thompson, J., Hoekstra, H. (2009). Isolatie-infusie effectief bij melanoom en sarcoom: Goed alternate voor regionale isolatieperfusie met cytostatica [Isolated infusion effective in melanoma and sarcoma: Good alternative for regional isolated cytostatic perfusion]. Nederlands Tijdschrift voor Geneeskunde, 153(11), 508-514. [More Information]
  • Spillane, A., Winstanley, J., Thompson, J. (2009). Lymph node ratio in melanoma: A marker of variation in surgical quality? Cancer, 115(11), 2384-2387. [More Information]
  • Uren, R., Thompson, J., Coventry, B., Chatterton, B. (2009). Lymphoscintigraphy in patients with melanoma. In Balch C; Houghton A; Sober A; Soong S; Atkins M; Thompson J (Eds.), Cutaneous Melanoma, (pp. 387-413). United States: Quality Medical Publishing.
  • Kroon, H., Lin, D., Kam, P., Thompson, J. (2009). Major amputation for irresectable extremity melanoma after failure of isolated limb infusion. Annals of Surgical Oncology, 16(6), 1543-1547. [More Information]
  • Guminski, A., Thompson, J. (2009). Predicting response to IL-2 therapy for metastatic melanoma. Expert Review of Anticancer Therapy: an essential contribution to decision making in cancer care, 9(11), 1571-1575. [More Information]
  • Shingde, M., Buckland,, M., Busam, K., McCarthy, S., Wilmott, J., Thompson, J., Scolyer, R. (2009). Primary cutaneous Ewing sarcoma/primitive neuroectodermal tumour: a clinicopathological analysis of seven cases highlighting diagnostic pitfalls and the role of FISH testing in diagnosis. Journal of Clinical Pathology, 62(10), 915-919. [More Information]
  • Gershenwald, J., Balch, C., Soong, S., Thompson, J. (2009). Prognostic Factors and Natural History of Melanoma. In Balch Houghton, Sober, Soong (Eds.), Cutaneous Melanoma, (pp. 35-64). Missouri: Quality Medical Publishing.
  • Spillane, A., Cheung, B., Stretch, J., Scolyer, R., Shannon, K., Quinn, M., Saw, R., McCarthy, W., Thompson, J. (2009). Proposed quality standards for regional lymph node dissections in patients with melanoma. Annals of Surgery, 249(3), 473-480. [More Information]
  • Moncrieff, M., Thompson, J., Stretch, J. (2009). Reconstruction after wide excision of primary cutaneous melanomas: part I-the head and neck. The Lancet Oncology, 10(7), 700-708. [More Information]
  • Moncrieff, M., Thompson, J., Stretch, J. (2009). Reconstruction after wide excision of primary cutaneous melanomas: part II--the extremities. The Lancet Oncology, 10(8), 810-815. [More Information]
  • Karim, R., Li, W., Sanki, A., Colman, M., Yang, J., Thompson, J., Scolyer, R. (2009). Reduced p16 and increased cyclin D1 and pRb expression are correlated with progression in cutaneous melanocytic tumors. International Journal of Surgical Pathology, 17(5), 361-367. [More Information]
  • Kroon, H., Lin, D., Kam, P., Thompson, J. (2009). Safety and efficacy of isolated limb infusion with cytotoxic drugs in elderly patients with advanced locoregional melanoma. Annals of Surgery, 249(6), 1008-1013. [More Information]
  • Howman-Giles, R., Shaw, H., Scolyer, R., Murali, R., Wilmott, J., McCarthy, S., Uren, R., Thompson, J. (2009). Sentinel Lymph Node Biopsy in Pediatric and Adolescent Cutaneous Melanoma Patients. Annals of Surgical Oncology, Online(DOI: 10.1245/s10434-009-0657-4), 1-6. [More Information]
  • Balch, C., Morton, D., Gershenwald, J., McMasters, K., Nieweg, O., Powell, B., Ross, M., Sondak, V., Thompson, J. (2009). Sentinel node biopsy and standard of care for melanoma. Journal Of The American Academy Of Dermatology, 60(5), 872-875. [More Information]
  • Mocellin, S., Thompson, J., Pasquali, S., Montesco, M., Pilati, P., Nitti, D., Saw, R., Scolyer, R., Stretch, J., Rossi, C. (2009). Sentinel Node Status Prediction by Four Statistical Models Results From a Large Bi-Institutional Series (n=1132). Annals of Surgery, 250(6), 964-969. [More Information]
  • Martin, R., Murali, R., Scolyer, R., FitzGerald, P., Colman, M., Thompson, J. (2009). So-called "malignant blue nevus": a clinicopathologic study of 23 patients. Cancer, 115(13), 2949-2955. [More Information]
  • Sanki, A., Scolyer, R., Thompson, J. (2009). Surgery for melanoma metastases of the gastrointestinal tract: Indications and results. European Journal of Surgical Oncology, 35, 313-319. [More Information]
  • Sladden, M., Balch, C., Barzilai, D., Berg, D., Freiman, A., Handiside, T., Hollis, S., Lens, M., Thompson, J. (2009). Surgical excision margins for primary cutaneous melanoma. Cochrane Database of Systematic Reviews, 10.1002/14651858.CD004835.pub2(4), 1-33. [More Information]
  • Sanki, A., Uren, R., Moncrieff, M., Tran, K., Scolyer, R., Lin, H., Thompson, J. (2009). Targeted High-Resolution Ultrasound Is Not an Effective Substitute for Sentinel Lymph Node Biopsy in Patients With Primary Cutaneous Melanoma. Journal of Clinical Oncology, 27(22), 5614-5619. [More Information]
  • Morton, R., Craig, J., Thompson, J. (2009). The Role of Surveillance Chest X-Rays in the Follow-Up of High-Risk Melanoma Patients. Annals of Surgical Oncology, 16(3), 571-577. [More Information]
  • Morton, D., Cochran, A., Thompson, J., Sondak, V. (2009). The sentinel lymph node and regional melanoma micrometastases. In Balch C; Houghton A; Sober A; Soong S; Atkins M; Thompson J (Eds.), Cutaneous Melanoma, (pp. 373-386). United States: Quality Medical Publishing.
  • Reynolds, H., Smith, N., Uren, R., Thompson, J., Rod Dunbar, P. (2009). Three-dimensional visualization of skin lymphatic drainage patterns of the head and neck. Head and Neck, 31(10), 1316-1325. [More Information]
  • Damian, D., Shannon, K., Thompson, J. (2009). Topical diphencyprone immunotherapy for cutaneous metastatic melanoma. Australasian Journal of Dermatology, 50(4), 266-271. [More Information]

2008

  • Amersi, F., Terando, A., Goto, Y., Scolyer, R., Thompson, J., Tran, A., Faries, M., Morton, D., Hoon, D. (2008). Activation of CCR9/CCL25 in cutaneous melanoma mediates preferential metastasis to the small intestine. Clinical Cancer Research, 14(3), 638-645. [More Information]
  • Moncrieff, M., Martin, R., O'Brien, C., Shannon, K., Clark, J., Gao, K., McCarthy, W., Thompson, J. (2008). Adjuvant Postoperative Radiotherapy to the Cervical Lymph Nodes in Cutaneous Melanoma: Is There Any Benefit for High-Risk Patients? Annals of Surgical Oncology, 15(11), 3022-3027. [More Information]
  • Van Es, S., Colman, M., Thompson, J., McCarthy, S., Scolyer, R. (2008). Angiotropism is an Independent Predictor of Local Recurrence and In-transit Metastasis in Primary Cutaneous Melanoma. American Journal of Surgical Pathology, 32(9), 1396-403. [More Information]
  • Thompson, J., Mohacsi, P. (2008). Cancer in dialysis and renal transplant patients. In Morris P; Knechtle S (Eds.), Kidney Transplantation: Principles and Practice, (pp. 564-577). United States: Saunders Elsevier.
  • Thompson, J., Hersey, P., Wachter, E. (2008). Chemoablation of metastatic melanoma using intralesional Rose Bengal. Melanoma Research: a journal for basic, translational and clinical research in melanoma, 18, 405-411. [More Information]
  • Thompson, J., Armstrong, B., Barbour, A., Barnetson, R., Beanland, H., Beer, T., Brookshank, M., Burmeister, B., Butow, P., Clark, K., Conway, R., Damian, D., Frommer, M., Kefford, R., Lee, S., Mason, R., Mann, G., McCarthy, W., Menzies, S., Olver, I., Quinn, M., Saw, R., Shaw, H., Stretch, J., Barraclough, B., Holt, P., Reeve, T., et al (2008).
  • Beavis, A., Dawson, M., Doble, P., Scolyer, R., Bourne, R., Li, L., Murali, R., Stretch, J., Lean, C., Uren, R., Thompson, J. (2008). Confirmation of Sentinel Lymph Node Identity by Analysis of Fine-Needle Biopsy Samples Using Inductively Coupled Plasma-Mass Spectrometry. Annals of Surgical Oncology, 15(3), 934-940. [More Information]
  • Moncrieff, M., Scolyer, R., Thompson, J., Beavis, A., Uren, R., Stretch, J. (2008). Correct identification of a sentinel node postselective lymphadenectomy using antimony levels. Melanoma Research: a journal for basic, translational and clinical research in melanoma, 18(5), 365-366. [More Information]
  • Thompson, J., Kam, P. (2008). Current status of isolated limb infusion with mild hyperthermia for melanoma. International Journal of Hyperthermia, 24(3), 219-225. [More Information]
  • Murali, R., Loughman, N., McKenzie, P., Watson, G., Thompson, J., Scolyer, R. (2008). Cytologic Features of Metastatic and Recurrent Melanoma in Patients With Primary Cutaneous Desmoplastic Melanoma. American Journal of Clinical Pathology, 130(5), 715-723. [More Information]
  • Spillane, A., Saw, R., Tucker, M., Byth Wilson, K., Thompson, J. (2008). Defining lower limb lymphedema after inguinal or ilio-inguinal dissection in patients with melanoma using classification and regression tree analysis. Annals of Surgery, 248(2), 286-293. [More Information]
  • Chen, J., Hruby, G., Scolyer, R., Murali, R., Hong, A., FitzGerald, P., Pham, T., Quinn, M., Thompson, J. (2008). Desmoplastic neurotropic melanoma: a clinicopathologic analysis of 128 cases. Cancer, 113(10), 2770-2778. [More Information]
  • Francken, A., Thompson, J., Bastiaannet, E., Hoekstra, H. (2008). Detection of the first recurrence in patients with melanoma: three quarters by the patient, one quarter during outpatient follow-up. Nederlands Tijdschrift voor Geneeskunde, 152(10), 557-562. [More Information]
  • Doubrovsky, A., Scolyer, R., Murali, R., McKenzie, P., Watson, G., Lee, C., McLeod, D., McCarthy, W., Uren, R., Stretch, J., Saw, R., Thompson, J. (2008). Diagnostic Accuracy of Fine Needle Biopsy for Metastatic Melanoma and Its Implications for Patient Management. Annals of Surgical Oncology, 15(1), 323-332. [More Information]
  • Moncrieff, M., Shannon, K., Hong, A., Thompson, J. (2008). Dramatic reduction of chronic lymphoedema of the lower limb with sorafenib therapy. Melanoma Research, 18(2), 161-162. [More Information]
  • Karim, R., Scolyer, R., Li, W., Yee, V., McKinnon, J., Li, L., Uren, R., Lam, S., Beavis, A., Dawson, M., Thompson, J., et al (2008). False Negative Sentinel Lymph Node Biopsies in Melanoma May Result From Deficiencies in Nuclear Medicine, Surgery, or Pathology. Annals of Surgery, 247(6), 1003-1010. [More Information]
  • Murali, R., Thompson, J., Scolyer, R. (2008). Fine-needle biopsy as a diagnostic technique for metastatic melanoma. Expert Opinion on Medical Diagnostics, 2, 1-10.
  • Francken, A., Accortt, N., Shaw, H., Colman, M., Wiener, M., Soong, S., Hoekstra, H., Thompson, J. (2008). Follow-up schedules after treatment for malignant melanoma. British Journal of Surgery, 95(11), 1401-1407. [More Information]
  • Chung, D., Saw, R., Thompson, J. (2008). Guidelines for imaging in cutaneous melanoma. Nuclear Medicine Communications, 29(10), 877-879. [More Information]
  • Chung, D., Saw, R., Thompson, J. (2008). Imaging in cutaneous melanoma. Nuclear Medicine Communications, 29(10), 847-876. [More Information]
  • Moncrieff, M., Kroon, H., Kam, P., Stalley, P., Scolyer, R., Thompson, J. (2008). Isolated Limb Infusion for Advanced Soft Tissue Sarcoma of the Extremity. Annals of Surgical Oncology, 15(10), 2749-2756. [More Information]
  • Moncrieff, M., Bowen, F., Thompson, J., Saw, R., Shannon, K., Spillane, A., Quinn, M., Stretch, J. (2008). Keystone Flap Reconstruction of Primary Melanoma Excision Defects of the Leg-The End of the Skin Graft. Annals of Surgical Oncology, 15(10), 2867-2873. [More Information]
  • Collinson, F., Lam, T., Bruijn, W., de Wilt, J., Lamont, M., Thompson, J., Kefford, R. (2008). Long-term survival and occasional regression of distant melanoma metastases after adrenal metastasectomy. Annals of Surgical Oncology, 15(6), 1741-1749. [More Information]
  • Cochran, A., Thompson, J. (2008). Lymphatic mapping and sentinel node biopsy: the data unclouded by speculation. Archives of Dermatology, 144(5), 687-8; author reply 688-9. [More Information]
  • Warner, R., Quinn, M., Hruby, G., Scolyer, R., Uren, R., Thompson, J. (2008). Management of Merkel Cell Carcinoma: The Roles of Lymphoscintigraphy, Sentinel Lymph Node Biopsy and Adjuvant Radiotherapy. Annals of Surgical Oncology, 15(9), 2509-2518. [More Information]
  • Kroon, H., Moncrieff, M., Kam, P., Thompson, J. (2008). Outcomes Following Isolated Limb Infusion for Melanoma. A 14-Year Experience. Annals of Surgical Oncology, 15(11), 3003-3013. [More Information]
  • Gallagher, S., Thompson, J., Indsto, J., Scurr, L., Lett, M., Gao, B., Dunleavey, R., Mann, G., Kefford, R., Rizos, H. (2008). p16INK4a expression and absence of activated B-RAF are independent predictors of chemosensitivity in melanoma tumors. NeoPlasia: an international journal of oncology research, 10(11), 1231-1239. [More Information]
  • Scolyer, R., Murali, R., McCarthy, S., Thompson, J. (2008). Pathologic examination of sentinel lymph nodes from melanoma patients. Seminars in Diagnostic Pathology, 25(2), 100-111. [More Information]
  • Kam, P., Thompson, J. (2008). Pharmacokinetics of regional therapy: isolated limb infusion and other low flow techniques for extremity melanoma. Surgical Oncology Clinics of North America, 17(4), 795-804. [More Information]
  • Francken, A., Accortt, N., Shaw, H., Wiener, M., Soong, S., Hoekstra, H., Thompson, J. (2008). Prognosis and determinants of outcome following locoregional or distant recurrence in patients with cutaneous melanoma. Annals of Surgical Oncology, 15(5), 1476-1484. [More Information]
  • Shaw, H., Scolyer, R., Thompson, J. (2008). Prognostic significance of histopathological parameters in sentinel nodes of melanoma patients. Histopathology, 53(3), 345. [More Information]
  • Murali, R., Thompson, J., Scolyer, R. (2008). Sentinel lymph node biopsy for melanoma: aspects of pathologic assessment. Future Oncology, 4(4), 535-551. [More Information]
  • Thompson, J., Gershenwald, J., Uren, R., Mariani, G. (2008). Sentinel lymph node biopsy in cutaneous melanoma. In G. Marian, A. Giuliano & H. W. Strauss (Eds.), Radioguided Surgery, (pp. 92-110). United States of America: Springer.
  • Wiener, M., Damian, D., Thompson, J. (2008). Systemic phototoxicity following intralesional rose bengal for subcutaneous melanoma metastases. Dermatology, 216(4), 361-362. [More Information]
  • Karim, R., van den Berg, K., Colman, M., McCarthy, S., Thompson, J., Scolyer, R. (2008). The advantage of using a synoptic pathology report format for cutaneous melanoma. Histopathology, 52(2), 130-138. [More Information]
  • Morton, R., Howard, K., Thompson, J. (2008). The Cost-Effectiveness of Sentinel Node Biopsy in Patients with Intermediate Thickness Primary Cutaneous Melanoma. Annals of Surgical Oncology, Published Online DOI: 10.1245/s10434-008-0164-z, 1-12. [More Information]
  • Scolyer, R., Murali, R., Satzger, I., Thompson, J. (2008). The detection and significance of melanoma micrometastases in sentinel nodes. Surgical oncology, 17(3), 165-174. [More Information]
  • Thompson, J., Shaw, H., Scolyer, R. (2008). The Prognostic Significance of Isolated Immunohistochemically Positive Cells in Sentinel Lymph Nodes of Melanoma Patients. The American Journal of Surgical Pathology, 32(7), 1106-7; author reply 1107-8. [More Information]
  • Morton, D., Cochran, A., Thompson, J. (2008). The rationale for sentinel-node biopsy in primary melanoma. Nature clinical practice. Oncology, 5(9), 510-511. [More Information]
  • Thompson, J. (2008). The value of sentinel node biopsy in patients with primary cutaneous melanoma. Dermatologic Surgery, 34(4), 550-555. [More Information]
  • Lui, R., Brown, A., Wu, B., Lin, M., Thompson, J., Braet, F., Dyer, W., Lattimore, J., Macdonald, P., Adelstein, S., Dos Remedios, C. (2008). Use of Antibody Microarrays in the Analysis of Inflammation, Autoimmunity, Viral Infection, and Cancer Metastases. In J. E. Van Eyk and M. J. Dunn (Eds.), Clinical Proteomics: From Diagnosis to Therapy, (pp. 571-592). Weinheim: Wiley - V C H Verlag GmbH & Co. KGaA.

2007

  • Thompson, J., Scolyer, R., Kefford, R., Uren, R. (2007). (Letter to the Editor) Melanoma Management in 2007. Australian Family Physician, 36(7), 487-488. [More Information]
  • Kelly, J., McArthur, G., Wolfe, R., Thompson, J., Liu, W. (2007). A confusing message will not improve the detection of melanoma. Archives of Dermatology, 143, 806-807.
  • Thompson, J. (2007). Abdominal resectional surgery in metastatic melanoma. ANZ Journal of Surgery, 77(10), 813. [More Information]
  • Morton, D., Cochran, A., Thompson, J. (2007). Authors' response to a letter to the editor re: Sentinel node biopsy for early-stage melanoma. Annals of Surgery, 245(5), 828-829. [More Information]
  • Thompson, J., Hodi, F., Zhang, Y. (2007). Case records of the Massachusetts General Hospital. Case 2-2007. A 49-year-old woman with a pigmented lesion on the arm. The New England Journal of Medicine, 356(3), 285-292. [More Information]
  • Murali, R., Gershenwald, J., Cochran, A., Thompson, J. (2007). Clinical relevance of melanoma micrometastases in sentinel nodes: too early to tell. Annals of Oncology, 18(4), 806-8. [More Information]
  • Tan, K., Thompson, J., Arnold, C., McCarthy, S., Scolyer, R. (2007). Current perspectives on the pathologic diagnosis and reporting of melanocytic tumors. Giornale Italiano di Dermatologia e Venereologia, 142, 83-97.
  • Thompson, J., Menzies, S., Shaw, H., Kefford, R. (2007). Cutaneous melanoma/Authors' reply. The Lancet, 365(9476), 2004-2005.
  • Francken, A., Shaw, H., Accortt, N., Soong, S., Hoekstra, H., Thompson, J. (2007). Detection of First Relapse in Cutaneous Melanoma Patients: Implications for the Formulation of Evidence-Based Follow-up Guidelines. Annals of Surgical Oncology, 14(6), 1924-1933. [More Information]
  • Francken, A., Shaw, H., Thompson, J. (2007). Detection of second primary cutaneous melanomas. European Journal of Surgical Oncology, 34(5), 587-592. [More Information]
  • Murali, R., Doubrovsky, A., Watson, G., McKenzie, P., Lee, C., McLeod, D., Uren, R., Stretch, J., Saw, R., Thompson, J., Scolyer, R. (2007). Diagnosis of metastatic melanoma by fine-needle biopsy: analysis of 2,204 cases. American Journal of Clinical Pathology, 127(3), 385. [More Information]
  • Kelly, J., McArthur, G., Wolfe, R., Thompson, J., Liu, W. (2007). Fast-growing and slow-growing melanomas. Archives of Dermatology, 143, 803-804.
  • Raja, C., Graham, P., Rizvi, S., Song, E., Goldsmith, H., Thompson, J., Bosserhoff, A., Morgenstern, A., Apostolidis, C., Kearsley, J., Allen, B., et al (2007). Interim Analysis of Toxicity and Response in Phase 1 Trial of Systemic Targeted Alpha Therapy for Metastatic Melanoma. Cancer Biology and Therapy, 6(6), 846-852. [More Information]
  • Elliott, B., Scolyer, R., Suciu, S., Lebecque, S., Rimoldi, D., Gugerli, O., Musat, E., Sharma, R., Lienard, D., Keilholz, U., Thompson, J., et al (2007). Long-term protective effect of mature DC-LAMP+ dendritic cell accumulation in sentinel lymph nodes containing micrometastatic melanoma. Clinical Cancer Research, 13(13), 3825-3830. [More Information]
  • Sanki, A., Kam, P., Thompson, J. (2007). Long-term results of hyperthermic, isolated limb perfusion for melanoma: a reflection of tumor biology. Annals of Surgery, 245(4), 591-596. [More Information]
  • Reynolds, H., Dunbar, P., Uren, R., Thompson, J., Smith, N. (2007). Mapping melanoma lymphoscintigraphy data onto a 3D anatomically based model. Annals of Biomedical Engineering, 35(8), 1444-1457. [More Information]
  • Zhuang, L., Lee, C., Scolyer, R., McCarthy, S., Hersey, P., Thompson, J., Zhang, X. (2007). Mcl-1, Bcl-XL and Stat3 expression are associated with progression of melanoma whereas Bcl-2, AP-2 and MITF levels decrease during progression of melanoma. Modern Pathology, 20(4), 416-426. [More Information]
  • Murali, R., McCarthy, S., Thompson, J. (2007). Melanocytic nevus with focal atypical epithelioid components (clonal nevus) is a combined nevus. Journal Of The American Academy Of Dermatology, 56(5), 889-890. [More Information]
  • Jabbour, J., Cumming, R., Scolyer, R., Hruby, G., Thompson, J., Lee, S. (2007). Merkel Cell Carcinoma: Assessing the Effect of Wide Local Excision, Lymph Node Dissection, and Radiotherapy on Recurrence and Survival in Early-Stage Disease-Results From a Review of 82 Consecutive Cases Diagnosed Between 1992 and 2004. Annals of Surgical Oncology, 14(6), 1943-1952. [More Information]
  • Howman-Giles, R., Chung, D., Thompson, J. (2007). Metastatic occlusion of a lymphatic collecting vessel in a patient with cutaneous melanoma and clinically normal lymph nodes. Clinical Nuclear Medicine, 32(4), 312-313. [More Information]
  • Scolyer, R., Thompson, J. (2007). Primary melanoma of the lung. The American surgeon, 73(9), 937-938. [More Information]
  • Shaw, H., Scolyer, R., Thompson, J. (2007). Re: NM patients and SN. The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland, 5(5), 320. [More Information]
  • Sanki, A., Li, W., Colman, M., Karim, R., Thompson, J., Scolyer, R. (2007). Reduced expression of p16 and p27 is correlated with tumour progression in cutaneous melanoma. Pathology, 39(6), 551-557. [More Information]
  • Murali, R., Sharma, R., Thompson, J., Stretch, J., Lee, C., McCarthy, S., Scolyer, R. (2007). Sentinel Lymph Node Biopsy in Histologically Ambiguous Melanocytic Tumors With Spitzoid Features (So-Called Atypical Spitzoid Tumors). Annals of Surgical Oncology, 15(1), 302-309. [More Information]
  • Thompson, J., Shaw, H. (2007). Sentinel node mapping for melanoma: results of trials and current applications. Surgical Oncology Clinics of North America, 16, 35-54. [More Information]
  • Morton, D., Cochran, A., Thompson, J. (2007). Sentinel-node biopsy in melanoma. New England Journal of Medicine, 356, 419-420.
  • Tan, K., Moncrieff, M., Thompson, J., McCarthy, S., Shaw, H., Quinn, M., Li, L., Crotty, K., Stretch, J., Scolyer, R. (2007). Subungual Melanoma: A Study of 124 Cases Highlighting Features of Early Lesions, Potential Pitfalls in Diagnosis, and Guidelines for Histologic Reporting. American Journal of Surgical Pathology, 31(12), 1902-1912. [More Information]
  • Sassen, S., Shaw, H., Colman, M., Scolyer, R., Thompson, J. (2007). The Complex Relationships Between Sentinel Node Positivity, Patient Age, and Primary Tumor Desmoplasia: Analysis of 2303 Melanoma Patients Treated at a Single Center. Annals of Surgical Oncology, 15(2), 630-637. [More Information]
  • Scolyer, R., Thompson, J., Shaw, H., McCarthy, S. (2007). The importance of mitotic rate as a prognostic factor for localized primary cutaneous melanoma. Journal Of Cutaneous Pathology, 33(5), 395-396. [More Information]
  • Uren, R., Sanki, A., Thompson, J. (2007). The utility of ultrasound in patients with melanoma. Expert Review of Anticancer Therapy, 7(11), 1633-1642. [More Information]
  • Reynolds, H., Dunbar, P., Uren, R., Blackett, S., Thompson, J., Smith, N. (2007). Three-dimensional visualisation of lymphatic drainage patterns in patients with cutaneous melanoma. Lancet Oncology, 8(9), 806-812. [More Information]
  • Makris, A., Thornton, C., Thompson, J., Thomson, S., Martin, R., Ogle, R., Waugh, R., McKenzie, P., Kirwan, P., Hennessy, A. (2007). Uteroplacental ischemia results in proteinuric hypertension and elevated sFLT-1. Kidney International, 71(10), 977-984. [More Information]

2006

  • Thompson, J., Shaw, H. (2006). Benefits of sentinel node biopsy for melanoma: a review based on interim results of the first Multicenter Selective Lymphadenectomy Trial. ANZ Journal of Surgery, 76(3), 100-103. [More Information]
  • Francken, A., Fulham, M., Millward, M., Thompson, J. (2006). Detection of metastatic disease in patients with uveal melanoma using positron emission tomography. European Journal of Surgical Oncology, 32(7), 780-784. [More Information]
  • Thompson, J., McCarthy, S., Strutton, G., Elder, D. (2006). Incomplete biopsy of melanocytic lesions can impair the accuracy of pathological diagnosis. The Australasian Journal of Dermatology, 47(1), 71-3; author reply 74-5. [More Information]
  • Thompson, J., Shaw, H. (2006). Is sentinel lymph node biopsy appropriate in patients with thin melanomas: Too early to tell? Annals of Surgical Oncology, 13(3), 279-281.
  • Uren, R., Thompson, J., Howman-Giles, R., Chung, D. (2006). Lymphatic drainage-in patients with primary cutaneous melanoma - the role of lymphoscintigraphy in sentinel lymph node biopsy. Current Medical Imaging Reviews, 2(2), 261-270.
  • de Vries, E., Bray, F., Coebergh, J., Cerroni, L., RUITER, D., Elder, D., Thompson, J., Barnhill, R., van Muijen, G., Scolyer, R., et al (2006). Malignant melanoma: Introduction. In LeBoit P; Burg G; Weedon D; Sarasin A (Eds.), Pathology and Genetics of Skin Tumours, (pp. 52-65). Lyon: IARC Press.
  • Wong, S., Morton, D., Thompson, J., Gershenwald, J., Leong, S., Reintgen, D., Gutman, H., Sabel, M., Carlson, G., McMasters, K., et al (2006). Melanoma patients with positive sentinel nodes who did not undergo completion lymphadenectomy: a multi-institutional study. Annals of Surgical Oncology, 13(6), 809-816. [More Information]
  • Cochran, A., Morton, D., Thompson, J. (2006). Pathology-driven immediate lymphadenectomy for primary melanoma: Impact on staging, prognostication and outcome. United States and Canadian Academy of Pathology Annual Meeting 2006, United States: Nature Publishing Group.
  • Thompson, J., Bishop, J., Scolyer, R. (2006). Primary melanoma of the lung. In Derek Raghavan, Martin L Brecher and David H Johnson etal (Eds.), Textbook of Uncommon Cancer, (pp. 293-297). United States: John Wiley & Sons.
  • Makris, A., Thornton, C., Thompson, S., Thompson, J., Martin, R., McKenzie, P., Ogle, R., Waugh, R., Hennessy, A. (2006). Primate Uteroplacental Ischaemia results in proteinuric hypertension and elevated soluble Flt-1 (Sflt-1). Hypertension in Pregnancy, 25(Supplement 1), 13 O005-13.
  • Zhuang, L., Lee, C., Scolyer, R., McCarthy, S., Zhang, X., Thompson, J., Screaton, G., Hersey, P. (2006). Progression in melanoma is associated with decreased expression of death receptors for tumor necrosis factor-related apoptosis-inducing ligand. Human Pathology, 37(10), 1286-1294. [More Information]
  • Kohonen-Corish, M., Cooper, W., Saab, J., Thompson, J., Trent, R., Millward, M. (2006). Promoter hypermethylation of the O(6)-methylguanine DNA methyltransferase gene and microsatellite instability in metastatic melanoma. The Journal of Investigative Dermatology, 126(1), 167-171. [More Information]
  • Liu, W., Dowling, J., Murray, W., McArthur, G., Thompson, J., Wolfe, R., Kelly, J. (2006). Rate of growth in melanomas: characteristics and associations of rapidly growing melanomas. Archives of Dermatology, 142(12), 1551-1558. [More Information]
  • Thompson, J., Shaw, H. (2006). Re: Sydney Melanoma Unit patients in breach of multicentre selective lymphadenectomy trial protocol? ANZ Journal of Surgery, 76(11), 1039-1040. [More Information]
  • Byrne, C., Thompson, J. (2006). Role of electrochemotherapy in the treatment of metastatic melanoma and other metastatic and primary skin tumors. Expert Review of Anticancer Therapy, 6(5), 671-8. [More Information]
  • Morton, D., Thompson, J., Cochran, A., Mozzillo, N., Elashoff, R., Essner, R., Nieweg, O., Roses, D., Hoekstra, H., Karakousis, C., et al (2006). Sentinel-node biopsy or nodal observation in melanoma. New England Journal of Medicine, 355(13), 1307-1317.
  • Thompson, J., Shaw, H. (2006). Surgical management of melanoma: have we made any progress in 100 years? Cancer Forum, 30(2), 103-107.
  • Thompson, J., Scolyer, R., Uren, R. (2006). Surgical management of primary cutaneous melanoma: excision margins and the role of sentinel lymph node examination. Surgical Oncology Clinics of North America, 15(2), 301-18. [More Information]
  • Barton, M., Gabriel, G., Frommer, M., Holt, P., Thompson, J. (2006). Surgical procedures for melanoma in public and private New South Wales hospitals, 2001-2002. ANZ Journal of Surgery, 76(5), 318-324.
  • Shaw, H., Quinn, M., Scolyer, R., Thompson, J. (2006). Survival in patients with desmoplastic melanoma. Journal of Clinical Oncology, 24(8), e12-e12. [More Information]
  • Uren, R., Howman-Giles, R., Chung, D., Thompson, J. (2006). The clinical importance of lymphoscintigraphy for sentinel lymph node biopsy in melanoma and breast cancer. World Journal of Nuclear Medicine, 5(Supplement 1), S379-S382.
  • Uren, R., Howman-Giles, R., Chung, D., Morton, R., Thompson, J. (2006). The Reproducibility in Routine Clinical Practice of Sentinel Lymph Node Identification by Pre-operative Lymphoscintigraphy in Patients with Cutaneous Melanoma. Annals of Surgical Oncology, 14(2), 899-905. [More Information]
  • Li, W., Sanki, A., Karim, R., Thompson, J., Soon, L., Zhuang, L., McCarthy, S., Scolyer, R. (2006). The role of cell cycle regulatory proteins in the pathogenesis of melanoma. Pathology, 38(4), 287-301. [More Information]
  • Thompson, J., Howman-Giles, R., Chung, D. (2006). The role of lymphoscintigraphy in the detection of lymph node drainage in melanoma. Surgical Oncology Clinics of North America, 15(2), 285-300. [More Information]
  • Thompson, J., Uren, R., Shaw, H. (2006). Time for comprehensive reporting of MSLT-I -author reply. Lancet Oncology, 7(1), 11-12.
  • Damian, D., Barnetson, R., Thompson, J. (2006). Treatment of refractory chromomycosis by isolated limb infusion with melphalan and actinomycin D. Journal of Cutaneous Medicine and Surgery, 10(1), 48-51.

2005

  • van Poll, D., Thompson, J., Colman, M., McKinnon, J., Saw, R., Stretch, J., Scolyer, R., Uren, R. (2005). A sentinel node biopsy does not increase the incidence of in-transit metastasis in patients with primary cutaneous melanoma. Annals of Surgical Oncology, 12(8), 597-608. [More Information]
  • Zhuang, L., Lee, C., Scolyer, R., McCarthy, S., Palmer, A., Zhang, X., Thompson, J., Bron, L., Hersey, P. (2005). Activation of the extracellular signal regulated kinase (ERK) pathway in human melanoma. Journal of Clinical Pathology, 58(11), 1163-1169. [More Information]
  • Thompson, J., Stretch, J., McCarthy, S. (2005). Collaboration between clinicians and pathologists: a necessity for the optimal management of melanoma patients. Cancer Forum, 29, 76-81.
  • Thompson, J., Saw, R., Stretch, J. (2005). Current strategies for the surgical management of melanoma. Cancer Forum, 29(2), 81-86.
  • Thompson, J., Shaw, H., Scolyer, R., Kefford, R. (2005). Cutaneous melanoma - Reply. The Lancet, 365(9476), 2004-2005.
  • Thompson, J., Scolyer, R., Kefford, R. (2005). Cutaneous melanoma. The Lancet, 365(9460), 687-701. [More Information]
  • Scolyer, R., Thompson, J. (2005). Desmoplastic melanoma: a heterogeneous entity in which subclassification as pure" or "mixed" may have important prognostic significance.". Annals of Surgical Oncology, 12(3), 197-9. [More Information]
  • Francken, A., Hong, A., Fulham, M., Millward, M., McCarthy, W., Thompson, J. (2005). Detection of unsuspected spinal cord compression in melanoma patients by 18F-fluorodeoxyglucose-positron emission tomography. European Journal of Surgical Oncology, 31(2), 197-204. [More Information]
  • Bron, L., Scolyer, R., Thompson, J., Hersey, P. (2005). Histological expression of tumour necrosis factor-related apotosis-induced ligand (TRAIL) in human primary melanoma. Pathology, 36(6), 561-565. [More Information]
  • McKinnon, J., Starritt, E., Scolyer, R., McCarthy, W., Thompson, J. (2005). Histopathologic excision margin affects local recurrence rate: analysis of 2681 patients with melanomas < or =2 mm thick. Annals of Surgery, 241(2), 326-333. [More Information]
  • Bourne, R., Stanwell, P., Stretch, J., Scolyer, R., Thompson, J., Mountford, C., Lean, C. (2005). In vivo and ex vivo proton MR spectroscopy of primary and secondary melanoma. European Journal of Radiology, 53(3), 506-513. [More Information]
  • Orange, S., Rasko, J., Thompson, J., Vaughan, J., Olive, E., Pedler, M., Horvath, J., Hennessy, A. (2005). Interleukin-10 regulates arterial pressure in early primate pregnancy. Cytokine, 29(4), 176-185. [More Information]
  • Thompson, J., Uren, R., Stevens, G. (2005). Internal mammary node metastasis from primary cutaneous melanoma on the anterior chest. ANZ Journal of Surgery, 75(8), 723-5. [More Information]
  • Allen, B., Raja, C., Rizvi, S., Li, Y., Tsui, W., Graham, P., Thompson, J., Reisfeld, R., Kearsley, J. (2005). Intralesional targeted alpha therapy for metastatic melanoma. Cancer Biology and Therapy, 4(12), 1318-1324. [More Information]
  • Scolyer, R., Thompson, J., McCarthy, S., Gershenwald, J., Ross, M., Cochran, A. (2005). Intraoperative frozen-section evaluation can reduce accuracy of pathologic assessment of sentinel nodes in melanoma patients. Journal of the American College of Surgeons, 201(5), 821-3; author reply 823-4. [More Information]
  • de Wilt, J., Farmer, S., Scolyer, R., McCaughan, B., Thompson, J. (2005). Isolated melanoma in the lung where there is no known primary site: metastatic disease or primary lung tumour? Melanoma Research: a journal for basic, translational and clinical research in melanoma, 15(6), 531-537. [More Information]
  • Thompson, J., Uren, R. (2005). Lymphatic mapping in management of patients with primary cutaneous melanoma. Lancet Oncology, 6(11), 877-885. [More Information]
  • Stretch, J., Thompson, J., Scolyer, R., Mountford, C., Lean, C. (2005). Magnetic resonance spectroscopy in the management of melanoma. Cancer Forum, 29(2), 73-76.
  • Stretch, J., Somorjai, R., Bourne, R., Hsiao, E., Scolyer, R., Dolenko, B., Thompson, J., Mountford, C., Lean, C. (2005). Melanoma metastases in regional lymph nodes are accurately detected by proton magnetic resonance spectroscopy of fine-needle aspirate biopsy samples. Annals of Surgical Oncology, 12(11), 943-949. [More Information]
  • Scolyer, R., Li, L., McCarthy, S., Shaw, H., Stretch, J., Sharma, R., Thompson, J. (2005). Micromorphometric features of positive sentinel nodes predict involvement of non-sentinel nodes in patients. United States: Mosby.
  • Mansberg, R., Crawford, B., Uren, R., Thompson, J. (2005). Minimally invasive radio-guided surgery for recurrent thyroid cancer using iodine-123. Clinical Nuclear Medicine, 30(1), 43-44.
  • Yee, V., Thompson, J., McKinnon, J., Scolyer, R., Li, L., McCarthy, W., O'Brien, C., Quinn, M., Saw, R., Shannon, K., Stretch, J., Uren, R. (2005). Outcome in 846 cutaneous melanoma patients from a single center after a negative sentinel node biopsy. Annals of Surgical Oncology, 12(6), 429-439. [More Information]
  • Pawlik, T., Ross, M., Shaw, H., Thompson, J., Gershenwald, J. (2005). Re: Selective lymphadenectomy in sentinel node-positive patients may increase the risk of local/in-transit recurrence in malignant melanoma, Thomas and Clark. European Journal of Surgical Oncology, 31(3), 323-324. [More Information]
  • Uren, R., Howman-Giles, R., Thompson, J., Chung, D. (2005). Role of lymphoscintigraphy for selective sentinel lymphadenectomy. Cancer Treatment and Research, 127, 15-38. [More Information]
  • Thompson, J., Uren, R., Stretch, J., Scolyer, R. (2005). Selective sentinel lymphadenectomy: progress to date and prospects for the future. Cancer Treatment and Research, 127(Supplement), 269-287. [More Information]
  • Morton, D., Cochran, A., Thompson, J., Elashoff, R., Essner, R., Glass, E., Mozzillo, N., Nieweg, O., Roses, D., Hoekstra, H., et al (2005). Sentinel Node Biopsy for Early-Stage Melanoma Accuracy and Morbidity in MSLT-I, an International Multicenter Trial. Annals of Surgery, 242(3), 302-313. [More Information]
  • Pawlik, T., Ross, M., Thompson, J., Eggermont, A., Gershenwald, J. (2005). The risk of in-transit melanoma metastasis depends on tumor biology and not the surgical approach to regional lymph nodes. Journal of Clinical Oncology, 23(21), 4588-4590. [More Information]
  • Byrne, C., Thompson, J., Johnston, H., Hersey, P., Quinn, M., Hughes, M., McCarthy, W. (2005). Treatment of metastatic melanoma using electroporation therapy with bleomycin (electrochemotherapy). Melanoma Research: a journal for basic, translational and clinical research in melanoma, 15(1), 45-51. [More Information]
  • Starritt, E., Uren, R., Scolyer, R., Quinn, M., Thompson, J. (2005). Ultrasound examination of sentinel nodes in the initial assessment of patients with primary cutaneous melanoma. Annals of Surgical Oncology, 12(1), 18-23. [More Information]
  • Thompson, J., Shaw, H. (2005). Who should treat patients with primary melanoma? British Journal of Dermatology, 153(2), 459-460. [More Information]

2004

  • Balch, C., Soong, S., Atkins, M., Buzaid, A., Cascinelli, N., Coit, D., Fleming, I., Gershenwald, J., Houghton, A., et, A., Thompson, J. (2004). An Evidence-Based Staging System For Cutaneous Melanoma. CA-a Cancer Journal for Clinicians, 54(3), 131-149.
  • Scolyer, R., Thompson, J., Li, L., Beavis, A., Dawson, M., Doble, P., Soper, R., Uren, R., Stretch, J., Sharma, R., et al (2004). Antimony Concentrations In Nodal Tissue Can Confirm Sentinel Node Identity. Modern Pathology, 17(10), 1191-1197.
  • Scolyer, R., Zhuang, L., Palmer, A., Thompson, J., McCarthy, S. (2004). Combined Naevus: A Benign Lesion Frequently Misdiagnosed Both Clinically And Pathologically As Melanoma. Pathology, 36(5), 419-427.
  • Thompson, J., Scolyer, R. (2004). Cooperation Between Surgical Oncologists And Pathologists: A Key Element Of Multidisciplinary Care For Patients With Cancer. Pathology, 36(5), 496-503.
  • de Wilt, J., Thompson, J., Uren, R., Ka, V., Scolyer, R., McCarthy, W., O'Brien, C., Quinn, M., Shannon, K. (2004). Correlation Between Preoperative Lymphoscintigraphy And Metastatic Nodal Disease Sites In 362 Patients With Cutaneous Melanomas Of The Head And Neck. Annals of Surgery, 239(4), 544-552.
  • Thompson, J., Shaw, H. (2004). Cutaneous Melanoma In Childhood: Incidence And Prognosis. In John F Thompson, Donald L Morton, Bin BR Kroon (Eds.), Textbook of Melanoma, (pp. 379-386). London: Martin Dunitz.
  • Sarris, M., Scolyer, R., Konopka, M., Thompson, J., Harper, C., Lee, S. (2004). Cytoplasmic Expression Of Nm23 Predicts The Potential For Cerebral Metastasis In Patients With Primary Cutaneous Melanoma. Melanoma Research: a journal for basic, translational and clinical research in melanoma, 14(1), 23-27.
  • Fife, K., Colman, M., Stevens, G., Firth, I., Moon, D., Shannon, K., Harman, R., Petersen-Schaefer, K., Zacest, A., Besser, M., Milton, G., McCarthy, W., Thompson, J. (2004). Determinants Of Outcome In Melanoma Patients With Cerebral Metastases. Journal of Clinical Oncology, 22(7), 1293-1300.
  • Lindner, P., Thompson, J., de Wilt, J., Colman, M., Kam, P. (2004). Double Isolated Limb Infusion With Cytotoxic Agents For Recurrent And Metastatic Limb Melanoma. European Journal of Surgical Oncology, 30(4), 433-439. [More Information]
  • Scolyer, R., Thompson, J., Li, L., Beavis, A., Dawson, M., Doble, P., Ka, V., McKinnon, J., Soper, R., Uren, R., Shaw, H., Stretch, J., McCarthy, S. (2004). Failure To Remove True Sentinel Nodes Can Cause Failure Of The Sentinel Node Biopsy Technique: Evidence From Antimony Concentrations In False-Negative Sentinel Nodes From Melanoma Patients. Annals of Surgical Oncology, 11(Supplement 3), 174S-178S.
  • Bron, L., Scolyer, R., Thompson, J., Hersey, P. (2004). Histological Expression Of Tumour Necrosis Factor-Related Apoptosis-Inducing Ligand (Trail) In Human Primary Melanoma. Pathology, 36(6), 561-565.
  • Scolyer, R., Li, L., McCarthy, S., Shaw, H., Stretch, J., Sharma, R., Thompson, J. (2004). Immunohistochemical Stains Fail To Increase The Detection Rate Of Micrometastatic Melanoma In Completion Regional Lymph Node Dissection Specimens. Melanoma Research: a journal for basic, translational and clinical research in melanoma, 14(4), 263-268.
  • Bonenkamp, J., Thompson, J., de Wilt, J., Doubrovsky, A., de Faria Lima, R., Kam, P. (2004). Isolated Limb Infusion With Fotemustine After Dacarbazine Chemosensitisation For Inoperable Loco-Regional Melanoma Recurrence. European Journal of Surgical Oncology, 30(9), 1107-1112. [More Information]
  • Starritt, E., Joseph, D., McKinnon, J., Lo, S., de Wilt, J., Thompson, J. (2004). Lymphedema After Complete Axillary Node Dissection For Melanoma: Assessment Using A New, Objective Definition. Annals of Surgery, 240(5), 866-874.
  • Scolyer, R., Li, L., McCarthy, S., Shaw, H., Stretch, J., Sharma, R., Thompson, J. (2004). Micromorphometric Features Of Positive Sentinel Lymph Nodes Predict Involvement Of Nonsentinel Nodes In Patients With Melanoma. American Journal of Clinical Pathology, 122(4), 532-539.
  • Howman-Giles, R., Thompson, J., Chung, D., Uren, R. (2004). Nuclear Medicine Aspects Of Melanoma And Breast Lymphatic Mapping. Seminars in Oncology, 31(3), 338-348.
  • Scolyer, R., Thompson, J., Stretch, J., Sharma, R., McCarthy, S. (2004). Pathology Of Melanocytic Lesions: New, Controversial, And Clinically Important Issues. Journal of Surgical Oncology, 86(4), 200-211. [More Information]
  • Thompson, J., Stretch, J., Uren, R., Ka, V., Scolyer, R. (2004). Sentinel Node Biopsy For Melanoma: Where Have We Been And Where Are We Going? Annals of Surgical Oncology, 11(Supplement 3), 147S-151S.
  • Doubrovsky, A., De Wilt, J., Scolyer, R., McCarthy, W., Thompson, J. (2004). Sentinel Node Biopsy Provides More Accurate Staging Than Elective Lymph Node Dissection In Patients With Cutaneous Melanoma. Annals of Surgical Oncology, 11(9), 829-836.
  • Thompson, J., Shaw, H. (2004). Should Tumor Mitotic Rate and Patient Age, As Well As Tumor Thickness, be Used to Select Melanoma Patients for Sentinel Node Biopsy? Annals of Surgical Oncology, 11(3), 233-235.
  • Thompson, J., Scolyer, R., Dahlstrom, J., Jain, S. (2004). Spitz Naevus: Diagnostic Problems And Their Management Implications. Pathology, 36(5), 452-457.
  • Thompson, J., Morton, D. (2004). Surgical Treatment of Systemic Metastases: Rationale And Principles. In John F Thompson, Donald L Morton, Bin BR Kroon (Eds.), Textbook of Melanoma, (pp. 492-494). London: Martin Dunitz.
  • Allen, B., Raja, C., Rizvi, S., Li, Y., Tsui, W., Zhang, D., Song, E., Qu, C., Kearsley, J., Graham, P., Thompson, J. (2004). Targeted Alpha Therapy For Cancer. Physics in Medicine and Biology, 49(16), 3703-3712.
  • Thompson, J., Uren, R. (2004). Teaching Points On Lymphatic Mapping For Melanoma From The Sydney Melanoma Unit. Seminars in Oncology, 31(3), 349-356.
  • Thompson, J., Morton, D., Kroon, B. (2004). Textbook of Melanoma. London: Martin Dunitz.
  • Thompson, J., Shaw, H., Hersey, P., Scolyer, R. (2004). The History And Future Of Melanoma Staging. Journal of Surgical Oncology, 86(4), 224-235. [More Information]
  • Francken, A., Shaw, H., Thompson, J., Soong, S., Accortt, N., Azzola, M., Scolyer, R., Milton, G., McCarthy, W., Colman, M., et al (2004). The Prognostic Importance Of Tumor Mitotic Rate Confirmed In 1317 Patients With Primary Cutaneous Melanoma And Long Follow-Up. Annals of Surgical Oncology, 11(4), 426-433.
  • Shaw, H., Thompson, J. (2004). Validity of reported melanoma incidence rates in New Zealand. ANZ Journal of Surgery, 74(11), 1016-1017.

2003

  • Dawson, M., Doble, P., Beavis, A., Li, L., Soper, R., Scolyer, R., Uren, R., Thompson, J. (2003). Antimony by ICP-MS as a marker for sentinel lymphnodes in melanoma patients. The Analyst, 128(3), 217-219.
  • Li, L., Crotty, K., Palmer, A., Kril, J., Scolyer, R., Thompson, J., Li, L., McCarthy, S. (2003). Argyrophilic staining of nucleolar organizer region count and morphometry in benign and melignant melanocytic lesions. American Journal Of Dermatopathology, 25(3), 190-197.
  • McJannett, M., Butow, P., Tattersall, M., Thompson, J. (2003). Asking questions can help: development of a question prompt list for cancer patients seeing a surgeon. European Journal of Cancer Prevention, 12(5), 397-405.
  • Slater, M., Scolyer, R., Gidley-Baird, A., Thompson, J., Barden, J. (2003). Increased expression of apoptotic markers in melanoma. Melanoma Research: a journal for basic, translational and clinical research in melanoma, 13(2), 137-145.
  • Scolyer, R., Shaw, H., Thompson, J., Li, L., Colman, M., Lo, S., McCarthy, S., Palmer, A., Nicoll, K., Dutta, B., Stretch, J., et al (2003). Interobserver reproducibility of histopathologic prognostic variables in primary cutaneous melanomas. American Journal of Surgical Pathology, 27(12), 1571-1576.
  • Reintgen, D., Thompson, J., Gershenwald, J. (2003). Intraoperative mapping and sentinel node technology. In Balch Houghton, Sober, Soong (Eds.), Cutaneous Melanoma, (pp. 353-377). Missouri: Quality Medical Publishing.
  • Thompson, J., Kam, P., Lindner, P., de Wilt, J. (2003). Isolated limb infusion. In Balch Houghton, Sober, Soong (Eds.), Cutaneous Melanoma, (pp. 495-506). Missouri: Quality Medical Publishing.
  • Thompson, J., Uren, R., Coventry, B., Chatterton, B. (2003). Lymphoscintigraphy. In Balch Houghton, Sober, Soong (Eds.), Cutaneous Melanoma, (pp. 329-352). Missouri: Quality Medical Publishing.
  • Balch, C., Buzaid, A., Soong, S., Atkins, M., Cascinelli, N., Coit, D., Fleming, I., Gershenwald, J., Houghton, A., Kirkwood, J., Thompson, J., et al (2003). New TNM melanoma staging system: linking biology and natural history to clinical outcomes. Seminars in Surgical Oncology, 21(1), 43-52. [More Information]
  • Li, L., Scolyer, R., Ka, V., McKinnon, J., Shaw, H., McCarthy, S., Thompson, J. (2003). Pathologic Review of Negative Sentinel Lymph Nodes in Melanoma Patients With Regional Recurrence: A Clinicopathologic Study of 1152 Patients Undergoing Sentinel Lymph Node Biopsy. American Journal of Surgical Pathology, 27(9), 1197-1202.
  • Uren, R., Howman-Giles, R., Thompson, J. (2003). Patterns of lymphatic drainage from the skin in patients with melanoma*. The Journal of Nuclear Medicine, 44, 570-582.
  • McKinnon, J., Yu, X., McCarthy, W., Thompson, J. (2003). Prognosis for patients with thin cutaneous melanoma. Cancer, 98(6), 1223-1231. [More Information]
  • Gershenwald, J., Balch, C., Soong, S., Thompson, J. (2003). Prognostic factors and natural history. In Balch Houghton, Sober, Soong (Eds.), Cutaneous Melanoma, (pp. 25-54). Missouri: Quality Medical Publishing.
  • Schofield, P., Butow, P., Thompson, J., Tattersall, M., Beeney, L., Dunn, S. (2003). Psychological responses of patients receiving a diagnosis of cancer. Annals of Oncology, 14, 48-56.
  • Lean, C., Bourne, R., Thompson, J., Scolyer, R., Stretch, J., Li, L., Russell, P., Mountford, C. (2003). Rapid detection of metastatic melanoma in lymph nodes using proton magnetic resonance spectroscopy of fine needle aspiration biospy specimens. Melanoma Research: a journal for basic, translational and clinical research in melanoma, 13(3), 259-261.
  • Uren, R., Howman-Giles, R., Thompson, J. (2003). Reconfirmation of clinical unpredictability of lymphatic drainage in cutaneous melanoma and new developments in sentinel lymph node diagnostics. The Journal of Nuclear Medicine, 11, 1871-1872.
  • de Wilt, J., McCarthy, W., Thompson, J. (2003). Surgical treatment of splenic metastases in patients with melanoma. Journal of the American College of Surgeons, 197(1), 38-43.
  • Thompson, J., Shaw, H., Stretch, J., McCarthy, W., Milton, G. (2003). The Sydney Melanoma Unit - a multidisciplinary melanoma treatment center. Surgical Clinics of North America, 83(2), 431-451.
  • Azzola, M., Shaw, H., Thompson, J., Soong, S., Scolyer, R., Watson, G., Colman, M., Zhang, Y. (2003). Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma: An analysis of 3661 patients from a single center. Cancer, 97(6), 1488-1498. [More Information]
  • Li, L., Crotty, K., Scolyer, R., Thompson, J., Kril, J., Palmer, A., McCarthy, S. (2003). Use of multiple cytometric markers improves discrimination between benign and malignant melanocytic lesions: a study of DNA microdensitometry, karyometry, argyophilic staining of nucleolar organizer regions and MIBI1-Ki67 immunoreactivity. Melanoma Research: a journal for basic, translational and clinical research in melanoma, 13(6), 581-586.

2002

  • Coates, A., Thompson, J., McMullen, A., Simes, R., McCarthy, W., Hersey, P., Sillar, R., Mcleod, R., Gill, P., Coventry, B., Dhillon, H. (2002). Adjuvant Immunotherapy of Patients with High-Risk Melanoma Using Vaccinia Viral Lysates of Melanoma: Results of a Randomized Trial. Journal of Clinical Oncology, 20(20), 4181-4189.
  • Shaw, H., Thompson, J. (2002). Frequency of nonsentinel lymph node metastasis in melanoma. Annals of Surgical Oncology, 9(9), 934-934.
  • Tattersall, M., Butow, P., Brown, J., Thompson, J. (2002). Improving doctors' letters. Medical Journal of Australia, 177(4), 516-520.
  • Lindner, P., Doubrovsky, A., Kam, P., Thompson, J. (2002). Prognostic Factors After Isolated Limb Infusion With Cytotoxic Agents for Melanoma. Annals of Surgical Oncology, , 127-136.
  • Thompson, J., Balch, C., Soong, S., Buzaid, A. (2002). Prognostic Factors and Staging of Melanoma. In DeVita VT, Hellman S, Rosenberg SA, Jones (Eds.), Progress in Oncology 2002, (pp. 215-250). Massachusetts, USA: Staempfli Publishers Ltd.
  • Zacest, A., Besser, M., Stevens, G., Thompson, J., McCarthy, W., Culjak, G. (2002). Surgical management of cerebral metastases from melanoma: outcome in 147 patients treated at a single institution over two decades. Journal of Neurosurgery, 96(3), 552-558.
  • Thompson, J. (2002). The dye-plus-isotope technique. In Hiram S Cody III (Eds.), Sentinel Lymph Node Biopsy, (pp. 113-120). London, United Kingdom: Staempfli Publishers Ltd.
  • Thompson, J., Shaw, H. (2002). The Prognosis of Patients With Thick Primary Melanomas: Is Regional Lymph Node Status Relevant, and Does Removing Positive Regional Nodes Influence Outcome? Annals of Surgical Oncology, 9(8), 719-722.

2001

  • Thompson, J., Uren, R. (2001). Anomalous lymphatic drainage patterns in patients with cutaneous melanoma. Tumori: a journal of experimental and clinical oncology, 87.
  • Thompson, J., Balch, C., Buzaid, A., Soong, S., Atkins,, M., Cascinelli, N., Coit,, D., Fleming, I., Gershenwald, J., Houghton,, A., et al (2001). Final version of the american joint committee on cancer staging system for cutaneous melanoma. Journal of Clinical Oncology, 19, 3635-3648.
  • Beeney, L., Thompson, J., Butow, P., Tattersall, M., Dunn, S., Schofield, P. (2001). Hearing the bad news of a cancer diagnosis: the Australian melanoma patient's perspective. Annals of Oncology, 12, 365-371.
  • Thompson, J., Fife, K. (2001). Lymph-node metastases in patients with melanoma: what is the optimum management? Lancet Oncology, 2, 614-621.
  • Thompson, J., Uren, R. (2001). Lymphatic mapping and sentinel node biopsy for melanoma. Expert Review of Anticancer Therapy, 1, 446-452.
  • Thompson, J., Siebert, G., Anissimov, Y., Smithers, B., Doubrovsky, A., Anderson, C., Roberts, M. (2001). Microdialysis and response during regional chemotherapy by isolated limb infusion of melphalan for limb malignancies. British Journal of Cancer, 85 (2), 157-165.
  • Thompson, J., Roberts, M., Wu, Z., Siebert, G., Anissimov, Y., Smithers, B. (2001). Pharmacokinetics and pharmacodynamics of melphalan in isolated limb infusion for recurrent localized limb malignancy. Melanoma Research: a journal for basic, translational and clinical research in melanoma, 11(4), 423-431.
  • Thompson, J., Balch, C., Soong, S., Gershenwald, J., Reintgen, D., Cascinelli, N., Urist, M., McMasters, K., Ross, M., Kirkwod, J., et al (2001). Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System. Journal of Clinical Oncology, 19, 3622-3634.
  • Thompson, J., Roberts, M., Wu, Z., Siebert, G., Smithers, B. (2001). Saturable dose-response relationships for melphalan in melanoma treatment by isolated limb infusion in the nude rat. Melanoma Research: a journal for basic, translational and clinical research in melanoma, 11, 611-618.
  • Thompson, J. (2001). The sydney melanoma unit experience of sentinel lymphadenectomy for melanoma. Annals of Surgical Oncology, 8.
  • Barnetson, R., Rose, B., Thompson, J., Damian,, D., Bonenkamp, J. (2001). Treatment of refractory hand warts by isolated limb infusion with melphalan and actinomycin D. Australasian Journal of Dermatology, 42, 106-109.

2000

  • Uren, R., Howman-Giles, R., Thompson, J., McCarthy, W., Quinn, M., Roberts, J., Shaw, H. (2000). Interval nodes: The forgotten sentinel nodes in patients with melanoma. JAMA (formerly Archives Of Surgery), 135(10), 1168-1172.

To update your profile click here. For support on your academic profile contact .